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Abstract
This thesis deals with the development of microfluidic tools for the engineering of
enzymes of therapeutic interest. Droplet microfluidics has enormous potential in the field of
quantitative biology. We are developing microfluidic tools based on the directed evolution
of the enzyme L-asparaginase, an enzyme used to treat acute lymphoblastic leukemia. This
treatment is based on an enzyme of bacterial origin, which leads to immune reactions that
result in the interruption of treatment, often fatal for the patient. However, a human version of
the enzyme L-asparaginase, which is less immunogenic, is currently not sufficiently active to be
used. The main objective of this thesis is to analyze and screen enzyme mutant libraries using
standard mutagenesis methods and to analyze each mutant individually through microfluidics.
For this, several microfluidic systems have been developed and optimized for different selection
criteria for the analysis and selection of the enzyme L-asparaginase. The bacterial version
serving as a positive control for the optimization of microfluidic workflows to analyze and
screen mutant libraries of the human version of the enzyme L-asparaginase.
Key words : Droplet based microfluidic, directed evolution, enzymes, single cell
analysis, Surface acoustic waves.
——————————————————————————————————————-
Cette thèse concerne le développement d’outils microfluidique pour l’ingénierie d’enzymes
d’intérêt thérapeutique. La microfluidique à base de gouttelettes présente un énorme potentiel
dans le domaine de la biologie quantitative. Nous développons des outils microfluidiques
pour l’évolution dirigée de l’enzyme L-asparaginase, enzyme utilisée comme traitement de la
leucémie lymphoblastique aiguë. Ce traitement est basée sur une enzyme d’origine bactérienne,
ce qui conduit à déclencher des réactions immunitaires qui se traduit par l’interruption du
traitement, souvent fatale pour le patient. Cependant, une version humaine de l’enzyme
L-asparaginase, qui est moins immunogénique, n’est à l’heure actuelle pas suffisamment active
pour être utilisée. L’objectif principal de cette thèse est d’alors d’analyser et de cribler des ban-
ques de mutants d’enzymes en utilisant des méthodes classiques de mutagenèse et d’analyser
chaque mutant individuellement par le biais de la microfluidique. Pour cela, plusieurs sys-
tèmes microfluidiques ont été développés et optimisés afin de répondre à différents critères de
sélection pour l’analyse et la sélection de l’enzyme L-asparaginase. La version bactérienne
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a servi de contrôle positif pour l’optimisation des systèmes microfluidiques afin de pouvoir
analyser et de cribler des banques de mutants de la version humaine de l’enzyme L-asparaginase.
Mots clés: Microfluidique en gouttes, évolution dirigée, enzymes, analyses à l’échelle
de la cellule unique, onde acoustique de surface.
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Résumé du projet
0.1 Contexte du projet
Cette thèse concerne le développement d’outils microfluidique pour l’ingénierie d’enzymes
d’intérêt thérapeutique. La microfluidique à base de gouttelettes présente un énorme potentiel
dans le domaine de la biologie quantitative. Nous développons des outils microfluidiques
pour l’évolution dirigée de l’enzyme L-asparaginase, enzyme utilisée comme traitement de la
leucémie lymphoblastique aiguë. Ce traitement est basée sur une enzyme d’origine bactérienne,
ce qui conduit à déclencher des réactions immunitaires qui se traduit par l’interruption du
traitement, souvent fatale pour le patient. Cependant, une version humaine de l’enzyme
L-asparaginase, qui est moins immunogénique, n’est à l’heure actuelle pas suffisamment active
pour être utilisée. L’objectif principal de cette thèse est d’alors d’analyser et de cribler
des banques de mutants d’enzymes en utilisant des méthodes classiques de mutagenèse et
d’analyser chaque mutant individuellement par le biais de la microfluidique. Pour cela,
plusieurs systèmes microfluidiques ont été développés et optimisés afin de répondre à différents
critères de sélection pour l’analyse et la sélection de l’enzyme L-asparaginase. La version
bactérienne a servi de contrôle positif pour l’optimisation des systèmes microfluidiques afin
de pouvoir analyser et de cribler des banques de mutants de la version humaine de l’enzyme
L-asparaginase
0.2 La microfluidique en gouttes
Le development technologique a donné naissance à une miniaturisation des systems flu-
idiques par l’utilisation d’une nouvelle technique appelée la microfluidique. La microfluidique
consiste en l’étude des fluides à l’échelle microscopique.
En 1990, la microfluidique a connu un essor important afin de participer à l’avancée des
analyses biologiques et chimiques. Ce domaine bénéficie de beaucoup d’avantages comme la
réduction du volume de réactifs utilisé et donc une réduction des coûts de l’expérience.
Un sous-domaine intéressant de la microfluique est la microfluique en gouttes. Ce domaine
utilise des gouttes de l’ordre du micronmetre de diamètre comme microreacteurs. Ces gouttes
sont créés à des fréquences de l’ordre d’une centaine de kilo hertz et peuvent être manipulées
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des différentes manières dépendant de l’expérience considérée. Les gouttes peuvent être
produites, incubées, mixées, fusionnées, criblées sur une seule et même puce afin d’étudier
différentes applications.
0.3 Développement de plateformes microfluidiques
pour l’étude d’enzymes d’intérêt thérapeutique
Dans cette partie, nous présentons le développement de plateformes microfluidiques
pour ingénierie et l’analyse des enzymes utilisées dans le traitement thérapeutique. Quatre
plateformes et protocoles différents ont été établis et optimisés pour l’analyse à base de
gouttelettes à la résolution unicellulaire, en fonction du système optique développé. Chaque
plateformes possèdent ses propres caractéristiques et objectifs: deux d’entre elles sont dévelop-
pées pour détecter l’activité cinétique d’une enzyme au cours du temps et les deux autres
pour sélectionner une bibliothèque de variants d’enzyme en fonction des propriétés souhaitées.
Les quatre plateformes microfluidiques sont produites à l’aide des techniques classiques de
softlithographie, caractérisées par l’utilisation d’un profilomètre et optimisées pour l’analyse
de la cinétique enzymatique au l’échelle de la cellule unique. L’optimisation consiste à
encapsuler des cellules dans une émulsion monodisperse en utilisant un tensioactif, et la
résolution unicellulaire est obtenue en tenant compte de la distribution de la loi de Poisson.
Pour utiliser ces plateformes, une station optique basée sur la détection de fluorescence a
été utilisée. Cette station est composée de trois lasers, d’un ensemble de miroirs et de tubes
photomultiplicateurs, d’un microscope inversé, d’une caméra haute vitesse et d’une carte
d’acquisition de données. Un programme écrit sous le logiciel LabView fournit des données
des gouttes détectées passant par le point du laser, telles que l’intensité de fluorescence. Les
données sont ensuite post-traitées avec des scripts maison à l’aide du logiciel SciLab à partir
duquel la distribution de fluorescence est générée au cours du temps à l’aide d’histogrammes.
0.4 Systèmes microfluidique pour la détection de
l’activité enzymatique de l’asparaginase d’origine
bactérienne
Au travers de cette partie, les différent modules microfluidique développés dans la partie
précédente vont être utilisés afin d’étudier une enzyme appelée L-asparaginase. Cette enzyme
est utilisée dans le traitement de la leucémie lymphoblastique aiguë touchant majoritairement
des enfants de moins de 15 ans.
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Un traitement existe mais est basée sur l’enzyme L-asparaginase d’origine bactérienne, ce qui
conduit à déclencher des réactions immunitaires qui se traduit par l’interruption du traitement,
souvent fatale pour le patient. Cependant, une version humaine de l’enzyme L-asparaginase,
qui est moins immunogénique, n’est à l’heure actuelle pas suffisamment active pour être
utilisée.
Cette partie se concentre sur l’analyse de la version bactérienne de l’enzyme, E. coli L-
asparaginase, exprimée dans trois systèmes d’expression différents: en cytoplasmique où les
protéines sont sécrétées dans le cytoplasme, en display où les protéines sont situées dans la
membrane interne et en périplasmique où les protéines sont sécrétées dans le périplasme de
la cellule. Afin de réaliser cette étude, une première étape a été menée par l’utilisation d’un
lecteur de microplaques afin de visualiser l’évolution cinétique au cours du temps de ces trois
systèmes d’expressions. L’expression périplasmique est le système le plus rapide avec une
activité enzymatique maximale au bout de 12 minutes, suivi de l’expression en display avec
une détection maximale en 36 minutes, quant à l’expression cytoplasmique, aucun maximum
d’activité atteint après 1 heure d’expérience.
Une fois caractérisés, les trois systèmes sont étudiés à l’aide des plateformes microfluiques
développées. Dans un premier temps, la plateforme numéro 1 permettant de détecter une activ-
ité enzymatique sur puce en moins de 15 minutes est utilisée. Avec l’aide de cette plateforme,
seul deux systèmes d’expressions sont détectés comme attendu suite aux résultats en lecteur
microplaque. Ces deux expressions sont en display et en périplasmique. En conséquence, les
trois systèmes d’expressions sont étudiées au travers de la plateforme numéro 2. Cette dernière
permet de détecter l’activité enzymatique sur puce en 45 minutes. Les vecteurs périplasmique
et display atteignent leur maximum d’activité au travers de cette plateforme, ce qui n’est pas
le cas du système d’expression en cytoplasmique dont l’activité ne sort pas du bruit du fond.
Ainsi pour la suite des expériences, seulement les vecteurs en display et en périplasmique sont
d’intérêt pour ce projet. Mais nous allons utiliser majoritairement le système en périplasmique
sachant que son activité enzymatique est détectable deux fois plus rapidement que celle en
display.
Afin de pouvoir analyser et cribler des banques de mutants, un tri modèle a été effectué
à partir de la version bactérienne de l’enzyme en utilisant la plateforme développée numéro 3.
Cette plateforme permet un criblage rapide de banques. En effet, environ 106 variants sont
triés en 6 heures.
Au travers de ces résultats concluant, la suite du projet est donc d’optimiser la version
humaine de l’enzyme L’asparaginase afin de pouvoir analyser et cribler des banques de mutants
de cette version.
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0.5 Application des systèmes microfluidique pour
la détection de l’activité enzymatique de l’asparaginase
humaine
Au travers de cette partie, l’enzyme L-asparaginase hASNase3-DM1 a été étudiée.
Cette enzyme est une version humain de la L-asparaginase et appartient à la famille dite
Ntn-hydrolases. La caractéristiques majeure de cette famille est que les enzymes nécessitent
un clivage intramoléculaire afin de devenir actives.
L’enzyme hASNase3-DM1 possède une activité enzymatique 2300 fois inférieure à celle de E.
coli. Cependant, elle serait d’un intérêt pour le traitement contre la leucémie aigüe afin d’éviter
tous effets secondaires dû à l’origine bactérienne du traitement actuel. Afin de pouvoir obtenir
des variants de cette enzyme possédant de meilleures propriétés, l’ingénierie moléculaire a été
utilisée par des expériences d’évolution dirigée.
Deux systèmes microfluidiques intégrés, développés dans la partie précédente, ont été
utilisés dans cette étude. L’enzyme hASNase3-DM1 a été produite dans deux systèmes
d’expression, en display et en périplasmique, et des banques de mutant ont été crées à partir
de l’enzyme en périplasmique.
Nous avons démontré que l’activité enzymatique de l’enzyme en display et en périplasmique
n’est pas détectable parfaitement en gouttes dans les conditions de la cellule unique. Cependant,
cette version de l’enzyme n’est pas d’un grand intérêt pour le projet et la fluorescence des
différents systèmes d’expression est très légèrement plus élevée que le fond. Cette valeur
de fluorescence a donc été prise comme référence de fluorescence pour les expériences de tri
qui ont suivies. Durant ces expériences de criblage, quelques résultats intéressants ont été
montrés. Cependant, d’autre expériences doivent être réalisées afin de caractériser exactement
la biologie récupérée au cours des criblages, comme par example du séquençage.
0.6 Développement de nouveaux modules utilisant
des ondes acoustiques de surface
Un projet en collaboration avec le groupe du Pr. Thomas Franke à l’université de
Glasgow a vu le jour grâce à un financement obtenu par une bourse de l’université de Bordeaux
portant sur la mobilité et l’internationalisation des études doctorales. Le projet s’est déroulé
sur trois mois à l’université de Glasgow.
Ce project consiste à réaliser la fusion entre deux gouttes stabilisées par du tensioactif à l’aide
d’ondes acoustiques de surface. Les ondes acoustiques de surface sont des ondes acoustiques
qui se propagent le long de la surface d’une surface piézoélectrique, à l’échelle nanométrique
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et oscillant dans l’ordre du méga hertz. Les ondes acoustique de surface représentent une
alternative à l’électrocoalescence utilisée dans certain systèmes microfluidique.
Au cours de ce projet, différents systèmes microfluidiques pour coupler deux gouttes provenant
de la littérature ont été utilisés afin de pouvoir développer une plateforme intégrée regroupant
les point forts du couplage et le module de fusion par ondes acoustiques de surface. Au travers
de cette plateforme développée, deux effets de fusion ont été observés: fusion par la droite et
fusion par la gauche. Comme leur noms indiquent, on peut choisir dans quel sens un couple
de gouttes va être réaliser et fusionner.
Les résultats obtenus sont très encourageants mais représentent que des résultats préliminaires.
La fusion de gouttes a été démontrée dans plusieurs conditions: concentration en tensioactif,
vitesse de production des gouttes, changement des paramètres des ondes acoustics. De part
ses résultats, plusieurs caractéristiques physiques ont pu être démontrées, comme la formation
d’un téton à la surface en contact entre les gouttes, avant leur fusion.
La suite du projet consiste en l’amélioration des designs de puces afin de pouvoir réaliser à
plus grande vitesse la fusion de gouttes, d’avoir une gamme de variation de taille de gouttes
plus étendue, et ainsi une gamme plus riche en concentration en tensioactif. Ces améliorations
seraient d’un grand intérêt afin de pouvoir appliquer ce système de fusion de gouttes par ondes
acoustique de surface à des applications biologiques précises, comme par example, l’évolution
dirigée en gouttes.
0.7 Conclusion
Le but de cette thèse est le développement et l’utilisation de plates-formes microflu-
idiques intégrées pour l’analyse et l’évolution d’une enzyme d’intérêt thérapeutique.
Dans les quatre premiers chapitres, l’enzyme L-asparaginase est détectée, analysée et criblée
via les plateformes microfluidiques développées. Ces plateformes ont été validées pour les
variants enzymatiques actifs avec l’enzyme L-asparaginase de type E. coli, ainsi que pour
les variants de faible activité avec la souche humaine de l’enzyme L-asparaginase. Pour
optimiser ces platesformes, trois vecteurs d’expression de l’enzyme sont produits, utilisés et
comparés: les expressions cytoplasmiques, en display et périplasmiques. Nous avons utilisé
l’enzyme E. coli L-asparaginase en tant que contrôle positif. Comme étape de validation,
l’activité enzymatique est détectable dans les gouttelettes monodisperses pour l’affichage
et les expressions périplasmiques, tandis que pour l’activité enzymatique dans l’expression
cytoplasmique, elle ne sort pas de l’arrière-plan. Nous devons prendre en compte le fait
que pour détecter une activité au sein de l’expression cytoplasmique, une étape de lyse doit
être effectuée à l’intérieur des gouttelettes afin de pouvoir détecter l’activité enzymatique.
Par conséquent, l’expression en display et en périplasmique sont les expressions les mieux
appropriées pour l’analyse de l’enzyme L-asparaginase humaine, pour des raisons pratiques.
Sur la base de ces validations, nous en sommes maintenant à une étape où les bibliothèques
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peuvent être systématiquement analysées et criblées, une étape importante pour la découverte
de médicaments.
Les résultats du dépistage de l’enzyme L-asparaginase humaine présentés au chapitre 4 sont
prometteurs. Bien qu’aucun mutant n’ait encore été clairement identifié, la méthode de
criblage est en cours d’exécution et entièrement optimisée. Les outils microfluidiques sont
développés et préparés à base d’électrocalescence ou d’ondes acoustiques de surface pour tous
les défis.
De plus, de nouveaux modules microfluidiques à base de gouttelettes ont été développés,
basés sur les ondes acoustiques de surface, comme alternative à l’électrocoalescence. Les
résultats préliminaires obtenus fournissent des analyses prometteuses théoriquement et expéri-
mentalement. Une paire de gouttelettes est fusionnée par des ondes acoustiques de surface à la
demande, déclenchées par une détection de fluorescence. Ces résultats peuvent être appliqués
à des expériences biochimiques générales, telles que la fusion de deux gouttes pour déclencher
une réaction. Ces modules pourraient fournir de nouvelles options pour la manipulation des
gouttelettes, allant au-delà des capacités actuelles de la microfluidique à base de gouttelettes.
Les résultats préliminaires doivent être améliorés avec une amélioration de la conception de la
plateforme microfluidique afin de contribuer à une fusion à haut débit et d’appliquer cette
plate-forme à des expériences biologiques.
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Introduction
Droplet based microfluidics provides tools for the encapsulation of biological compounds
such as cells, proteins or DNA and provides a high potential in biochemical applications. The
ability to parallelize and automatize the assays is a key properties in several applications, such
as in drug screening applications by providing reliable and statistically relevant measurements
for discovering new drugs. In addition, the microfluidics capabilities are used to design new
strategies for experimental tests for the detection and analysis of biological materials. For
molecular diagnostics, several groups have shown that the sensitivity detection of mutant
DNA sequences can be increased by more than three orders of magnitude using droplets as
microreactors which provides new tools for the detection of cancer in patients in early stages,
for example. Another area of interest for droplet-based microfluidics is the possibility to
screen specific variants in population at very high speed. The microfluidic tools are therefore
used for directed evolution and protein engineering and large libraries of mutants are selected
and screened for their improved properties.
Aim of my project
During my thesis, I developed and used integrated droplet-based microfluidics platforms
for the study of an enzyme of therapeutical interest, called L-asparaginase. This enzyme is
used in the treatment of Acute Lymphoblastic Leukemia (ALL) cancer. This treatment is
based on an enzyme of bacterial origin, leading to immune reactions from some hosts organism,
thereby leading to the interruption of the treatment. There is then no further therapeutic
solution. However, a human version of the enzyme L-asparaginase exists. This version is
potentially much less immunogenic. But currently it is not sufficiently active to be used.
Based on the directed evolution of the human enzyme L-asparaginase, an improvement of this
catalytic properties could be achieved: this is our goal.
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The development of the microfluidic modules used during my thesis is described in the
Chapter 2. I performed a complete analysis of the kinetic enzymatic activity of several strains
of this enzyme expressed in two organisms: bacterial (E. coli) and human. To determine the
enzymatic activity, a fluorogenic assay based on the natural substrate of the L-asparaginase
designed at the Max Plank Institute in Goettingen by the group of Manfred Konrad. Once
the kinetic evolution determined, directed evolution assays was performed with the human
L-asparagine to create libraries of mutants. The libraries are then screened onto microfluidic
modules to select the mutants with improved properties based on an evolution of fluorescence
for the enzymatic activity. The results of those analysis are shown in Chapter 3 for the study
of the E. coli L-asparaginase, and in Chapter 4 for the human version. This work was done in
collaboration with an another PhD student, Mickaël Morvan, who was mainly in charge of
the biological aspect.
The developed microfluidic modules are based on fluorescence detection for directed evo-
lution assays and operate under electrocoalescence using electric field. An another approach is
developed in this thesis and consists on the development of new microfluidic modules based on
surface acoustic waves as an alternative to electric field. The Chapter 5 represents preliminary
results for the merging of selected stabilized droplets using this technique, merging selected
by fluorescence detection. This work was made at the University of Glasgow in the group of
Pr. Thomas Franke.
This work was funded by the Region Aquitaine (Chaire d’accueil: JCB laboratory)
and by the French Government Investments for the Future Programme, University of Bor-
deaux Initiative of Excellence (IDEX Bordeaux) [Reference Agence Nationale de la Recherche
(ANR)-10-IDEX-03-02] through a senior chair (Jean-Christophe Baret). The Idex Bordeaux
has also founded a three months internship in the laboratory of Prof. Thomas Franke in the
framework of the program "Mobilité, Internationalisation des études doctorales 2017".
This work was also supported by the Max Planck Society through our extensive collaboration
with the laboratory of Manfred Konrad on the biochemical aspects of the project.
We thank emulseo (www.emulseo.com) for providing the surfactant used in this work.
Emulseo commercializes formulations for droplet-based microfluidics and was created as a
spin-off of the SMS lab in September 2018.
14
1C
h
a
p
t
e
r
Droplet-based microfluidics as a tool in
biotechnology
Microfluidics is the study of fluid flow at the sub millimeter scale. It took off in the
1990’s thanks to the MEMS technology (Micro Electro Mechanical System). Over the past
15 years, microfluidics offered a tremendous technological breakthrough for the scientific
community as a means to miniaturize classical chemical and biological assays ([Whitesides,
2006]). The benefits worth mentioning consists in the fact that the volumes of reagents are
reduced, meaning less waste of products and lower costs. In essence, microfluidics is a high
throughput technology, increasing the rate at which assays are performed, improving their
accuracy, and reducing their costs.
Many interesting developments in the microfluidic field have emerged. The most
relevant for this PhD is droplet-based microfluidics, providing essential tools to miniaturize
and automatize biochemical assays in emulsion droplets. This field allows for the study of
compartmentalization of fluids at low volumes (picoliter range usually), providing microreactors
which can be individually manipulated. Fundamental and applied research in physics, chemistry
and biology benefits from huge opportunities provided by droplet-based microfluidic systems.
Indeed, picoliter droplets allow approximately 106 fold reduction in reaction volume compare
to 96-wells microtiter plate, the golden standard for industrial screening.
Droplet-based microfluidics consists in controlling monodisperse droplets in an oil phase
(water in oil emulsion) within microchannels. The droplets are produced with a very high
monodispersity, they can be manipulated at the single droplet level and at a very high-
throughput: they are produced, fused, injected, incubated and sorted at kHz frequencies.
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1.1 Physics of miniaturization
Theoretical microfluidics at the micron scale is based on continuous fluid mechanics of
immiscible liquids in submillimeter-sized systems. The book written by Henrik Bruss provides
the essential compilation of theoretical concepts of relevance for microfluidic systems ([Henrik,
2008]).
Fluid flow characteristics at the microscale are substantially different to those at the
macroscale counterpart. By analyzing the physical properties, using simple scaling argument,
we obtain that when the length scale decrease, body forces like gravity lose their significance
and surface forces such as interfacial forces become dominant. The gravity force acting on a
volume of fluid V reads F = mg = ρVg while the interfacial force scale as F = γS. The ratio
of both is given by the equation 1.1:
ρR3g
γR2
=
ρgR
γ
(1.1)
This ratio is a dimensionless number called the Bond Number Bo: Bo = ρgR/γ. For
small Bo, interfacial forces dominate which is the case when R decreases at fixed fluid properties
(ρ, g, γ): in microfluidics, we will neglect body forces and consider only interfacial forces.
1.1.1 Reynolds number
Within microfluidic systems, fluid flows are governed by the Navier-Stokes equation
(equation 1.2):
ρ(
∂u
∂t
+ u.∇u) = −∇p+ µ∇2u+ f (1.2)
To characterize those flows, several key dimensionless parameters are used for example,
to analyze the droplet breakup as detailed in the litterature ([Christopher and Anna, 2007],
[Teh et al., 2008], [Baroud et al., 2010], [Seemann et al., 2012], [Lagus and Edd, 2013], [Zhu
and Wang, 2017]).
The Reynolds number, Re is an important dimensionless number in fluid mechanics
used for the prediction of flow patterns by correlating the inertia forces to the viscous forces.
It allows identifying the laminar or turbulent flow regimes (figure 1.1). The Reynolds number
was first described by Reynolds in 1883 and is expressed as the equation 1.3. This number
is introduced by the analysis of the Navier Stokes equation by comparing the weight of the
steady non linear term ρ(v.∇)v to the viscous terme µδu.
Re =
ρνl
µ
(1.3)
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where ρ is the density (kg.m−3), ν is the velocity (m2.s−1), µ is the dynamic viscosity
(kg.m−1.s−1) and l is the characteristic dimension of the system (m).
(a) Laminar flow (Re  1). (b) Turbulent flow (Re  1).
Figure 1.1: Flow characteristics inside a microchannel. (A)Laminar
flow. (B)Turbulent flow.
The turbulent regime is characterized by a Reynolds number Re  1 where the inertial
forces dominate and the laminar flow by a Reynolds number Re  1 where the viscous forces
dominate.
The flows in microfluidic channels are characterized by low values of the Reynolds number.
Indeed, the microfluidic channels are in the order to 100µm2 and depending on the viscosity
of fluids, the Reynolds number in microfluidic channels is generally inferior to 1, leading to a
laminar regime for the liquid phase flow. Therefore, the flows are stable and the flow lines are
well defined, as seen is figure 1.1a, and the Navier Stokes equation is reduced to the linear
Stokes equation (equation 1.4):
−∇p+ µ∇2u+ f = 0 (1.4)
where p is the pressure, µ the viscosity, u the mean velocity and f the body forces.
Although, Re > 1 can however be obtained in microchannels. Therefore, the assumption
that inertial is negligible does not always hold.
1.1.2 Capillary number and Weber number
One of the characteristic aspect of microfluidics is the dominance of surface effects (Bo
 1) at the micrometer scale. The balance between the flow properties and interfacial tension
forces of the aqueous phase is quantified by the Capillary number and the Weber number.
For Reynolds number  1, meaning that viscous forces dominate over inertia, a
dimensionless number comparing the viscous forces to surface tension is introduced. The
capillary number Ca is then introduced in processes where shear stress is applied on surface,
such as in droplet production. The Capillary number is expressed by the equation 1.5):
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Ca =
µu
σ
(1.5)
where µ is the oil fluid viscosity (kg.m−1.s−1), u is the mean fluid velocity (m.s−1) and σ is
the interfacial tension between the two immiscible fluids (N.m−1).
When inertial forces are not negligible, the Weber number, We, is introduced and
expressed by the equation 1.6. It is a measure of the relative importance of the fluid’s inertia
compared to its surface tension. This number is paired to the Capillary number since by doing
the ratio between the Weber number and the Capillary number, the result is the Reynolds
number.
We =
ρu2Dh
σ
= Re×Ca (1.6)
where ρ represent the aqueous fluid density (kg.m−3), u the mean velocity (m.s−1), Dh
the channel hydraulic diameter (m) and σ the interfacial tension between the two immiscible
fluids (N.m−1).
These numbers are crucial for droplet production. By plotting the aqueous phase Weber
number according to the oil-phase capillary number, it provides a drop formation regime map
and highlights the critical Weber and Capillary numbers marking the transition from steady
drops to jetting ([Utada et al., 2007]). From this map and within microfluidic channels, to
produce monodisperse emulsion, the system needs to work at small aqueous and oil flow rates
(We  1 and Ca  1).
1.1.3 Peclet number
Within the laminar flow regime, the mixing by diffusion is slow compared to convection
mixing. To characterize this phenomenon, the ratio of the rate of diffusion transport (equation
1.7) to the rate of convection transport (equation 1.8) is introduced as the Peclet number Pe
(equation 1.9).
τdiffusion =
l2
D
(1.7) τconvection =
u
l
(1.8) Pe = lu
D
(1.9)
where l is a characteristic length (m), u is the local flow velocity (m.s−1) and D is the
mass diffusion coefficient (m2.s−1).
For high Peclet numbers, τconvection  τdiffusion and thus convection happen faster
than diffusion. As for low Peclet numbers τdiffusion  τconvection and thus diffusion is the
dominating phenomenon.
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1.1.4 Miniaturization within microfluidic channels
To summurize, within microfluidic channels interfacial and visocous forces are dominant
meaning that flows are characterized by a Bond and Reynolds numbers of Bo  1 and Re ≤
1. For the formation of droplets inside those channels, a combinaison of the Capillary and
Weber numbers is needed. Indeed, to produce droplets, those two numbers must be high (Ca
≥ 1, We ≥ 1) while for manipulate droplets those numbers are low (Ca ≤ 1, We ≤ 1). As for
the mixing occuring inside those microfluidic channels, it occurs by diffusion therefore the
Peclet number is low (Pe  1).
1.2 Droplet-based microfluidics
Droplet-based microfluidics is an emerging technology based on hydrodynamics princi-
ples, fluids are handled in a precise and reliable manner providing essential tools to miniaturize
and automatize biochemical assays. It consists in controlling monodisperse droplets of water
in an oil phase (w/o: water in oil droplets) within microchannels and picoliter-volume droplets
are produced at kilohertz rate. The generation of droplets is a complex dynamical process
depending on shear stress tending to draw the fluids along the channel and surface forces
acting towards the droplet formation to minimize the surface tension ([Joanicot and Ajdari,
2005]).
Droplets formed within microfluidic channels serve as microreactors containing different
chemical or biological compound, allowing massive numbers of independent reactions to be
performed rapidly using a minimal amount of total reagent.
Microdroplets are typically generated by two microfluidic geometries, the T-junction and
flow-focusing junction. To form droplets a dispersed and aqueous phases are needed with the
continuous phase flow rate has the greatest impact on the droplet size and on the mechanism
of formation inside microfluidics channels. Abate et al ([Abate et al., 2009]) studied the
impact of inlet channel geometry on droplet formation as seen in figure 1.2.
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Figure 1.2: Schematics of drop makers with different inlet channel
geometries. The drop maker nozzle channel dimensions for all devices
are constant and the scale bar is equal to 100µm. Reprinted from Abate
et al, 2009.
1.2.1 Droplet generation using a T-junction
Droplets production using a T-junction design is represented in figure 1.3. The disperse
phase and the continuous phase are injected from two branches of the "T". Droplets of the
disperse phase are produced as a result of shear force and interfacial tension at the fluid-fluid
interface.T-junction may facilitate the production of small or viscous droplets ([Song et al.,
2006]).
In the literature, several works are focused on the dynamical of the generation of droplets
using a T-junction design.
The first studies on the production generation using this shape were made by Thorsen et
al ([Thorsen et al., 2001]). They showed that droplets are formed as a result of shear force
and interfacial tension at the fluid-fluid interface. During the process, the liquid neck formed
by the dispersed phase coming into the main channel gets thinner and breaks, creating a
droplet flowing in the main channel. The collapse of the neck is mainly controlled by the
flow of the dispersed phase and surface tension. Indeed, as surface tension gets smaller, the
detachment period gets longer and then more volume of dispersed phase can enter into the
emerging droplet prior to the formation.
In their article, Thorsen et al proposed the equation 1.10 to calculate theoretically the
size of the generated droplet.
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(a) Sketch module.
(b) Experiment image.
Figure 1.3: Generation of droplets using a T-junction microfluidic
module. (A)Sketch of the microfluidic module where an aqueous phase
(blue) is entering the main channel from a perpendicular channel and
droplets are formed due to the dispersed phase. (B)Image of a production
of droplets by a T-junction module. Reprinted from Thorsen et al, 2001.
r ≈ γ
η
(1.10)
where r is the final radius of the formed droplet, γ is the interfacial tension, η the
viscosity of the continuous phase and  is the shear stress within the T-junction.
Other groups focused more on different aspect of the formation within this design.
Garstecki et al ([Garstecki et al., 2006]) demonstrated that a typical process of droplet
formation begins when the stream of the dispersed phase penetrates into the main channel
and spans the whole cross-section of the main channel. Abate et al ([Abate et al., 2012])
experimentally validated the plugging effect during droplet formation, whereas others focused
more onto the role of several physical parameters for the formation ([Gupta et al., 2009],
[Malsch et al., 2010]). Within all those studies, the size of droplets formed in this configuration
was found to be dependent on the flow rate of the two liquids ([Thorsen et al., 2001]), the
dimensions of the channel ([Garstecki et al., 2006]), the relative viscosity between the two
phases ([Tice et al., 2004]) and the concentration of surfactant ([Baret et al., 2009]).
Depending on the applications, more sophisticated designs have been realized, such as the
production of droplets pairs via two T-junctions ([Hung et al., 2006], [Barbier et al., 2006],
[Frenz et al., 2008], [Hong et al., 2010]) or the mass production of emulsion with up to 256
junctions in parallel ([Nisisako and Torii, 2008], [Zeng et al., 2011]).
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1.2.2 Droplet generation using a flow-focusing junction
Droplets production using a flow-focusing junction design is represented in figure 1.5. In
flow focusing, the continuous phase is injected through two outside channels and the disperse
phase is injected through a central channel into a narrow orifice. Within this device, the
central channel ends and the liquids flow together into a downstream contraction.
(a) Sketch module.
(b) Experiment image.
Figure 1.4: Generation of droplets using a flow-focusing microfluidic
module. (A)Sketch of the microfluidic module where an aqueous phase
(blue) is squeezed by the dispersed phase to form droplets. (B)Image of
a production of droplets using a flow-focusing device. Image taken from
one of my experiment.
This geometry was first proposed by Anna et al and Dreyfus et al ([Anna et al., 2003],
[Dreyfus et al., 2003]), and further studies demonstrated that the droplet size within this
junction is depending on the total flow rate ratio involving the two phases ([Ward et al.,
2005], [Collins and Lee, 2007]), on the channel geometries ([Lee et al., 2009]) and on the
viscosity of the two phases ([Cubaud and Mason, 2008], [Nie et al., 2008]). Several groups
present theoretical analysis of physical behavior for droplet formation using a flow focusing
device ([Garstecki et al., 2005], [Lee et al., 2009], [Romero and Abate, 2012], [Gupta et al.,
2014]), however to date, only a few models predicting exactly the formation of droplets due to
the multitude of influential parameters ([Dupin et al., 2006], [Chen et al., 2015], [Lan et al.,
2015]). For that reason, many variations of the basic flow focusing device geometry have been
developed to improve the control over the size and the size distribution of the droplets. Those
variants can be a two-phase flow forced through a circular orifice integrated inside a silicon-
based microchannel ([Yobas et al., 2006]) or an antisymmetric flow focusing device which
confines droplets to the central axis of the channel which prevents them from being sheared
or damaged at the channel walls ([Takeuchi et al., 2005]) or a 3D dimensional flow focusing
device for the formation of single/double emulsions. Otherwise, it was demonstrated that
multiple flow focusing devices can be combined in parallel to increase the droplet production
rate ([Li et al., 2008], [Hashimoto et al., 2008]).
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1.2.3 Droplet generation using other methods
Droplet formation is usually achieved through passive techniques taking advantages
of the flow field to deform the interface and promote the natural growth of interfacial insta-
bilities. However, active droplet formation techniques exist on which the formation can be
triggered by external forces. The throughput of active methods is usually lower compared to
passive productions, however it allow higher flexibility in droplets generation. Several reviews
present all the different possibility for the production of droplets using microfuidic devices
([Christopher and Anna, 2007], [Baroud et al., 2010], [Gu et al., 2011], [Zhu and Wang, 2017]).
For active drops generation, surface acoustic waves can be used ([Schmid and Franke, 2013])
or electric field ([He et al., 2005], [Kim et al., 2007]).
Other passive methods are used such as the production of simple or paired droplets by
step emulsification ([Chokkalingam et al., 2008], [Li et al., 2015]) and production of double
emulsion by the use of Janus particles ([Chen et al., 2009]), by a two-step droplet breakup as
seen in figure 1.5a ([Okushima et al., 2004], [Nisisako et al., 2005]), by parallelized microfluidic
device ([Romanowsky et al., 2012]) or by using capillary microfluidics as seen in figure 1.5b
([Utada et al., 2005], [Shah et al., 2008], [Kim and Weitz, 2011]).
(a) Two-step droplet breakup.
(b) Capillary microfluidics.
Figure 1.5: Passive droplets production. (A)Basic concept for preparing
double emulsions (W/O/W) using T-shaped microchannels. Reprinted
from Okushima et al, 2004. (B)Microcapillary geometry for generation
double emulsions from coaxial jets. Reprinted from Utada et al, 2005.
1.2.4 Wetting
The selection of appropriate materials for fabrication of droplet-based microfluidic
devices is important. Indeed, hydrophobic channel surfaces treatment is required to prevent
unstable, polydisperse, water in oil drops formation due to wetting effects regardless of the
geometry used to produce microdroplets ([Dreyfus et al., 2003]). To obtain a homogenous
production of microdroplets and transport of the reagents within the microdroplets, the
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continuous phase should preferably wet the walls of the channels relative to the dispersed
phase. In this case, the dispersed phase does not come into contact with the channel walls,
since it is constantly isolated by a continuous oil phase thin film ([Günther and Jensen, 2006]).
Within those observations, it shows that the wettability of the substrate is the controlling
factor for the dispersity of the emulsion produced.
Usually, polydimethylsiloxane (PDMS) devices are used in droplet-based microfluidics. Indeed,
a microfluidic device is composed on a PDMS chip engraved with the channels design bounded
to a glass slide. This material is hydrophobic but when treated to plasma bounding, it becomes
hydrophilic. Therefore, a treatment of the final devices has to be done prior to experiments.
1.3 Microfluidic modules for droplets manipulation
To perform reactions inside microreactors, the handling of fluid and evaporation within
the compartments, as cross-contamination need to be controlled. A large panel of microfluidic
modules are available to control the different aspects of using microdroplets. Here is the
presentation of the basic modules for biotechnology.
1.3.1 Droplet production
Theoretical works have identified three distinct mechanisms for droplet formation (figure
1.6) squeezing, dripping and jetting modes ([De menech et al., 2008], [Lee et al., 2009], [Gu
et al., 2011]). The squeezing mechanism proceeds as the emerging dispersed phase obstructs
the flow of the continuous phase, causing its pressure to rise, allowing the continuous phase to
squeeze on the disperse phase and pinching off a droplet. The jetting mode is characterized
by the formation of long threads in the dispersed phase, which are broken due to the Plateau-
Rayleigh instability. As for the dripping mechanism, it occurs when shear stresses overcome
the interfacial tension and droplet breakup is caused by the shearing of the dispersed phase
by the continuous phase. By playing with the Weber and the Capillary numbers, the droplet
formation regime changes.
Figure 1.6: The different breakup regimes. From left to right: squeez-
ing regime, dripping regime and jetting regime. The arrows show the
flow direction of the aqueous and the oil phase.
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To achieve the production of droplets at kilohertz rate, several geometries are possible.
Those geometries have already be explained in the last section.
1.3.2 Incubation of droplets
A large variety of biochemical applications require incubation of droplets from minutes
to hours or to days, as for example kinetics reaction. Indeed, the determination over time of
the effect on a biological compound is very interesting for multiple fields (drugs, environment
etc...). To perform such reactions inside a droplet, there is therefore a need to incubate the
drops for minutes to hours prior analysis.
In the literature, there is a variety of engineering incubation part on a microfluidic chip,
depending on the project. It can be a part of the same microfluidic design, named on-chip
incubation or on the side where the drops are collected outside the chip, named off-chip
incubation.
For the incubation on-chip, two types of designs are presented in the literature: static
incubation in traps or on-flow incubation in delay lines. For the static incubation, it can take
the form of pillars ([Courtois et al., 2009]), circular shape ([Shi et al., 2008], [Leung et al.,
2012], [Gruner et al., 2015], [Fan et al., 2016]), tilted with an angle ([Huebner et al., 2007])
or square shape ([Shim et al., 2009]) traps. Those designs allow an incubation time from
minutes to a day and useful to obtain kinetic information from individual droplets. However,
the number of droplets traps on chip is limited (<1000) and moreover, during long incubation
time on chip a risk of droplets shrinkage is available by the use of PDMS and oil. Yet, Genot
et al ([Genot et al., 2016]) recently proposed a 2D chamber where droplets are packed on a
monolayer of monodisperse droplets and sandwiched between two glass slide. This method
allows an incubation time higher than 10 hours and the analysis at once of 10 000 droplets by
confocal laser spectroscopy.
The number of droplets analyzed is not an issue with the on-flow incubation designs where
droplets are in constant flow inside microfluidic channels. Delay lines are taking different
forms in the literature, allowing the droplets to be incubated from few seconds ([Agresti et al.,
2010], [Miller et al., 2012], [Stratz et al., 2014]) to 15 minutes ([Frenz et al., 2009], [Brouzes
et al., 2009], [Kintses et al., 2012], [Mongersun et al., 2016]), to 40 minutes ([Koster et al.,
2008]) and up to one hour ([Konry et al., 2011], [Obexer et al., 2017], [Beneyton et al., 2018]).
Using those designs, the kinetic of a reaction can be followed from 1 to 60 minutes.
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(a) Delay lines.
(b) Droplet array. (c) Droplet array.
Figure 1.7: "On-chip" droplets incubation. (A)Droplets incubation in
a 70µm deep microfluidic channel delay line. The black arrow indicate
the direction of the flow. Scale bar is equal to 100µm. (B)Image of an
droplet trapping array. Scale bar correspond to 75µm. Reprinted from
Huebner et al,2009. (C)Image of 24 droplets array. Reprinted from Shi
et al, 2008.
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However, this mechanism is not suitable for incubation time more than an hour due
to the limited place on the chip to increase the length of the delay lines and therefore, the
related pressure drop.
Therefore, to achieve longer incubation time (>1h), the incubation off-chip is executed
by the use of a plastic or glass syringe ([Mazutis et al., 2013], [Beneyton et al., 2014], [Sjostrom
et al., 2014], [Colin et al., 2015]) or an Eppendorf microtube as seen in figure 1.8a ([Pekin
et al., 2011], [Guo et al., 2012], [Chokkalingam et al., 2013], [Liu et al., 2016], [Obexer et al.,
2017]) or Pasteur pipette ([Baret et al., 2010]) as an incubator from minutes to several days.
However, some groups rather use tubing as an incubation line for hundred of hours ([Gielen
et al., 2016]) or use an 3D printer to build a pump incubator that provides oxygen availability
for the emulsion for days as seen in figure 1.8b ([Mahler et al., 2015]).
(a) Eppendorf reservoir. (b) 3D printed reservoir.
Figure 1.8: "Off-chip" droplets incubation. (A)The emulsion is collected
into an eppendorf during experiment. Reprinted from Pekin et al, 2011.
(B)Droplet incubation setup (on the left) and local oxygen availability
setup. 1 Droplet incubator, 2 oil reservoir, 3 peristaltic pump, 4 droplet
population, 5 perfluorinated oil, 6-8 valves. reprinted from Mahler et al,
2015.
After incubation of the desired amount of time according to the experiment, the emulsion
is reinjected on-chip for further analysis and manipulation within usually, the same design
used for the generation of the emulsion.
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1.3.3 Adding reagent
In biochemical experiments such as directed evolution or enzymatic assays, multiple
steps are necessary to add new reagents to control specifically the time to start, modify or
terminate a reaction. Droplet-based microfluidics offer the module of pairing merging to
overcome this time issue.
However, there are two main problems during droplet merging assays which are to first ensure
the stability of droplets as microreactors but also, to be able to destabilized the surface of the
droplet at a desired moment.
Several types of merging phenomenon are represented in microfluidic studies over the
years: passive merging (spontaneous), active merging (induced by an active control) and
picoinjection of reagent.
1.3.3.1 Passive merging
Passive merging consists on spontaneous coalescence of droplets within microfluidic
channels. In the literature, several methods are shown to merge efficiently the non-stabilized
droplets and usually occur by channel geometry mediation or physico-chemical induction. Niu
et al ([Niu et al., 2008]) used a chamber divided into three branches by two rows of pillar
(figure 1.9a), Song et al ([Song et al., 2003b]) designed two streams coming inside the main
channel with one stream smaller (figure 1.9b), or other studies ([Hung et al., 2006], [Um
and Park, 2009], [Bremond et al., 2008]) changed the geometry of the channels to induce
merging of droplets(figure 1.9c & figure 1.9d). Also, non-stabilized droplets can be merged by
hydrophobic surface patterns on the walls of the main microfluidic channel ([Fidalgo et al.,
2007], [Liu and Ismagilov, 2009]), by merging a new stream passing by a perpendicular orifice
with the droplets from the main channel ([Zheng and Ismagilov, 2005], [Sivasamy et al., 2010])
or by a system of membrane valves ([Lin and Su, 2008]).
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(a) Pillar induced (b) Stream induced
(c) Geometry induced (d) Abacus channel
Figure 1.9: Spontaneous merging of a pair of unstabilized droplets.
(A)Merging of two different droplets. Complete mixing is achieved
when the merged droplet moves out of the merging element. Reprinted
from Niu et al, 2008. (B)Spontaneous merging of droplet pairs into
single channel. Reprinted from Song et al, 2003. (C)Fusion of droplets
containing different reagents in milliseconds. Reprinted from Tan et al,
2007. (D)Merging of droplets in a microfluidic abacus channel. Reprinted
from Um et al, 2009.
Most of the microfluidic designs fused drops generated on chip directly, however some
teams works with reinjected emulsion using active and passive merging. For example, Mazutis
et al presents a passive droplet fusion technique allowing high-throughput and highly con-
trollable one-to-one fusion of drops without external energy sources or accurate droplet
synchronization, as seen in figure 1.10 ([Mazutis et al., 2009a]).
Figure 1.10: Droplet pair fusion within the coalescence region of pair
of drops stabilized with 2.8% of surfactant. The black arrow indicates
the direction of the flow and the red arrowq indicate the pathe of a
reinjected drop. Reprinted from Mazutis et al, 2009.
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However, spontaneous merging of droplets non stabilized by surfactant always requires a
synchronization of the droplets otherwise it gives an important number of undesirable merging
events, which are to be avoided for biochemical assays. Also, in the absence of surfactant to
stabilize the interface of droplets, further droplets manipulations are restricted because the
fused droplets are unstable, and the contamination between droplets exists.
1.3.3.2 Active merging
Alternatively, droplets stabilized by surfactant are less prone to contamination and
are resistant to uncontrolled coalescence which facilitates droplet storage and reinjection for
further droplets manipulations.
Active merging consists on the fusion of droplets by applying an active controls onto
the microfluidic chip.
In the different studies present in the literature, the employment of electric field is highly used
to merge stabilized droplets ([Ahn et al., 2006], [Link et al., 2006], [Priest et al., 2006], [Niu
et al., 2009], [Gu et al., 2011], [Guzman et al., 2015]), and especially for biological screening
assays. Frenz et al ([Frenz et al., 2008]) utilized this method to synthesize magnetic iron oxide
nanoparticles (figure 1.11a), and Mazutis et al ([Mazutis et al., 2009b]) to analyze the kinetic
of cotA laccase genes in droplets (figure 1.11b).
An emulsion of droplets is synchronized in a microfluidic channel and then electroco-
alesced by applying an alternating current AC field, as seen in figure 1.11c. The essential
feature to use electocoalescence by an AC field is the presence of the pair of droplets between
the electrodes ([Chabert et al., 2005]). Coalescence induced by an electric field occurs when
conductivity of the droplets is much higher than the conductivity in the continuous phase
and when the pair of droplets are close pack together ([Thiam et al., 2009]). Indeed, when
two droplets are exposed to an electric field, their induced dipoles align which lead to an
attractive force between the both droplets. This force being proportional to the square of the
electrical field, when the pair of droplets are in close contact, the dipolar force rapidly drains
the film between the two interfaces, leading to the fusion of the two droplets.
The operation of electrocoalescence requires microfluidic chips with integrated electrodes and
good electrical shielding to prevent unwanted coalescence. And, the geometry of the electrodes
plays an important role with the direction of the applied field to obtain an efficient merging
([Eow and Ghadiri, 2003]).
There is also the possibility to induce coalescence by local heating from a focused laser as
seen in figure 1.11d. This merging method was introduced by Baroud et al but this approach
is useful in the simplest microfluidic case ([Baroud et al., 2007]).
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(a) Electocoalescence (b) Electocoalescence
(c) Electocoalescence (d) Laser induced
Figure 1.11: Merging of stabilized droplets by applying an active control
onto the microfluidic chip. (A)Paired droplets coalesced by applying an
electrical voltage U between the two electrodes. Reprinted from Frenz
et al, 2008. (B)A Droplet pair is fused in the electrocoalescence region
between the two fusion electrodes (black) by application of an AC field.
Reprinted from Mazutis, Baret et al, 2009. (C)Merging of the droplets
entering the chambrer with an applied electric field. Reprinted from
Niu et al,2009. (D)Time sequence showing fusion through laser heating.
Reprinted from Baroud et al, 2007.
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1.3.3.3 Picoinjection of a reagent
Adding reagents to an emulsion is one of the most important function in droplet-based
microfluidic systems. As explained previously, different modules are available to fuse two
droplets together. However, those techniques are not as robust as the picoinjection module
presented by Abate et al in 2010 ([Abate et al., 2010]).
In 2007, Li et al described a multijunction microfluidic device to inject reagent into
unstabilized droplets without cross-contamination ([Li et al., 2007]). However in biochemical
assays, the drops are usually stabilized by surfactant to avoid any unvoluntary coalescence
and contamination. Therefore, Abate et al introduced the picoinjector module allowing to
add controlled volume of reagent into a surfactant-stabilized droplet using electrocoalescence,
triggered by an electric field. This system works at high-frequency (10KHz) which is important
for high-throughput biochemical applications.
The picoinjector chip is designed as an reinjection module where droplets enter the
main channel and are spaced by oil from side channels. A perpendicular channel contains
the reagent and is connected to the main channel by a small orifice. At the opposite of this
orifice, a positive and a ground electrodes are present to apply electric field (figure 1.12).
Figure 1.12: Microfluidic module for picoinjection of controlled volume
of reagent by merging the droplets with a pressurized channel containing
the reagent, triggered by an electric filed applied by electrodes. Reprinted
from Abate et al, 2010.
The picoinjector module operates by using electric fields to overcome the Laplace
pressure to electrocoalesce the droplets. Indeed, the channel design is made as the main
channel where the emulsion is reinjected abruptly narrows to a small orifice for the injector.
This creates a high curvature between the reagent and the oil phase from the droplet which
prevents the flow of the aqueous phase. Then, when the electric field is activated the droplet
interface is ruptured by electrocoalescence and a controlled volume of reagent can fuse with
the droplet, and the stability of the interface is reach again when the droplet exits the electric
field.
However this module works with precise parameters. Indeed, if the voltage is less than 30V,
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the reagent/oil interfaces are not stable and therefore no injection can occurs. Also, to achieve
an injection of controlled volumes inside each droplets, the emulsion must enter at regular
spacing all along.
Within this design, it is also possible to perform a serial injections to an emulsion while
passing through the main channel assembled with several picoinjectors (figure 1.13).
Figure 1.13: Three picoinjectors are used in series. Each is activated
by the electrode opposite, while ground electrodes on either side shield
the picoinjectors nearby. Reprinted from Abate et al, 2010.
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1.3.4 Mixing of droplet content
The mixing of liquids inside a droplet is an important point for the tracking of chemical
or biological reactions.
Figure 1.14: Laminar
flow for a two phases flow.
As explained before, the fluid flows are
laminar in microfluidic systems. In this
configuration, the mixing occurs only by
diffusion in the transverse direction.
Advection occurs with a time scale given by τa ≈ L/U where L is the length in the
direction of the channel. In contrast, diffusion of molecule in the transverse direction takes a
time given by τd ≈ w2 / D where w is the width of the channel.
So the distance traveled by the elements of fluids in the direction of the flow during the time
of diffusion is given by the equation 1.11:
w2
D
≈ L
U
<=> L ≈ Uw
2
D
<=>
L
W
≈ Uw
D
= Pe (1.11)
However, we have seen that in microfluidic channels, the Peclet number is characterized
by Pe»1. Therefore the fluid has to move over large distances to be mixed as if Pe»1 then
L/w»1 so L»w. Mixing is thus not efficient in laminar flows at high Peclet number.
In contrast, droplet-based microfluidics offers a simple method for rapid mixing and no
dispersion during transport.
The process of mixing inside a droplet is determined by physical equations ([Tabeling, 2009],
[Tam et al., 2009]) and depends on the droplet size, the composition and ratio of liquids to be
mixed, the design of the microfluidic channels and the speed of the droplet.
When a droplet is flowing along a rectangular microfluidic channel, two cycles of re-
circulation are induced ([Handique and Burns, 2001]). The model proposed by Handique
et al represents the two liquids located in the perpendicular half of the droplet (figure 4.3)
and achieves 85% of mixing on a distance equivalent to three times of the droplet diameter.
However, in real time experiment, the two liquids inside a droplet are localized in the direction
of the flow (figure 1.15b). In this case, the two liquids stay in independent parts and the
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mixing occurs only by diffusion ([Song and Ismagilov, 2003], [Song et al., 2003a]).
Fast merging can be induced in microfluidic channels in two different manners: one aqueous
stream could be introduced into the middle of the other aqueous phase (figure 1.15c) or
the droplets could flow through a serpentine channel and allow mixing by chaotic advection
(figure 1.15d) ([Bringer et al., 2004], [Stone and Stone, 2005], [Suh and Kang, 2010], [Jiang
et al., 2012]). When a droplet flow through a serpentine, the droplet experience different
velocities relative to the walls, inducing asymmetric circulation flows and allowing the mix of
the droplet contents in a few milliseconds ([Tice et al., 2003]). Also, the group of Sarrazin et
al proved that the angle in the serpentine channels plays a crucial role for the mixing efficiency
([Sarrazin et al., 2007]).
(a) Fast mixing (b) Mixing by diffusion
(c) Fast mixing (d) Fast mixing
Figure 1.15: Mixing within microfluidic designs. Two solutions are
encapsulated using a co-flow drop maker. (A)Theoretical model where the
two liquids are located in the perpendicular half of the droplet. (B)Two
liquids encapsulated inside a droplet are localized in the direction of the
flow. (C)One aqueous stream is introduced into the middle of the other
aqueous phase. (D)Mixing by chaotic advection through a serpentine
channel. The black arrow in the four sketches represents the flow inside
the channel.
To improve mixing of multiple solutions, several researches have led to add bumps onto
the edged of the serpentine channel design, enhancing therefore the asymmetry of the shear
forces on either side of the drop as the drop flows inside the serpentine channel, leading to a
better mixing ([Liau et al., 2005], [Song et al., 2006], [Pompano et al., 2008]).
To study the mixing dynamic inside microfluidic channel generated droplets fluorescence
photographs are usually used with the articles mentioned before. However the team of Zeng
et al used two-photon fluorescence lifetime imaging to quantify in high-quality the mixing
dynamics ([Zeng et al., 2011]).
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1.3.5 Droplet detection & analysis
Detection methods in droplet-based microfluidics are essential for the identification of
biological or chemical species present inside an emulsion of droplets. Most commonly, the
fluorescence detection is used in microfluidic.
The optical setup is composed of basic components of detection system such as a
microscope, light-emitting source(s), optical detector(s) and a sample, a microchip in our field.
The transparency of the microfluidic PDMS-glass chip and its planar shape permit to have all
droplet manipulations available for optical monitoring.
The majority of reported studies are using a reverse microscope coupled with a high-speed
camera ([Baret et al., 2010]). High-speed camera is essential to control the high frequency of
droplets operations as visual droplet inspection on-chip. However, the choice of light emitting
sources and optical sensors system are related to the type of information needed to be collected
from the droplets studied.
The fluorescence system are usually coupled with lasers which are combined with highly
sensitive optical detectors ([Zhu and Fang, 2013], [Sesen et al., 2017]). Lasers are used for their
intense, collimated excitation light with well-defined wavelengths. The most common optical
detectors for fluorescence microscopy are photomultiplier tubes (PMTs) which show excellent
sensitivity enabling detection of individual photons, and are well-suited for applications
requiring low-noise and high-sensitivity detection. The signal output is usually analyzed using
a data acquisition card executing a program written in a computer software, such as LabView,
allowing the identification of a single drop by its fluorescence, as well as other parameters
indicated in the program (width, spacing...).
Sometimes the fluorescence detection of a microfluidic optical setup can be induced using
other type of light source such as light emitting diodes (LEDs) or Hg-lamps ([Chabinyc et al.,
2001], [Huebner et al., 2007], [Lim et al., 2013], [Gruner et al., 2015]).
A variety of fluorescence probes are suitable for detection in microfluidic systems and
come in different forms. Some studies used fluorescent organic dye molecules ([Song et al.,
2003a], [Pekin et al., 2011], [Lim et al., 2015]), fluorescent proteins ([Dittrich et al., 2005]),
fluorescent beads ([Kumaresan et al., 2008]) or quantum dots ([Klostranec et al., 2007], [Zhang
et al., 2010]). The ideal probe must be small in size, have a minimal interference with
biochemical assays and provide a strong, stable and highly specific signal ([Walter et al.,
2008]).
1.3.6 Droplet sorting for high-throughput screening
High-throughput detection, selection and screening of droplets composed of variants
with desired properties is a major step in assays for biological applications.
Despite latest advantages in screening techniques, these screens are often limited in sensitivity
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or throughput. The figure 1.16 represents the three main platforms for enzymatic screening
([Longwell et al., 2017]).
Figure 1.16: Platforms for the screening of enzyme presenting different
methods for library analysis and sorting. (a)The cell library can be ana-
lyzed and sorted by FACS. (b)Single emulsion (water-in-oil) droplets can
be manipulated in complex ways and are analyzed and sorted, usually by
dielectrophoresis or sophisticated microfluidic devices. (c)Microchamber
arrays include microwell and microcapillary arrays and use micron-scale
chambers to separate enzyme variants. The arrays are analyzed with
a fluorescence microscope and sorted by optical extraction. Reprinted
from Longwell et al, 2017.
Platforms using droplet-based microfluidics are a recent technology that provides a
method for high-throughput screening of heterogeneous population of cells or particles at
the single-cell resolution. The paper from Anh et al ([Ahn et al., 2006]) is the first proof-of-
principle for microfluidic droplet-based screening by sorting. The design include transparent
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ITO electrodes that pull drops with desired properties into a collection channel (figure 5.17a).
Nowadays, different type of microfluidic platforms are present in the literature operating
on various active controls to enable the sorting of droplets.
Majoritary, screening methods employ electric field in diversified manner. The sorting of
drops can be performed using electrocoalescence at a few kHz frequency, where the droplets
are forced to coalesce with an aqueous stream by application of an electrical field across the
channel to extract on-chip the contents of droplets and incorporating them into the continuous
stream, as seen in figure 5.18a ([Fidalgo et al., 2008], [Fallah-Araghi et al., 2012]). Also
microfluidic screening can be done by image processing using the voltage generated by a
droplet to transform it into a signal for camera triggering to screen at a frequency of 100Hz
([Zang et al., 2013]) or by combining two algorithms to recognize any object in a droplet and
enable the sorting using liquid electrodes for a frequency screening of 10Hz ([Girault et al.,
2017]).
However, the sorting module activated by fluorescence is more reliable to screen one positive
droplet among an emulsion of negative droplets. This method was first presented by Baret et
al ([Baret et al., 2009]) allowing single-cell sorting at rates up to 2kHz with an error rate of 1
for 100 drops. This method is called fluorescence activated drops sorting (FADS) and consists
on reinjected droplets spaced out by oil and sorted at an Y-shaped asymmetric junction
triggering on drop fluorescence (figure 5.19a). The Y-shaped junction sets for the collection
channel and the waste channel. When no electrical field is on, droplets flow preferably to
the waste channel which have been design to have a lower fluidic resistance compare to the
collecting channel. This system was demonstrated for an emulsion of droplets of a volume set
between Vdroplets = [12-20]pL.
Several groups employed the FADS design to realize high-throuhput screening for biological
applications. Directed evolution assays are the most represented with a screen of 106 up to
108 variants by assay in a few hours ([Granieri et al., 2010], [Agresti et al., 2010], [Kintses
et al., 2012], [Gielen et al., 2016]). However, other applications can be done using this design
such as study the behavior of cells ([Najah et al., 2014],
[Wang et al., 2014]), specially of mammalian cells ([El Debs et al., 2012]), or the analysis for
medical ([Mazutis et al., 2013], [Liu et al., 2016]) and industrial purpose ([Sjostrom et al.,
2014]).
Recently, Frenzel et al ([Frenzel and Merten, 2017]) present a sorting system composed of
multiple electrode pairs running in parallel to the channels which enables highly reliable
sorting with an efficiency of 100% for a frequency sorting of droplets of Fdroplets ≈ 200Hz.
Unfortunately, all of those studies succeed to reach a sorting frequency of a few hundred of
hertz to 2kHz. Sciambi et al ([Sciambi and Abate, 2015]) succeed to achieve an accurate
screening of droplets at a frequency of Fdroplets = 30kHz. To perform a high frequency
screening, they design a sorting region with a gapped divider allowing droplets to be squeezed
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into an energetically unfavorable region and due to Laplace pressure, droplets are pushed to
the nearest channel, the waste one (figure 1.17d).
(a) ITO electrodes (b) Electrocoalescence
(c) Fluorescence activated (d) Fdroplets=30kHz
Figure 1.17: Microfluidic platforms for high-throughput screening for
biological applications. (A)First proof-of-principle. The arrow marks
the droplet of interest. One droplet directed to the collect channel out
of the streamline by a pulse of electric field. Reprinted from Ahn et
al, 2006. (B)Scheme of the device and micrograph of the sorting effect
when the electric field is On and Off. Reprinted from Fidalgo et al,
2008. (C)Trajectories of droplets stream through the sorting junction.
When an AC electric field was applied across the electrodes, the droplets
were deflected into the positive arm. Reprinted from Baret et al, 2009.
(D)A schematic of the fast droplet sorter with detected and selectively
displaced black droplets being separated by a gapped divider (red) of
reduced channel height. Reprinted from Sciambi et al, 2015.
Other possibilities for high-throughput sorting are available and described in the lit-
erature. The screening can be done by using surface acoustic waves where a piezoelectric
material creates surface acoustic waves that induce acoustic streaming to move droplets into
the collection channel ([Franke et al., 2010], [Collins et al., 2016]), or magnetic force where
encapsulated magnetic particles are used to deflect droplets into different channels with a
magnetic field ([Zhang et al., 2009]), or by an holographic beam optical shaping where by
positioning the laser in the middle of the main channel, droplets are sorted into the desired
channel ([Cordero et al., 2008]).
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1.4 Biological applications
Compartmentalization of biological and chemical reactions in picoliter droplets using
microfluidic technology is a powerful method in evolution and offers new possibilities for
high-thoughput screening and analysis. By controlling the volume of reagent and flow rates,
microfluidic droplets generate a high level of control over the content and size of the droplets.
Once produced, monodisperse droplets can be incubated, merged, sorted and manipulated in
various ways as discussed in the previous section.
Various droplet-based microfluidic experiments published in the literature are used for
directed evolution and other biological applications. The examples related to those fields
of applications are continuously increasing, making it difficult to cover all the achievements
and possibilities in details in a single work. This report will focus then on a discussion over
biological experiments related to my PhD project, namely directed evolution and the screening
of library of variants, the amplification of DNA in drops and single-cell analysis assays. For
other types of biological applications, several reviews are available for the interested reader
([Dittrich and Manz, 2006], [Sackmann et al., 2014], [Ho et al., 2015], [Mashaghi et al., 2016]).
1.4.1 Directed evolution & screening of library of variants
Nature relies on Darwinian evolution to create or improve functional molecules. In
the laboratory, there is an equivalent of this process by the method of directed evolution
([Turner, 2009], [Bornscheuer et al., 2012]). Directed evolution is powerful tool to develop new
variants of enzyme and proteins in general. Within this method, a DNA library of mutations
is generated and the screening of desired properties (increased catalytic efficiency, solubility,
specificity for a substrate ...) is possible.
Droplet-based microfluidics is a major step to perform directed evolution by allowing efficient
and robust systems to detect the activity of biological materials in droplets. To date, the use of
water in oil droplets is the most employed microfluidic method ([Brouzes et al., 2009], [Kintses
et al., 2012], [Beneyton et al., 2014]). However other groups caged enzymes in biomimetic
gel-shell beads encoding DNA and the fluorescent reaction of the product to perform directed
evolution assays ([Fischlechner et al., 2014]).
Using droplet-based microfluidic technology permits that each element individually of
a library is encapsulated into droplets and the same library can be screened multiple times
within high statistics. Conventional high-throughput screens use low high-throughput methods
to screen a large number of unique elements. Leemhuis et al ([Leemhuis et al., 2009]) present
a review of the different strategies for screening a library of mutants, from agar plate to FACS
(fluorescence activated cell sorting).
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However, directed evolution is a method crucially dependent on screening large numbers of
library members in high quantitative enzyme assays as a basis for selecting clones satisfying
desired criterions. Using droplet-based microfluidic modules made achievable high-throughput
screening of 106 to 107 variants in a few hours compare to usual techniques which can take
days.
The groups of Weitz and Merten were the first one to use FADS module to achieve high-
throughput screening of a precise type of enzyme ([Agresti et al., 2010], [Granieri et al.,
2010]) in just few hours, reducing time and cost. Moreover, other groups used other type of
microfluidic modules to screen libraries. Chen et al ([Chen et al., 2015]) used microcapillary
arrays where a library of variants is mixed with opaque microbeads. This mixture is pipetted
into array at a certain concentration resulting in a mean single-cell occupancy and the array
is imaged via fluorescence microscopy. This method allows robust isolation of rare clones with
high precision and imaging, analysis of the entire population of microcapillaries.
The review from Guo et al ([Guo et al., 2012]) offers a view on the possibilities for
screening of biological assays using droplet-based microfluidics. Usually, the detection of
droplet content is done through fluorescence detection ([Sjostrom et al., 2014], [Colin et al.,
2015], [Obexer et al., 2017]), however other type of detection can be done. Gielenet al
([Gielen et al., 2016]) succeeded to screen a library by absorbance detection allowing a 6-fold
more enrichment. Yet, this method is 3-4 times in order of magnitude, less sensitive compared
to fluorescent assays. Chrimes et al ([Chrimes et al., 2013]) present a screening system based
on Raman spectroscopy detection coupled with dielectrophoresis (DEP) providing extremely
sensitive and accurate measurements, and can be utilized to study small sample volumes of
interest and a large number of different materials. Alternatively, Kuczenski et al ([Kuczenski
et al., 2011]) used dielectrophoretic microfluidic devices to screen an enzyme. All of those
platforms present promising results but there is a heavy part of engineering regarding the
chip which consists on the design of complex electrodes.
1.4.2 Amplification of DNA in droplets
Similarly, to perform directed evolution assays, the use of polymerase chain reaction
(PCR) constitutes a main approach for biological applications. Since the late 1980s, it has
provided DNA sequencing technologies a tool for deciphering complete genes and entire
genomes. Compartmentalization coupled with PCR amplification of DNA circumvents major
problems of this approach such as reducing amplification bias (shorter DNA fragment tend to
be amplify in preference to longer one and generation of artificial fragments). The review from
Zhang et al ([Zhang and Jiang, 2016]) explains the advances and challenges of this method,
yet to my point of view, articles from Fallah et al ([Fallah-Araghi et al., 2012]) and Pekin et al
([Pekin et al., 2011]) represent two main articles for PCR in droplets. Droplets containing the
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PCR mix are produced on chip, collected and thermocycled off-chip before being reinjected,
fused by electrocoalescence with IVT droplets produced on chip and analyzed. Fallah et al
present a ultra high-throughput platform where single-genes are compartmentalized in aqueous
droplets, dispersed in inert carrier oil and amplified using PCR. After amplification droplets
contain 30 000 copies of each gene and are merged by fluorescence activated electrocoalescence
with a droplet containing the fluorogenic assay, leading to an enrichment of 502-fold from a
1:100 molar ratio. As for Pekin et al, the method consists in allowing highly sensitive detection
of mutated DNA in a quantitative manner within complex mixtures of DNA enabling the
determination of mutant allelic specific in several cancer cell-lines and the precise quantification
of a mutated KRAS gene in the presence of a 200 000-fold excess of unmutated KRAS genes.
1.4.3 Analysis of single-cell assays
Analysis of biological component at the single-cell resolution is one of the key steps
to achieve screening of a library of mutants. Indeed, when performing single-cell analysis
within single droplets, this leads to an occupancy of either 0 or 1 cell per droplet following
the Poisson distribution, with 90% of the emulsion being empty droplets.
The first theoretical analysis to control the encapsulation of single-cell into droplets
have been done by Edd et al ([Edd et al., 2008]) with the use of HL60 cells into a flow focusing
device. Huebner et al ([Huebner et al., 2007]) were one of the first using this approach by
the demonstration of controllable compartmentalized single-cells within aqueous droplets in
the analysis of protein expression. Nowadays, most biological assays, specially concerning
directed evolution, are using this approach for the analysis of enzymes based on fluorescence
or absorbance ([Gielen et al., 2016]), hybridoma ([El Debs et al., 2012]) or circulating tumor
cells (CTCs) by the detection based on pH measurement ([Del Ben et al., 2016]).
A review from Joensson et al ([Joensson and Andersson Svahn, 2012]) gives all the tools
needed for single-cell analysis using droplet-based microfluidics.
1.5 Scope of the thesis
The objective of the doctoral project is the development of droplet-based microfluidic
systems used for the detection and the screening of an enzyme at the single-cell resolution
used in therapeutical treatments called L-asparaginase.
The integration of the different microfluidic modules explained in this chapter have to be
done for the specific case of the L-asparaginase enzyme. Engineering and optimization of
microfluidic systems are the important steps of this project. New protocols and new methods
must be developed for the creation of new modules that can be useful for different expression
systems of a biological compound. For those different steps, various analysis have been done
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and are summarized into the droplet map seen in figure 1.18. First, a work of designing and
producing microfluidic chips while the biological part is done on the side. When everything is
in place, a control experiment is done through a microtiter plate assay to ensure the detection
of fluorescence. Then, biological systems are transfered to microfluidic platforms where the
fluorescence is first detected at the single-cell resolution for a certain amount of time, then
a desired fluorescence population is screened to create libray of mutants. And finally, new
modules are developped using surface acoustic waves.
Figure 1.18: Droplet map technology principle.
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1.6 Résumé du chapitre et but de la thèse
Le development technologique a donné naissance à une miniaturisation des systems flu-
idiques par l’utilisation d’une nouvelle technique appelée la microfluidique. La microfluidique
consiste en l’étude des fluides à l’échelle microscopique.
En 1990, la microfluidique a connu un essor important afin de participer à l’avancée des
analyses biologiques et chimiques. Ce domaine bénéficie de beaucoup d’avantages comme la
réduction du volume de réactifs utilisé et donc une réduction des coûts de l’expérience.
Un sous-domaine intéressant de la microfluique est la microfluique en gouttes. Ce domaine
utilise des gouttes de l’ordre du micronmetre de diamètre comme microreacteurs. Ces gouttes
sont créés à des fréquences de l’ordre d’une centaine de kilo hertz et peuvent être manipulées
des différentes manières dépendant de l’expérience considérée. Les gouttes peuvent être
produites, incubées, mixées, fusionnées, criblées sur une seule et même puce afin d’étudier
différentes applications.
Le but de cette thèse est d’élaborer de nouveaux systèmes microfluidiques pour la
détection et le criblage d’une enzyme d’intérêt thérapeutique. Ces modules microfluidiques
seront basés sur la technique d’électrocoalescence et un travail préliminaire consistera à
développer le module de fusion microfluidique à l’aide d’ondes acoustique de surface.
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Summary Chapter 1
• Microfluidic modules are a key technology for biochemical experiments.
• Those modules provide a high-troughput manipulation of droplets.
• Many modules are available in the literature for diverse applications in biology and
chemical field.
• The purpose of this PhD is the optimization of microfluidic workflows for a specific case
of the directed evolution of L-asparaginase, an enzyme of therapeutic interest.
• These optimizations are based on:
– The analysis of the biochemistry of the L-asparaginase enzyme.
– The development of several expression systems for the enzyme.
– The development and optimization of integrated microfluidic modules usefull for
single-cell level analysis.
– The development of microfluidic protocols depending on the module.
• An important part of the project is to be able to screen new library of enzymes mutants
provided by directed evolution assays.
• And to achieve an efficient screening rate with our biological systems comparable to
the rate from the literature.
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Development of microfluidic protocols
for enzymatic activity measurements
This chapter focuses on the design and development of microfluidic platforms for
the engineering and analysis of enzymes used in therapeutical treatment. We describe the
development of microfluidic devices for the high-throughput screening of libraries of enzyme
variants, involving the on-chip detection of enzymatic activity and sorting of populations
of interest based on a fluorescence readout. Preliminary experiments have been performed
by Christos Karamistros, Philipp Gruner and Jiseok Kim that give us the basis to start the
project.
2.1 Analysis system
We built up an optical set up to monitor the fluorescence inside the droplets within
microfluidic channels based on previous work ([Baret et al., 2009]). The laser position on
chip and the flow rate of the two phases used determined the age of the droplet at which the
fluorescence is measured. The sensibility of the station will depend on the fluorogenic assay
used during an experiment.
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2.1.1 Optical setup
The optical station represented in figure 2.1 is composed of three lasers (375nm with
20mW, Omicron; 473nm with 250mW, Cobolt; 532nm with 25mW, Cobolt Samba) focused
with three objectives (5x, 10x, 20x, Olympus) into the microfluidic channels using a set of
mirrors and dichroics (M1: ND10A, Thorlabs; D1: F38-M03, AHF ; D2: F38-M01, AHF).
The microfluidic chip is mounted on the x-y stage of an inverted microscope (IX71, Olympus).
Droplets are imaged with a high speed camera (v210, Phantom) using a white LED (Olympus)
from above. The LED is turned off for data acquisition of the fluorescence signal of the
droplets. The dyes in the droplets are excited by the lasers and the fluorescent light is
directed through several notches and filters and split with dichroics (N1: F40-473, AHF ;
N2: F40-532, AHF ; S1: F21-002 (80R/20T), AHF ; F1: 30mm lens; S2: F38-458, AHF ; B1:
F21-002, AHF ; S3: F33-563, AHF ; B2: F21-002, AHF ; B3: F21-002, AHF) to be recorded by
three photomultiplier tubes (PMTs, H9656-20, Hamamatsu). PMTs respective windows are:
424-453 nm (PMT1), 497-545 nm (PMT2) and 565-595 nm (PMT3). Data acquisition and
control are performed by a data aquisition card (National Instruments) executing a program
written in LabView (National Instruments) allowing the detection of droplets by fluorescence
peaks. The program was wroten by Pr Baret J.C and Dr Frenz L. and updated by Vrignon J.
The data acquisition rate for the system is 200kHz.
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Figure 2.1: Schematic representation of the optical setup. Lasers are
combined with an ensemble of mirrors (M1: ND10A _ Thorlabs) and
dichroics (D1: F38-M03 _ AHF & D2: F38-M01 _ AHF). The laser
beam is passed into a dichroic (D0: F73-049 _ AHF): one part is going to
the microscope lens and the other one is going to the optical setup. For
the path through the optical setup, the laser beam goes via two notches
(N1: F40-473 _ AHF & N2: F40-532 _ AHF)), to go to a mini-splitter
80/20 (S1: F21-002 _ AHF) which split 80% on the camera and 20% on
the PMTs. Before coming to the PMTs, the laser beam passes through
a lens F1 with a focal of 30mm, then goes by a two splitters. The first
one, S2: F38-458 _ AHF), leads one part of the beam to a bandpass B1
(F21-002 _ AHF) and arrives to the first PMT (PMT1: 438 ±24nm), &
the second part to the second splitter S3 (F33-563 _ AHF). This one
leads the beam to two other bandpass: B2 (F21-002 _ AHF), which
goes to the second PMT (PMT2: 524 ±24nm), & B3 (F21-002 _ AHF)
which goes to the third PMT (PMT3: 580 ±15nm).
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2.1.2 Fluorescence measurement
To determine the fluorescence inside the droplets, two dyes are used. The first dye is used
to label the different population of droplets in each experiment and is called Dextran-Cascade
Blue (Thermo Fisher) with a fluorescence specter equal to λexcitation = 400nm, λemission
= 420nm. The second dye is the final product of the enzmatic cascade used to detect our
enzymatic activity and is called Amplex Ultra-Red (AUR) with a fluorescence specter equal
to λexcitation = 568nm, λemission = 581nm.
Therefore, two lasers are used (375nm with 20mW, Omicron and 532nm with 25mW, Cobolt
Samba) in the optical setup. The lasers are focused into the microfluidic channels with a 20x
objective (Olympus) and the fluorescent light is recorded by photomultipliers (Hamamatsu).
The voltage of the two PMTs corresponding to the range of wavelengths desired are recorded
with a gain G=0.5 for both and transferred by the FPGA card to the LabView software
(National Instruments).
The fluorescence signals of the two dyes are recorded for approximately 100 000 droplets for
each points in a text file. Those text files contain the time, fluorescence intensity at each
PMTs, the width and the spacing of each droplets detected. Those files are then post-processed
with homemade scripts using SciLab software (Scilab Entreprises). From the raw data, the
distribution of fluorescence is generated over time using histograms.
Images and videos from experiments are also recorded by the high speed camera software
(v210, Phantom) and are analyzed using Image J software (National Institutes of Health,
NIH ).
2.2 Integrated microfluidic systems
In the literature there are a lot of different microfluidic tools for the high-throughput
screening of enzyme libraries that can be used to screen different type of enzymes
([Fallah-Araghi et al., 2012], [Beneyton et al., 2014], [Sjostrom et al., 2014], [Hosokawa et al.,
2015]). Some reviews described some possibilities for screening using droplet-based microflu-
idics ([Griffiths and Tawfik, 2006], [Bershtein and Tawfik, 2008], [Guo et al., 2012], [Du et al.,
2016]). Unfortunately, those platforms use lysis agent, deterioring the bacteria which expresses
the enzyme. Therefore to identify the screened enzyme, supplementary steps are needed such
as the amplification of the lyzed bacteria plasmid.
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During my PhD, I have developed high-throughput screening microfluidic platforms
to (i) detect the activity of an enzyme produced by an expression E. coli strain, (ii) sort a
selected positive population and (iii) recover the corresponding strains.
To design those platforms, the enzymatic activity detection is the important point. It
corresponds to the ability of an enzyme to catalyze a specific reaction. This activity value
is characterized by the time of reaction, time of detection which can vary from few seconds
to hours depending on the enzyme considered. For example, Agresti et al ([Agresti et al.,
2010]) incubated the emulsion 5 minutes prior screening to ensure the enzymatic activity to
be detectable, El Debs et al ([El Debs et al., 2012]) incubated for 30 minutes and Granieri et
al ([Granieri et al., 2010]) for six hours.
Therefore, to obtain the same incubation time inside each individual droplets, different layers
have to be drawn within the design of microfluidic platforms by adding incubation chambers
for the droplets. For this particular design, the article from L.Frenz et al in Lab on Chip
from 2009 ([Frenz et al., 2009]) has been used. In the article, the group used delay lines with
deep and wide channels implying longer droplet incubation time with reduced hydrodynamic
resistance.
With the help of the equation 2.1, we express the theoretical incubation time as a function of
the total flow rates and the characteristics of the microfluidic channels.
t =
lwh
Q
(2.1)
where t is the time (s), l is the length of the channel (µm), w is the width (µm), h is
the depth of the channel (µm) and Q is the total flow rate (µL.s−1).
Aqueous and oil phases in microfluidic systems are used in constant flows by syringe
pumps where the total flow rate Q is determined in our microfluidic chips. However, in
some cases, the use of pressure system is needed and Q is then determined by the pressure
differential but is difficult to model. Indeed, in pressure system, flows are adapted to the
system but the pressure system used in our project does not have a correlation between
pressure and flow rates. Therefore, the equation 2.1 can not be used in platforms using
pressure system.
In this chapter, the design of the four platforms will be presented, along with the
optimization of four protocols to measure the enzymatic activity of an enzyme. Each platforms
has its own characteristics and purpose. Workflows # 1 and # 2 are used only for the detection
of the enzymatic activity in a range of time between 4 minutes and 40 minutes, while workflows
# 3 and # 4 are for the screening of desired populations of variants according to their enzymatic
activity.
51
2.2.1 Workflow # 1: enzymatic activity detection in 15 min-
utes
Within this first microfluidic workflow (figure 2.11), a cell suspension is co-encapsulated
in droplets at the single-cell level and the reagent mix on a co-flow drop maker design. Droplets
are generated with fluorinated oil (Novec7500, 3M ) containing 1% of Fluosurf surfactant
(Emulseo, France). Once formed, the droplets are squeezed all together by an extraction of oil
before being incubated into 70 µm deep delay line (incubation chamber). The fluorescence
is then detected by a laser point (λlaser = 532nm) through 20µm deep constriction where
droplets are passing one by one allowing the detection of the increase of fluorescence at
different positions along the incubation chambers line. Onto this chip, twenty-three check
points are added with t0 positioned after the mixing part. The total number of check points
allows to detect the activity between 15 seconds and 1 minute, according to the flow rates used.
Figure 2.2: Microfluidic platform for the detection of enzymatic activity.
Microfluidic workflow. 60pl droplets formation to compartmentalize
single cells with a fluorogenic substrate. Blue: 60pL droplets formation;
red: mixing inside the droplets; yellow: extraction of oil to compact the
droplets; pink: 15 minutes incubation time; green: enzymatic check point
for fluorescence by laser. Scale bar is equal to 100µm.
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The monodisperse droplets are generated by a co-flow drop maker design and the use
of Nemesys syringe pumps (Cetoni, Germany). The cell suspension at the desired optical
density, the reagent mix and the oil with the desired percentage of surfactant are introduced
inside 1mL plastic syringes (Omnifix, Carl Roth), and are loaded inside the microfluidic
chip. The flow rates for the two acqueous phases is set between Qaq=[20;100]µL.h−1 and
Qoil=[100;300]µL.h−1 for a droplet volume equivalent to Vdroplet=[50-70]pL. The oil extraction
consists on a 1mL plastic syringe filled with HFE-7500, loaded on the microfluidic chips and
have a flow rate set between Qextraction=[-50;-300]µL.h−1 .
According to equation 2.1, the incubation time expected is set between 4 minutes and 13
minutes with a length of the channel of l=0.4m, a width of w=1mm, a depth of the channel of
h=70µm for a desired drop volume of 60pL, using syringe pumps.
2.2.2 Workflow # 2: enzymatic activity detection in 45 min-
utes
To use the second integrated worflow, a cell suspension is first encapsulated inside
droplets at the single-cell level using a drop maker design on the side. Droplets of 15 pL
are generated with fluorinated oil (Novec7500, 3M ) containing 1% of Fluosurf surfactant
(Emulseo, France) and collected inside a vial containing fluorinated oil (Novec7500, 3M )and
1% of Fluosurf surfactant (Emulseo, France).
The emulsion is then reinjected inside the workflow represented in figure 2.3 where the droplets
are spaced by fluorinated oil (Novec7500, 3M ), until reaching the picoinjection zone where
15pL of reagent mix is introduced inside the droplet due to electrocoalescence. 30pL droplets
are then compacted by an oil extraction to continue through 70 µm deep incubation chambers.
The fluorescence is then detected by a laser point (λlaser = 532nm) through 20 µm deep
constriction where droplets are passing one by one allowing the detection of the increase
of fluorescence at different positions along the incubation chambers line. Onto this chip,
twenty-three check points are added with t0 positioning after the mixing part. The total
number of check points allows to detect the activity between 30 seconds and two minute
approximately according to flow rates.
The emulsion is first generated on a co-flow drop maker module using Nemesys syringe
pumps (Cetoni, Germany). The cell suspension at the desired optical density, the reagent
mix and the oil with the desired percentage of surfactant are introduced inside three different
1mL plastic syringes (Omnifix, Carl Roth), and are loaded inside the microfluidic chip. The
flow rates for the two aqueous phases is set at Qaq = 50µL.h−1 and Qoil = 600µL.h−1 for a
droplet volume equivalent to Vdroplet = 15pL. The emulsion is then collected into a plastic
or glass vial filled with HFE-700 mixed with the desired percentage of surfactant and then
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Figure 2.3: Microfluidic platform for the detection of enzymatic
activity. Single-cell compartmentalization encapsulated in 15pL droplets
are reinjected and picoinjected with the fluoreogenic substrate. Purple:
15pL droplets reinjection; blue: picoinjection of 15pL substrate inside
the droplets (20kHz, 100Vpp); red: mixing inside the droplets; yellow:
extraction of oil to compact the droplets; pink: 45 minutes incubation
time; green: enzymatic check point for fluorescence by laser. Scale bar is
equal to 100µm.
reinjected in the workflow # 2. For this second workflow, Fluigent pressure system is used.
The emulsion is reinjected with a pressure between Pemulsion = [700;1000]mBar, spaced with
a phase made of HFE-7500 mixed with the desired percentage of surfactant within a pressure
of Pspacing = [700;1000]mBar, and the reagent mix is injected with a pressure of Preagent =
[700;900]mBar to inject the equivalent of 15pL of mix. This injection is possible by applying
an electric field onto the chip, activated by a high-voltage amplifier, outputting a voltage of
100Vpp at a frequency of 20kHz through the electrodes of the chips.
2.2.3 Workflow # 3: screening based on enzymatic activity
This worflow will be used for enzymatic activity which can be detected in less than 20
minutes.
First, an emulsion of cell suspension is encapsulated at the single-cell level with the fluorogenic
assay using a co-flow drop maker and is collected into a vial, as seen in figure 2.4. The vial is
placed into ice while encapsulation to stop the chemical reaction inside the droplets and to
define the same t0 of the reaction for all droplets.
Once the emulsion collected, this one is incubated at room temperature for a desired
amount of time and then reinjected into a FADS design ([Baret et al., 2009]) to sort the
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(a) Sketch platform. (b) Experiment images.
Figure 2.4: Microfluidic modules for the screening of enzyme variants.
(A)Single-cell encapsulation through two drop maker design. (B)Glass
vial filled with a layer of emulsion of droplets on top and oil mixed with
surfactant at the desired percentage.
different populations triggered on droplet fluorescence (see figure 2.5).
Figure 2.5: Reinjection of a monodisperse emulsion into the fluores-
cence activated sorting device. When an AC electric field was applied
across the electrodes, the droplets were deflected into the positive arm.
In the absence of a field, the droplets flowed into the negative arm owing
to the lower hydraulic resistance. Scale bar is equal to 100µm.
The emulsion containing two population of droplets (cells and a control) is first generated
on a co-flow drop maker module using Nemesys syringe pumps (Cetoni, Germany). The
cell suspension at the desired optical density, the reagent mix and the oil with the desired
percentage of surfactant are introduced inside three different 1mL plastic syringes (Omnifix,
Carl Roth), and are loaded inside the microfluidic chip. The flow rates for the two acqueous
phases is set at Qaq = 50µL.h−1 and Qoil = 600µL.h−1 for a droplet volume equivalent to
Vdroplet = 15pL. The emulsion is then collected onto ice into a plastic or glass vial filled with
HFE-700 mixed with the desired percentage of surfactant and once the encapsulation done,
the emulsion is incubated at room temperature. Then the emulsion is reinjected into the
sorting design at a flow rate of Qemulsion = [50-150]µL.h−1, spaced out in the main channel
by a flow of oil mixed with the desired percentage of surfactant at a flow rate of Qspacing
= [200-400]µL.h−1, and a flow of oil is injected beneath the emulsion at a flow rate of Qoil
= [400-1000]µL.h−1. The droplets are then analyzed by the optical setup and the desired
population is sorted at a frequency of Fsorting = [100-800]Hz by the data acquisition card
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providing a signal to the high-voltage amplifier at a frequency of 30kHz through the electrodes
of the chips.
2.2.4 Workflow # 4: screening on chip based on enzymatic
activity
This workflow will be used for a screening of desired populations based with the enzy-
matic activity detected on-chip through time in less than 40 minutes.
It is also an integrated system but instead of determining the activity through check points
all along incuabation chambers, there is a sorting of droplets system according to fluorescence
(FADS) at the end of the delay line (see figure 2.6).
This workflow works the same as workflow #2: a cell suspension is encapsulated at the
single-cell level into 15pL droplets and collected into a vial. Then the emulsion is reinjected
inside the platform, where the droplets are spaced by fluorinated oil (Novec7500, 3M ), until
reaching the picoinjection zone where 15pL of reagent mix is introduced inside the droplet
due to electrocoalescence. 30pL droplets are then compacted by an oil extraction to continue
through 50 µm deep incubation chambers. Once the emulsion reaching the end of the delay
line, the droplets are spaced by fluorinated oil (Novec7500, 3M ), the fluorescence is detected
by a laser point (λlaser = 532nm) at a defined place, to allow sorting of the selected population.
Figure 2.6: Microfluidic platform for the screening of enzyme variants.
Microfluidic workflow. Single-cell compartmentalization encapsulated
in 15pL droplets are reinjected and picoinjected with the fluoreogenic
substrate. Purple: 15pL droplets reinjection; blue: picoinjection of 15pL
substrate inside the droplets (20kHz, 100mVpp); red: mixing inside the
droplets; yellow: extraction of oil to compact the droplets; pink: 45
minutes incubation time; dark blue: FADS. Scale bar is equal to 100µm.
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The emulsion is first generated on a co-flow drop maker module using Nemesys syringe
pumps (Cetoni, Germany). The cell suspension at the desired optical density, the reagent
mix and the oil with the desired percentage of surfactant are introduced inside three different
1mL plastic syringes (Omnifix, Carl Roth), and are loaded inside the microfluidic chip. The
flow rates for the two aqueous phases is set at Qaq = 50µL.h−1 and Qoil = 600µL.h−1 for a
droplet volume equivalent to Vdroplet = 15pL. The emulsion is then collected into a plastic
or glass vial filled with HFE-700 mixed with the desired percentage of surfactant and then
reinjected in the workflow # 4. For this workflow, Fluigent pressure system is used. The
emulsion is reinjected with a pressure between Pemulsion = [750;1050]mBar, spaced with a
phase made of HFE-7500 mixed with the desired percentage of surfactant within a pressure
of Pspacing = [750;1050]mBar, and the reagent mix is injected with a pressure of Preagent =
[750;950]mBar to inject the equivalent of 15pL of mix. This injection is possible by applying
an electric field onto the chip, activated by a high-voltage amplifier, outputting a voltage of
100Vpp at a frequency of 20kHz through the electrodes of the chips. Once the emulsion is
flowing out of the delay lines, the droplets are spaced out by a flow of oil mixed with the
desired percentage of surfactant at a flow rate of Qspacing = [20-150]µL.h−1. The droplets
are then analyzed by the optical setup and the desired population is sorted at a frequency
of Fsorting = [100-300]Hz by the data acquisition card providing a signal to the high-voltage
amplifier at a frequency of 30kHz through the electrodes of the chips.
2.3 Microfabrication & characterisation of platforms
One of the key steps of microfluidics technology is to produce microfluidic devices in a
reliable and efficient process.
2.3.1 Photolithography & Softlithography
The technique used to transfer copies of a master pattern onto the surface of a solid
metal, a silicon wafer (Si-Mat, Germany), is called photolithography
([Xia and Whitesides, 1998], [McDonald et al., 2000]). It is an optical method using a light
sensitive polymer, a photoresist, for exposition and development to form 3D relief image on
the substrate, the silicon wafer.
The first photolithography was made in 1827 by Joseph Nicéphore Niépce who engraved
Cardinal Georges d’Amboise ([Gernsheim, 1977]).
For microfluidic purpose, designs of microchannels are created using the software Au-
toCAD (Autodesk, Inc) and are printed as transparent features on an opaque plastic sheet,
a photomask, by Selba (Selba S.A, Switzerland) with a 50800 dpi resolution. The mask
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is patterned onto the silicon wafer, chemically compatible with almost all solvents, by UV
exposure using an MJB4 (SUSS Microtec, Germany) using spin coated negative photoresist
SU8 3025 or SU8 3050 (MicroChem Corp., USA) depending on the desired layer depth. The
negative photoresist allows the portion exposed to the light to crosslink and become insoluble
to photoresist developer (SU8 developer, MicroChem Corp, Germany). Two rounds are
performed for the developed designs, starting by the thinner layer.
Microfluidic devices fabrication is dominated by molding approaches to transfer the
channels pattern into the substrate by using a soft polymer, usually PDMS (polydimethyl-
siloxane). This method is called softlithography (figure 2.7). PDMS is optically transparent
(from 240 to 1100nm), biocompatible, low cost, have a resolution down to few nanometers
and has a low auto-fluorescence ([Teruo, 2002], [Wei et al., 2005]). The PDMS polymer also
has some limitations ([Lee et al., 2003]), but it will no affect our microfluidic systems.
The usual protocol is defined as followed. A 5 inch silicon wafer is placed on a hot plate
for 5 minutes at 95◦C. The wafer is then put onto a spin coater where the negative photoresist
SU8-3025 is poured onto it.
For a first layer of 20µm height, it is spined at 500 rpm for 10 seconds with an acceleration of
100 rpm.second−1, then at 4200 rpm for 30 seconds with an acceleration of 300 rpm.second−1,
according to data sheet of the photoresist (SU8-3000, MicroChem). Then, the wafer is placed
on a hotplate for 10 minutes at 95◦C to realize the soft baking. After cooling down to
room temperature, the wafer is exposed for 16.5 seconds with a mask aligner (MJB4, SUSS
MicroTec) holding the photomask (Selba S.A, Switzerland) on which the features are printed.
After exposing, the wafer is post-baked for 1 minutes at 65◦C and for 3 minutes at 95◦C. The
wafer is then developed in a developer solution (MicroChem) for 6 minutes and placed for 3
minutes at 180◦C on a hot plate for an hard baking. The table 2.1 represents the different
data to change in the protocol for an another height of the negative photoresist.
Thickness SU8-3000 Speed Exposure Soft Bake Post Bake Develop
20µm 3025 4200rpm 16.5s 10min 3min 6min
30µm 3025 3000rpm 20s 15min 5min 10min
50µm 3050 3000rpm 24s 15min 5min 8min
70µm 3050 2100rpm 27.5s 25min 10min 8min
Table 2.1: Lithography protocol using negative photoresist SU8-3000
For a double layer mold with a second layer of 70µm, the same wafer is used. Once
cooled down to room temperature after the hard bake, it is placed onto a spin coater where the
negative photoresist SU8-3050 is poured onto it. it is spined at 500 rpm for 10 seconds with
an acceleration of 100 rpm.second−1, then at 2100 rpm for 30 seconds with an acceleration of
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300 rpm.second−1, according to data sheet of the photoresist (SU8-3000, MicroChem). Then,
the wafer is placed on a hotplate for 25 minutes at 95◦C to realise the soft baking. After
cooling down to room temperature, the wafer is placed onto the mask aligner (MJB4, SUSS
MicroTec) holding the photomask (Selba S.A, Switzerland) on which the features are printed,
the alignment of the mask features and the one on the first layer of the wafer is done and
then the exposition starts for 27.5 seconds. After exposition, the wafer is post-baked for 1
minutes at 65◦C and for 10 minutes at 95◦C. The wafer is then developed in a developer
solution (MicroChem) for 8 minutes and placed for 3 minutes at 180◦C on a hot plate for an
hard baking.
Once the wafer cooled down at room temperature, a mixture of Sylgard 184 silicon elastomer
with a curing agent (Samaro, France) at the ratio 10:1 (w/w). This mix is degassed under
vacuum, poured onto the silicon wafer and cured at 65◦C during at least 2 hours. The cured
PDMS layer is pealed off and inlets and outlets are punched out of the PDMS with a 0.75mm
diameter Uni-Core biopsy punch (WPI, France) and electrodes inlets with a 0.5mm diameter
Uni-Core biopsy punch (WPI, France). PDMS chips are washed with isopropanol and dried
out with compressed air. Then sealed to a microscope glass slide by exposing both parts to
oxygen plasma (Brand plasma) by pressing them together and placed in the oven at 65◦C for
at least 20 minutes. Exposure to plasma permits to form a covalent connection between the
polymer and the glass slide to sealed them perfectly by destroying and introducing chemical
groups (Katzenberg2005). For devices with electrodes, indium tin oxide (ITO) coated glass
slide are used (brand) and the electrode microfluidic channels are filled with low-temperature
alloy (Indium corporation of America, USA) melted at 90◦C. Electric connections are made
with short pieces of electric wire and glue to the PDMS with an UV glue (brand).
The figure 2.7 represents the exemple of the process for photolithography, softlithography
and chip bonding using PDMS polymer.
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(a) Photomask (b) Wafer with PDMS
(c) PDMS (d) PDMS chip
Figure 2.7: Microfluidic basis. (A)Photomask printed with the channels
design. (B)Wafer engraved by the channels and covered with PDMS.
(C)PDMS layer after baking. (D)Final microfluidic chip when PDMS is
bonded onto the glass slide. Scale bar is equal to 2cm.
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2.3.2 Characterisation
All channels from the integrated systems are characterized by using a profilometer
(Bruker, France). A profilometer is an optical microscope used for high-resolution 2D/3D
roughness measurements of a substrate.
The important parts of each platforms have been analyzed by this technique and represented
in the tables 2.3.2. Those parts consists on the height of the co-flow or the picoinjection
nozzle, the entrance, inside and the end of the delay line and the sorter module.
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2.4 Emulsification
2.4.1 Oil & surfactant
An emulsion of droplets is by definition unstable and tends to coalesce when in contact.
Adding a surface active agent, a surfactant, provides an energy barrier to stabilize the
dispersion in a metastable state and overcome problems of stability, leakage and biological
compatibility ([Baret, 2012]).
The role of the surfactant molecules is to increase the height of the energy barrier between
the local energy minima of the system and its global minimum. This minimum is reached
with a simple system where both phases are separated by an interface of minimal energy and
in which the chemical potentials of all species is homogeneous (figure 5.18) ([Bibette et al.,
1991], [Gruner et al., 2016]).
(a) Structure of one surfactant molecule.
(b) Arrangement of micelles.
Figure 2.8: (A)Surfactant structure with a head hydrophilic and a tail
hydrophobic. (B)Arrangement of molecules around water and oil (w/o)
droplets.
The surfactant used during this project is a home-made perfluoroether polypropylene
oxide chain copolymer made of krytox and synthesized according to the protocol described in
Gruner et al ([Gruner et al., 2016]). The production of the surfactant is protected by a patent
(EP2077912) from the CNRS and Harvard made in 2008 and now produced and sold by the
start up Emulseo in Bordeaux.
All experiments are performed using 1% of surfactant mixed with fluorinated oil HFE-7500
(3M, USA) to circumvent the exchange of molecules between droplets. This percentage of
surfactant is used since it combined a high monodispersity of the emulsion (figure 2.9) and no
satellitte droplets at the formation.
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Figure 2.9: Diameter of droplets according to surfactant percentage.
Experimental data for the formation of droplets for a hypothetic volume
of 15pL with a diameter ddroplet=77µm (acqueous flow = 100µL.h−1, oil
flow = 600µL.h−1). Error bars correspond to the standard deviation
over 200 droplets.
Through the graph 2.9 one important role of surfactant is represented: there is no
dependence of the surfactant concentration for the droplet diameter within same flow rates
experiment. Indeed, the control of flows along calibrated channels and nozzle designed
specifically for a range of droplet diameter, plus the use of surfactant permit to control the
diameter of droplets on a microfluidic chip. The article from Baret et al ([Baret et al., 2009])
explained the utility of surfactant in this phenomenon. Indeed, the mean droplet size of a
stabilized emulsion is governed by two fundamental processes, which are droplet rupture and
droplet coalescence. The use of surfactant affects those processes by reducing the interfacial
tension providing a barrier to prevent coalescence via the repulsive interaction between the
adsorbed layers on the two colliding droplets. Therefore it helps the droplet stability and
hence the monodispersity of the emulsion.
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2.4.2 Single-cell level analysis
To screen libraries of enzyme, the experiment must be done at the single cell measure-
ment. For that, droplet-based microfluidics presents good advantages ([Hümmer et al., 2015]).
Griffiths and Tawfik demonstrated first that aqueous microdroplets in an oil carrier phase
can be used to link genotype and phenotype leading to the selection of enzymes with altered
specificity or enhanced activity ([Griffiths and Tawfik, 2003], [Cohen et al., 2004]). Single-cell
analysis is an interesting topic knowing that by encapsulating individual cells in droplets,
proteins secreted from a cell remain associated with it. Therefore, single-cell screening of
expressed protein is open for directed evolution analysis ([Huebner et al., 2007]).
Our project is to analyze and screen libraries of enzymes at the single-cell level (figure
2.11). Therefore, the number of cells inside each droplets can be estimated using the Poisson
law distribution in which the probability P(X) of finding x cells per droplet is given by the
equation 2.10a.
P (x) = e−λ
λx
x!
(2.2)
(a) Poisson law equation.
(b) Graph.
Figure 2.10: (A)with λ representing the mean number of cells in the
volume of each droplet ([Huebner et al., 2007], [Collins et al., 2015]).
Droplet occupancy is tuned by changing the cell density in the aqueous
phase. (B)Poisson law distribution graph for different λ.
As a result, our experiments are considered in the case where λ=0.1 cells. Considering
that the cell encapsulation process is random (figure 2.10b), it will results as 90% of the
emulsion remain empty while 10% contain only one cell.
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(a) Encapsulation.
(b) One drop.
Figure 2.11: Schematic of the project experiment at the single-cell level
representing (A)the encapsulation in droplets of individual cell using the
Poisson law statistic & (B)the reaction inside one droplet containing one
cell.
2.5 Conclusions
In this chapter, we presented the development of microfluidic platforms for the engineer-
ing and analysis of enzymes used in therapeutical treatment. Four different platforms and
protocols for droplet-based analysis at the single-cell resolution have been established and
optimized based on an optical setup. Each workflow possesses their own characteristics and
purpose: two of them are developed to detect the kinetic activity of an enzyme over time, and
two to screen a library of enzyme variants according to desired properties. The advantages of
those workflows are summarized in the table 2.6.
The four microfluidic platforms are produced using standard softlithographic techniques,
characterized by the use of a profilometer and optimized for the analysis of enzyme kinetics
at the single-cell level. To use those platforms, an optical setup has been employed based
on the fluorescence detection. This setup is composed of three lasers, a set of mirrors and
photomultiplier tubes, an inverted microscope, a high-speed camera and a data acquisition
card.
Those microfluidic workflows will be used for the high-throughput screening of the enzymatic
activity of an enzyme used in therapeutical treatment.
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Droplet volume Incubation Flow rates Readouts Thickness
Workflow # 1 Vdrop = 60pL t = 12min Qacq = 30µL.h
−1 23 h(1stlayer) = 20µm
Qoil = 150µL.h−1 h(2ndlayer) = 70µm
Workflow # 2 Vdrop = 30pL t = 40min Pacq = [750;800]mBar 23 h(1
stlayer) = 20µm
Poil = [800;850]mBar h(2ndlayer) = 70µm
Workflow # 3 Vdrop = 30pL Leakage Qacq = 50 µL.h
−1 2 h(co− flow) = 20µm
dependence Qoil = 300µL.h−1 h(FADS) = 30µm
Workflow # 4 Vdrop = 30pL t > 15min Pacq = [750;800]mBar 2 h(1
stlayer) = 20µm
Poil = [800;850]mBar h(2ndlayer) = 70µm
Table 2.6: Properties of the droplet-based protocols established during
the project.
2.6 Résumé du chapitre
Dans ce chapitre, nous présentons le développement de plateformes microfluidiques
pour ingénierie et l’analyse des enzymes utilisées dans le traitement thérapeutique. Quatre
plateformes et protocoles différents ont été établis et optimisés pour l’analyse à base de
gouttelettes à la résolution unicellulaire, en fonction du système optique développé. Chaque
plateformes possèdent ses propres caractéristiques et objectifs: deux d’entre elles sont dévelop-
pées pour détecter l’activité cinétique d’une enzyme au cours du temps et les deux autres
pour sélectionner une bibliothèque de variants d’enzyme en fonction des propriétés souhaitées.
Les quatre plateformes microfluidiques sont produites à l’aide des techniques classiques de
softlithographie, caractérisées par l’utilisation d’un profilomètre et optimisées pour l’analyse
de la cinétique enzymatique au l’échelle de la cellule unique. L’optimisation consiste à
encapsuler des cellules dans une émulsion monodisperse en utilisant un tensioactif, et la
résolution unicellulaire est obtenue en tenant compte de la distribution de la loi de Poisson.
Pour utiliser ces plateformes, une station optique basée sur la détection de fluorescence a
été utilisée. Cette station est composée de trois lasers, d’un ensemble de miroirs et de tubes
photomultiplicateurs, d’un microscope inversé, d’une caméra haute vitesse et d’une carte
d’acquisition de données. Un programme écrit sous le logiciel LabView fournit des données
des gouttes détectées passant par le point du laser, telles que l’intensité de fluorescence. Les
données sont ensuite post-traitées avec des scripts maison à l’aide du logiciel SciLab à partir
duquel la distribution de fluorescence est générée au cours du temps à l’aide d’histogrammes.
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Summary Chapter 2
• The development of four droplet-based protocols based on fluorescence detection have
been optimized.
• The microfabrication of microfluidic chips is controlled for the four different platforms.
• Four different protocols using the developed workflows have been established:
– Workflow #1 to detect on chip over time the enzymatic kinetic of highly active
variants identify in less than 15 minutes.
– Workflow #2 to detect on chip over time the enzymatic kinetic of active variants
identify in less than 45 minutes.
– Workflow #3 to screen active variants with an enzymatic activity detectable on
chip.
– Workflow #4 to screen active variants with an enzymatic activity detectable in
less than 40 minutes on chip through time.
– Control of the designs for biological workflows embeddable in droplets by the use
of Poisson law distribution and a percentage of surfactant to encapsulate cells in
monodisperse emulsion.
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Microfluidic systems for the detection
of the bacterial L-asparaginase enzymac-
tic activity
We describe in this chapter the use of three microfluidic platforms for the screening of
L-asparaginase, an enzyme used in therapeutics for the treatment of Acute Lymphobastic
Leukemia (ALL). This work is done in collaboration with the group of Manfred KONRAD at
the Max Planck Institute (MPI) for Biophysical Chemistry in Goettingen, and an another
PhD student, Mickaël MORVAN, who was in charge of the biological aspect of the project. My
contribution concerns the development of analytical and screening tools using droplet-based
microfluidics.
3.1 L-asparaginase: an enzyme for clinical treat-
ment
L-asparaginase is an enzyme which occurs naturally in a variety of plants, animals (mam-
mals, birds) and microorganisms (bacteria, fungi, algae, yeast) ([Clementi, 1922]; [Michalska
et al., 2006]). Though the enzyme is widely distributed, only few L-asparaginase possess
anti-neoplastic activity ([Kotzia and Labrou, 2005]) and are used as a clinical treatment for
ALL.
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The enzyme was first found in 1904 by Lang but the history really starts in 1922 when
Clementi first observed L-asparaginase in the blood serum of guinea pigs ([Clementi, 1922]).
The discovery of L-asparaginase as an anti-tumor began in 1953 when Kidd reported that the
growth of certain neoplasms in mice and rats was inhibited by guinea pig serum ([Kidd, 1953]).
In a series of experiments, Broome defined L-asparaginase as the active factor in guinea pig
serum ([Broome, 1961]). The next major advance came in 1964 when Mashburn showed that
L-asparaginase isolated from E. coli was as effective as an anti-tumor agent as guinea pig
serum ([Mashburn and Wriston, 1963]).
3.1.1 Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia (ALL) is a type of cancer concerning hematologic
malignancies representing approximately 25% of cancer diagnoses among children younger
than 15 years old ([Egler et al., 2016]; [Meti et al., 1995]).
L-asparaginase was introduced into pediatric treatment protocols after a 5-years event-free
survival rate of about 70% for the total group of patients ([Ettinger et al., 1997]). The goal of
the treatment with L-asparaginase is to deplete the availability of the serum pool found in
the human blood ([Egler et al., 2016]).
In a significant number of patients with ALL, the malignant cells are dependent on an ex-
ogenous source of the amino acid L-asparagine to complete protein synthesis ([Prager and
Bachynsky, 1968]).
The enzyme L-asparaginase has the ability to deplete the amino acid L-asparagine from
human blood and other extracellular fluids ([Vieira Pinheiro et al., 2006]) by catalyzing the
conversion of L-asparagine to aspartic acid and ammonia ([Campbell et al., 1967], [Roberts
et al., 1966], [Broome, 1981]). This depletion of the systemic pool leads to nutritional
deficiencies and induces apoptosis of malignant cells as seen in figure 3.1 ([Onuma T, 1971];
[Ho et al., 1970]; [Broome, 1981]; [Mitchell et al., 1994]).
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Figure 3.1: Role of L-asparaginase in normal and tumor cells. In the
absence of L-asparagine synthetase enzyme, intracellular synthesis of
L-asparagine does not take place in tumor cells.
Tumor cells have an unusually high requirement for L-asparagine: as they can not
synthetize this amino acid, they depend on serum levels of L-asparagine for their proliferation
and survival ([Prager and Bachynsky, 1968], [Miller et al., 1969], [Onuma T, 1971]). Whereas
normal cells which are protected from L-asparagine requirement due to their ability to produce
this amino acid by themselves ([Kotzia et al., 2007]).
The first clinical trial for patients suffering of ALL was performed with L-asparaginase
both from guinea pig and E. coli. Both enzymes showed clinical efficiency which was confirmed
in further studies ([Dolowy et al., 1966], [Roberts et al., 1966], [Hill et al., 1967], [Campbell
et al., 1967], [Clarkson et al., 1970]).
Nowadays, E. coli L-asparaginase is the therapeutic agent used in the treatment of ALL
([Keating et al., 1993], [Müller and Boos, 1998]). However, E. coli L-asparaginase is also
known as an exogenous species which affects normal tissues ([Oettgen et al., 1970]). The
treatment is then often rejected by the patient through immuno-response (production of
specific antibodies, hypersensitivity, coagulation disorder, ...).
Naturally, the enzyme L-asparaginase is produced inside the human body and would provide
an alternative to the use of E. coli enzyme. Injection of human L-asparaginase would avoid
any immune-response from patient by increasing the tolerance and efficiency of the treatment.
However, the human L-asparaginase is 1000-fold less active than the bacterial one.
Our goal is thus to use directed evolution to engineer variants of the human L-
asparaginase to increase its activity and try to reach the bacterial activity level.
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3.1.2 Directed evolution
In the process of directed evolution (figure 3.2), a diverse library of genes is translated
into a corresponding library of mutated proteins and screened in a manner that maintains the
correspondence between genotype and phenotype. It mimics the natural process of evolution
based on the selection of the fittest sequences in principle ([Kuchner and Arnold, 1997]). This
technique employs the generation of random mutations through the whole protein sequence,
succeeded by the selection and screening of variants with desired properties ([Romero and
Arnold, 2009]). The critical steps in directed evolution are the selection of the starting point,
the generation of the mutant library, the development of the screening assay and finally, the
analysis of the output of the screening method ([Martínez and Schwaneberg, 2013]).
Figure 3.2: Key steps in the cycle of directed evolution. The process
of directed evolution in the laboratory mimics biological evolution. A
diverse library of genes is translated into a corresponding library of gene
products and screened or selected for functional variants in a manner that
maintains the correspondence between genotype (genes) and phenotype
(gene products and their functions). These functional genes are replicated
and serve as starting points for subsequent rounds of diversification and
screening or selection. Reprinted from Packer et al, 2015 ([Packer and
Liu, 2015]).
However, directed evolution experiments are often limited by the screening technique
employed ([Leemhuis et al., 2009]). Indeed most of cell biology experiments are performed
in bulk, leading to a lack of high throughput analysis. Using those platforms, only 103-104
variants per screen are allowed.
However, Tawfik et al presented a model system of cell-like compartment for molecular
evolution using the compartmentalization of water-in-oil emulsions allowing a faster selection
([Tawfik and Griffiths, 1998]). Enzymes are isolated from numerous organisms and directed
evolution is performed only in a few different host organisms such as E. coli, Bacillus subtilis
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and Saccharomyces cerevisiae being the standard hosts, based on their high transformation
efficiencies and well established genetic manipulation tools. Consequently, in the litterature,
different techniques are used to allow the high-throughput single-cell screening of biodiversity
using microfluidics and those hosts. Longweel et al, proposes microchambers arrays ([Longwell
et al., 2017]), Terekhov et al works with a FACS assisted platform ([Terekhov et al., 2017]),
Agresti et al incubates for a small amount of time on chip by using delay lines ([Agresti et al.,
2010]). Otherwise, some teams handles platforms using a time of incubation off-chip ([Kintses
et al., 2012], [Beneyton et al., 2014]). All of those methods allow the screen of 107-108 variants
and a sorting of desired droplets at a rate close to 1kHz.
As for the L-asparaginase enzyme, recently some experiments using directed evolution
to find potential clinical use of this enzyme has been developed. Two groups proposed two
different fast screening systems. One is based on the growth of several potentials strains on
agar plate and the selection from the dependence on the reaction product on ammonium
([Rigouin et al., 2017]), and the other one on the screening through 96-deep well plates based
on Nessler reaction ([Li et al., 2018]). Those types of platforms are not as fast and efficient as
microfluidic platforms. Therefore, for the precise case of L-asparaginase, there is a need to
develop a microfluidic platform allowing a high statistic screening for competent strains.
3.1.3 Definition of the project
The project aims to use microfluidic platforms for the high-throughput screening of
libraries of variants of the human L-asparaginase to select individually the most active clones.
My aim is to design and run microfluidic systems for the analysis and screening of cells express-
ing L-asparaginase. At first, E. coli enzyme will be used to enable a positive demonstration
of the platforms developed, to then adapt the conditions to the human L-asparaginase one.
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3.2 Vector expressions of L-asparaginase
E. coli is the main host microorganism used for the high-level production of recombinant
proteins. E. coli and other Gram negative bacteria are enclosed by two discrete membranes,
the outer membrane and inner or cytoplasmic membrane. There is a panel of expression
systems available to export the protein of interest to a specific cellular compartment ([Hannig
and Makrides, 1998], [Cornelis, 2000]). Each expression vector is a plasmid designed to
introduce a specific gene into a target cell and to exert the cell’s mechanism for protein
synthesis (Figure 3.3).
• Secretion. Secretion mechanism causes the enzyme to secret directly into the medium.
Therefore, the accessibility of the enzyme is not possible and the encapsulation of cells
at the single-cell level is not doable.
• Cytoplasmic expression. In the litterature, cytoplasmic expression is the most employed
for protein production because of a result of an acceptable production yield and a
simpler plasmid construct ([Kintses et al., 2012]). However, the enzyme expression
is not easily accessible and this expression requires a cellular lysis to circumvent the
cell barrier (figure 3.3 (A)). The lysis of E. coli may be achieved using chemical lysis
methods such as detergents (Triton-X100; Tween-20...) or lysozyme. Unfortunately, the
lysis can affect enzymatic reaction and mainly complicate the analysis of the interesting
mutant after high throughput screening. Therefore, the encapsulation at the single-cell
level inside droplets is possible but not interesting in this project.
• Display expression. Display expression is based on anchoring proteins to the periplasmic
face of the inner membrane of Escherichia coli using membrane-based fusion strategies
(figure 3.3 (B)). The antibody fragment displayed is easy of access since it only has
to cross one membrane, the inner membrane ([Harvey et al., 2004]). Therefore, the
encapsulation at the single-cell level inside drops is possible and in interest of this
project.
• Periplasmic expression. Periplasmic expression contains several advantages over cyto-
plasmic production, such as separation from cytoplasmic proteins, enhanced biological
activity, enhanced product solubility ([Gholipour et al., 2010]). Therefore, this expres-
sion system permits a better access to the enzyme with a good yield and can be used in
microfluidic single-cell experiments (figure 3.3 (C)).
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Figure 3.3: Schematic drawing of the three expression way used in this
study (adapted from Harvey, 2004 ([Harvey et al., 2004]). (A) pET14b
vector allowing cytoplasmic expression. (B) pAPEx4b vector anchoring
periplasmic expression. (C) pET22b(+) vector permitting periplasmic
localization of E. coli.
In this project, we compared only three expression systems: cytoplasmic (pET14b),
periplasmic (pET22b(+)) and display (pAPEx4b)vectors. Our choice was brought to those
three strains because of the ability to be used under microfluidic conditions for the project,
meaning the possibility to encapsulate them at the single-cell level (Table 3.1).
Accessibility Yield Single-cell encapsulation Processability
Secretion 7 3 7 3
Cytoplasmic 7 3 3 3
Display 3 3 3 3
Periplasmic 3 3 3 3
Table 3.1: Theoretical features of vector expressions according to
litterature.
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3.3 Fluorescent assay for asparaginase activity de-
tection
An enzymatic cascade was designed at the MPI Goettingen to detect the activity of
L-asparaginase based on the natural substrate of the enzyme, the L-asparagine (Figure 3.4).
The use of the natural substrate is essential to overcome some disadvantages encountered in
other assays using analog of the natural substrate such as the selection of variants showing
improved catalytic efficiency and selectivity for the non-natural substrate ([Cooney and Hand-
schumacher, 1970], [Ylikangas and Mononen, 2000], [Karamitros et al., 2014]).
L-asparaginase catalyzes the hydrolysis of L-asparagine to L-aspartate and ammonium.
L-aspartate is then oxidized by aspartate oxidase and the coenzyme flavin adenine dinucleotide
(FAD) to form oxaloacetate and hydrogen peroxide. This hydrogen peroxide is finally used
by horseradish peroxidase to oxidize Amplex Ultra Red (AUR) into a fluorescent product, a
resorufin analogue (λexcitation = 532nm, λemission = 581nm). The readout of this fluorescent
compound gives directly enzymatic activity value.
The rate-determining step of fluorescence changes in the cascade is the initial L-asparaginase
reaction ([Karamitros et al., 2014]).
Figure 3.4: Fluorescent assay based on its natural substrate for L-
asparaginase activity detection: L-asparaginase catalyzes the hydrolysis
of asparagine to aspartic acid. In the fluorescent assay, aspartic acid is oxi-
dized by aspartate oxidase and cofactor flavin adenine dinucleotide (FAD)
resulting in oxaloacetate and hydrogen peroxide. Hydrogen peroxide is
then utilized by horsradish peroxidase (HPR) to oxidize AmplexUltraRed
(AUR) into resorufin.
This resorufin analogue is detected either in microtiter plates using a spectrophotometer
or in water in oil (w/o) droplets using the developed microfluidic tools. The fluorescence data
determined during experiments are arbitrary values given by the measurement setup.
A simple test is executed to determine a linear relation for the concentration of resorufin
formed over time. For that, the same protocol was used on microtiter plate and microfluidic
platforms: the determination of the maximum level of fluorescence reached for a known
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concentration of AUR, knowing that the final concentration of resorufin that is formed during
the enzymatic cascade depends on the concentration of AUR added into the reagent mix.
In both case, the fluorescence is found to be lineary correlated to the resorufin concen-
tration (figure 3.5).
(a) Resorufin in bulk. (b) Resorufin in drops.
Figure 3.5: Fluorescence intensity versus resorufin concentration plot
from (A)values recorded in a 96-well plate (λexcitation = 532nm, λemission
= 581nm). Error bars correspond standard deviation determined from
duplicated experiments. & (B)values determined in 30pL droplets (λlaser
= 532nm). Error bars correspond to the standard deviation of the
experiment.
Therefore, for the following experiments, the fluorescence data will be expressed as
resorufin concentration according to the calibration of both systems.
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3.4 Detection of the model E. coli L-asparaginase
We first considered the E. coli L-asparaginase as a model for the detection of the
detection of the enzymatic activity using the fluorescent assay based on the natural substrate
of L-asparaginase. We tested three different vector expressions and detected the activity of E.
coli L-asparaginase using both microtiter plate and the developed microfluidic tools (article
in preparation).
3.4.1 Microtiter plate experiment
The fluorescent assay on the E.coli strain was first performed in microtiter plate as a
control step. To determine if the assay could be transferable to a microfluidic platform, the
maximum fluorescence must be detected in a minimum amount of time, typically in less than
30 minutes, to ensure a fast and efficient screening.
The enzyme was produced in the three expression vectors explained in section 3.3 and tested
all together in the following analysis.
In this experiment, the activity of each vectors is measured with a plate reader and the
fluorescence intensity determined by the spectrophotomer is plotted as a function of time.
The figure 3.6 shows the increase of fluorescence reflecting the formation of resorufin, for the
three expressions vectors of E. coli developed and a blank.
The grey curve represents the control parameter of the experiment. It is a mixture
between Phosphate-buffered saline (PBS) buffer and the substrate. The purple, blue and wine
curves represent the periplasmic (pET22b(+)), the display (pAPEx4b) and the cytoplasmic
(pET14b) expressions respectively.
The blank and the cytoplasmic (pET14b) expressions kinetic are considered as equivalent
with a speed near zero (0.76µM.min−3 and 2.79µM.min−1 respectivly).
For the periplasmic (pET22b(+)) and the display (pAPEx4b) vectors, the same behaviors is
observed. Initially, the fluorescence increase promptly until the maximum value of 12.5µM is
reached in 36 minutes with a speed of 39.5µM.min−1 for the display (pAPEx4b) expression
and in 12 minutes with a speed of 113µM.min−1 for the periplasmic (pET22b(+)) expression.
The maximum fluorescence value means that the maximal concentration of resorufin is formed.
The kinetic is then followed by a slow decrease of the fluorescence intensity (natural oxidation
of the resorufin formed as it is formed with AUR, which is a sensitive compound) ([?]).
This hypothesis is represented in figure 3.7 where the the fluorescence from the resorufin is
measured in bulk during 7 hours after the maximum concentration of product is formed. This
control experiment was executed in identical conditions using a spectrophotomer where a
measurement point was taken every 10 minutes.
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Figure 3.6: Calibrated fluorescent assay in microtiter plate. L-
asparaginase activity was determined in 96-wells plates using a three-step
coupled enzyme assay AUR dependant. Each well contained 100µL of E.
coli suspension (OD600nm = 0.03; 3.106 cells.mL−1) mixed with 100µL
of the reaction mixture (L-asparagine (250µM), L-AspOx (700µg.mL−1),
HRP (0.2U.mL−1), FAD (20µM), AUR (12.5µM)). Fluorescence was mea-
sured every 30 seconds during 1 hour (λexcitation = 532nm, λemission =
581nm) with a Spectramax Plate Reader (Molecular Devices). Error bars
represent standard deviation determined from duplicate measurements.
Figure 3.7: Degradation of resorufin according to time in bulk. Values
recorded in a 96-well plate (λexcitation = 532nm, λemission = 581nm).
Error bars correspond to the standard deviation of the experiment.
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The results from the microtiter plate assay for the enzymatic cascade are expected since,
for the display expression, the substrate does not have to diffuse inside the cells, therefore the
activity is identified more promptly than the cytoplasmic expression. As for the periplasmic
vector, the maximum fluorescence is achieved in 24 minutes less time than the display expres-
sion as the the enzyme is in a periplasmic localization so faster in contact with the fluorescent
substrate.
Through this experiment, only two expression vectors have a fluorescence higher than
the control parameter within 30 minutes with a cell density corresponding to the one expected
in drops. The two strains are the periplasmic (pET22b(+)) and the display (pAPEx4b)
expressions. Therefore, those two expressions are the best suitable candidates for a fast
detection of L-asparaginase enzymatic activity using a microfluidic high-throughput screening
system.
3.4.2 Microfluidic experiments
We developed two microfluidic systems to detect the enzymatic activity of the L-
asparaginase at the single-cell level using the three-step coupled fluorogenic assay using the
natural substrate of L-asparagine and to enable the screening of positive variants.
3.4.2.1 Worflow #1: Co-flow & delay lines platform
In this workflow (figure 3.8a), the three expressions vectors and a blank are co-
encapsulated one-by-one at the single-cell level following the Poisson distribution with the
fluorescent assay using HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo,
France) and then incubated through delay lines for 13 minutes. The fluorescence of each
droplets is measured at the encapsulation (t0) and through all the enzymatic check points
(figure 3.8a).
This microfluidic workflow allows the analysis of only one population of cell per chip.
Therefore, the data processing have been reiterated for the periplasmic (pET22b(+)), the
display (pAPEx4b), the cytoplasmic (pET14b) vectors and for the blank (PBS buffer). Each
population of vector expressions was coded with a fluorescent dye called Dextran-Cascade
Blue (Thermo Fisher) with a concentration of 10µM.
The figure 3.8b shows the kinetic evolution of the different E. coli expressions within an
incubation time of 12 minutes.
The grey curve represents the control parameter of the experiment. The purple, blue and wine
curves represent the periplasmic (pET22b(+)), the display (pAPEx4b) and the cytoplasmic
(pET14b) expressions respectively.
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(a) Sketch of the workflow #1. (b) Kinetic evolution of the L-asparaginase
activity.
Figure 3.8: Calibrated fluorescent assay in droplets. (A)HTS microflu-
idic platform. Cells suspension (OD600nm = 0.03; 3.106 cells.mL−1) are
co-encapsulated at the single-cell level following the Poisson distribu-
tion with the fluorescent assay in 60pL droplets and incubated on chip
through delay lines. (B)Kinetic evolution of the L-asparaginase activ-
ity. Resorufin concentration versus time for the cytoplasmic (pET14b),
display (pAPEx4b), periplasmic (pET22b(+)) vector expressions (wine,
blue & purple respectively) and a blank (λlaser = 532nm). Droplets
are encoded with Dextran-Cascade Blue (λlaser = 375nm). Error bars
correspond to the standard deviation of the experiment.
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The behavior observed during microtiter plate experiment is only seen with the periplas-
mic expression (pET22b(+)). A raise of the fluorescence is detected until reaching the
maximum value of 15µM with a speed of 3.37 µM.min−1, to finally discerning a decrease in
fluorescence after 8 minutes.
The decrease of fluorescence represents also the natural oxidation of the resorufin formed as
it is formed with AUR, which is a sensitive compound ([?]). This hypothesis is tested and
represented in figure 3.9 where the the fluorescence from the resorufin is measured in bulk
during 8 hours after the maximum concentration of product is formed. This control experiment
was executed in identical conditions using the three lasers station where a measurement point
was taken every 30 minutes.
Figure 3.9: Degradation of resorufin according to time in droplets. Val-
ues determined in 30pL droplets (λlaser = 532nm). Error bars correspond
to the standard deviation of the experiment.
For the cytoplasmic vector (pET14b), the differentiation is not possible between its
activity and the blank. Both increase speed are close to zero (1.97.10−1 µM.min−1 for the
cytoplasmic and 2.18.10−1 µM.min−1 for the control).
As for the display vector (pAPEx4b), its activity is not clearly enough to be perfectly screened,
with a speed of 5.45.10−1 µM.min−1. This is mainly due to the fact that the incubation time
is too short for this expression system. Indeed, during microtiter plate experiment, the display
expression reaches the maximal concentration of resorufin after 36 minutes with a cell density
of 3.106 cells.mL−1; in drops the cell density is also 3.106 cells.mL−1 but the incubation time
is 12 minutes and there is only one cell per droplet. Consequently, with an incubation time
longer, the fluorescence will hypothetically reach higher values.
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Through this first microfluidic workflow, the periplamic vector (pET22b(+)) is easily
detected (8 minutes to reach the maximum concentration of resorufin formed) and can be
perfectly screened if a sorter module is added at the end of the chip. Nevertheless, the display
vector (pAPEx4b) shows good abilities. Yet, the use of the second microfluidic workflow is
needed to detect the enzymatic activity in 30 minutes of time and then to conclude precisely
on the screening capacity of the display expression system.
3.4.2.2 Worflow #2: Picoinjection & delay lines platform
We then assayed the different expression vectors with the second microfluidic workflow
designed to reach an incubation time of 45 minutes.
The protocol of this workflow is seen in figure 4.4a. The three E. coli expressions and a
control (PBS buffer) are encapsulated at the single-cell level following the Poisson distribution,
using drop makers with HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo,
France). Each populations are encoded with Dextran-Cascade Blue fluorescent dye with a
different concentration. Droplets are collected into a vial filled with HFE-7500 (Novec, 3M )
and 1% of Fluosurf surfactant (Emulseo, France). Then, droplets are reinjected into the
second microfluidic platform where the droplets are injected one-by-one with the fluorescent
assay, thanks to a picoinjection module ([Abate et al., 2010]). The picoinjection allows the
injection of an aqueous phase in every droplets by merging due to electro-coalescence with
an AC field. Finally, droplets are incubated on chip, passing through delay lines and the
fluorescence of each drops is measured at the encapsulation (t0) and through all the enzymatic
check points (see figure 4.4a).
The figure 3.10b represents the kinetic evolution of the three different vector expressions
of E. coli and the kinetic of the control parameter within an incubation time of 45 minutes.
The grey curve represents the control parameter of the experiment. The purple, blue and wine
curves represent the periplasmic (pET22b(+)), the display (pAPEx4b) and the cytoplasmic
(pET14b) expressions respectively.
The cytoplasmic expression (pET14b) is still not detected compared to the background.
The activity is so low that it follows the natural oxidation of the resorufin (control parameter)
with a same speed of 1.5.10−1 µM.min−1.
As for the periplasmic vector (pET22b(+)), the characteristic behavior of the enzymatic
activity is again observed. The fluorescence rises with a speed of 7.74.10−1 µM.min−1 until
reaching a plateau at 26 minutes. Then, the fluorescence starts to decrease with a small speed
of -4.68.10−2 µM.min−1.
Regarding the display vector (pAPEx4b), the resorufin concentration reached the maximum
after 40 minutes of incubation with a speed of 3.85.10−1 µM.min−1.
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(a) Sketch of the workflow #2. (b) Kinetic evolution of the L-asparaginaseactivity.
Figure 3.10: Calibrated fluorescent assay in droplets. (A)HTS mi-
crofluidic platform. Cells are encapsulated (OD600nm = 0.03; 3.106
cells.mL−1) at the single-cell level, collected into a vial & reinjected on
chip where the fluorescent assay is picoinjected by applying AC field
(20kHz, 100Vpp). (B)Kinetic evolution of the L-asparaginase activity. Re-
sorufin concentration versus time for the cytoplasmic (pET14b), display
(pAPEx4b), periplasmic (pET22b(+)) vector expressions (wine, blue &
purple respectively) and a blank (grey). Droplets of 30pL are encoded
with Dextran-Cascade Blue. Error bars correspond to the standard
deviation of the experiment.
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Through this second microfluidic system, it is still not possible to distinguish the cytoplas-
mic expression (pET14b) from the control parameter, and the periplasmic vector (pET22b(+))
is also perfectly screenable. There is a time difference for the beginning of the enzymatic
reaction compare to the first microfluidic system due to mixing characteristics. However,
regarding the display expression (pAPEx4b), within 30 minutes of incubation, the popula-
tion is differentiable enough from the control parameter to permit a screening of the expression.
In conclusion, all results given by the two different microfluidic workflows are in accor-
dance with the enzymatic kinetic of E. coli L-asparaginase strain observed during microtiter
plate assay: the exact same behaviors are exhibited for the different E. coli vector expressions.
Therefore, the screening of libraries for the display (pAPEx4b) and the periplasmic (pET22b(+))
expressions is possible, while the cytoplasmic expression (pET14b) is discarded.
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3.4.3 Model screening of E. coli L-asparaginase strain
A model screening have been done using the E. coli L-asparaginase enzyme and the
workflow # 3 (figure 4.8a).
To determine the efficiency of the sorting device, a positive and a negative solutions were
mixed. For that, two strains of E. coli was used: one strain expressing L-asparagine in
periplasmic expression, the positive population and the other without a vector expressing the
enzyme ∆E. coli, the negative one.
10% of the periplasmic expression of E. coli L-asparaginase enzyme was mixed to 90% of ∆E.
coli at an OD600nm=0.03 in a 1mL solution. The mix is encapsulated at the single-cell level
following the Poisson distribution with the reagent mix in 30pL droplets using a co-flow drop
makers with HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo, France). The
emulsion is encoded with Dextran-Cascade Blue fluorescent dye to labeled the population.
Droplets are then collected into a vial placed into ice filled with HFE-7500 (Novec, 3M ) and
1% of Fluosurf surfactant (Emulseo, France). The emulsion is incubated at room temperature
for 1 hour. Afterward, droplets are reinjected into the sorting system where selected droplets
detected by the laser are deflected to the collect arm at a frequency comprise between Fsorting
= [400-800]Hz. During the sorting experiment, on the labview software, a screen box has
been define to select the desired population of droplets (figure 4.8b). The background has a
fluorescence level of 0.05RFU and the screening threshold was placed at 0.1RFU.
(a) Sketch of the FADS design.
(b) 2D histogram.
Figure 3.11: Screening of E. coli L-asparaginase enzymatic activity.
(A)Sketch of the microfluidic system used. (B)2D histogram of the
resorufin fluorescence in 30pL droplets (λlasers = 375 & 532 nm). The
red box corresponds to the E. coli population screened under LabView
software.
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The selected droplets are collected inside an ependorf during the experiment, grew and
recovered on an agar plate to determine the enrichment value (figure 3.12a). Three dilutions
of screened droplets have been poured onto agar plates: 1/10, 1/100, 1/1000. Within those
dilutions, the number of drops recovered are of 15800 ± 34% for Fsorting = 400Hz, 14000 ±
60% for Fsorting = 600Hz and 39000 ± 3% for Fsorting = 800Hz.
To determine the composition of the emulsion after the screening experiment, a colori-
metric test on microtiter plate via the Nessler test have been operated. The Nessler analysis
consists on the addition of a Nessler’s reagent, which is an aqueous solution of potassium
iodide, mercuric chloride, and potassium hydroxide used to determine the presence of ammonia.
When this reagent detects ammonia in a particular substance, the color of the solution will
change to a range of color from yellow to brown for low to high concentration of amonia. In
the case of L-asparaginase enzyme, the presence of amonia is detected when the L-asparagine
is catalyzed by L-asparaginase.
This test was performed by absorbance measurements in 96-wells microtiter plate (figure
3.12b) on which each wells contained a culture of an E. coli colony screened.
(a) Agar plates.
(b) Nessler test.
Figure 3.12: E. coli model screening analysis. (A)Agar plates with
active population screened on two different dillutions for the sorting at
Fsorting = 400Hz. 100µL of screened droplets emulsion is mixed in 900µL
of LB and different dilutions of this mix are poured onto agar plates
and incubated (37◦C over night). (B)Nessler test on 96-wells microtiter
plate for the three conditions of sorting: Fsorting = 600Hz from A1 to
B9, Fsorting = 400Hz from B10 to E6, Fsorting = 800Hz from E7 to G12
and the trash from H1 to A12.
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To determine the enrichment values, the model presented by Baret et al ([Baret et al.,
2009]) is used. This model is based on the Poisson distribution and gives a theoretical
enrichment by the equation 3.1:
ηtheo =
1
1− e0λ/1+0 (3.1)
where 0 is the ratio between E. coli:∆E. coli before screening assay and λ is the number
of cells encapsulated per droplet.
The table 3.2 sums up the different requirement to characterize the screening experi-
ments. A colony have been considered as positive when its absorbance was strictly superior
to 1.6. This value of absorbance was chosen as strictly superior to the mean absorbance of
the screening trash which was at 1.26 (0.17).
The mean number of encapsulated cells per droplet λ and the ratio 0 have not been tested
prior experiment as we expected the distribution of cells to follow the Poisson distribution.
As for the determination of ηexp, it is defined as the ratio between 0:1 where 1 is the ratio
between E. coli:∆E. coli after screening assay.
Fsorting 0 Analysed droplets Screened droplets Purity ηtheo ηexp Absorbance
1 400 Hz 0.11 3.105 12000 97% 101 291 2.60 (0.26)
2 600 Hz 0.11 3.105 12000 71% 101 18 2.53 (0.51)
3 800 Hz 0.11 5.105 25000 93% 101 127 2.54 (0.46)
Table 3.2: Requierement data to characterize the screening experiment
of E. coli L-asparaginase.
Regarding the purity of screening, the percentage is high (>90%) for a frequency of
400Hz and 800Hz. Only for the frequency of 600Hz, the value is lower. The first frequency
tested was Fsorting = 600Hz, this is perhaps the reason of a weaker rate, with certainly a
wrong setting for this frequency. If we consider the result for the two other frequency, the
experimental enrichment rate is in the order of 100, which corresponds to the theoretical
enrichment. We can declare this order knowing that the Poisson distribution is a random
encapsulation of cells and to achieve an encapsulation of one cell per droplet, the cell solution
must be diluted at a certain optical density, and this attray has incertitude. Also, on the
Labview software, the percentage of droplets selected to be screened is equal to approximately
4% instead of 1% according to the Poisson Law.
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Therefore, this screening method is validated with a reasonable efficiency for this type
of enzyme kinetic allowing to screen an emulsion 104 active cells in approximately 10 minutes.
However, according to the FADS characteristics in the literature, a higher screening frequency
can be achieved ([Baret et al., 2009]).
3.4.4 From microtiter plate to microfluidic systems
Kinetic measurements are very powerful tools to determine the mechanism of an enzyme.
Those measurements inform on the specificity and physical characteristics of an enzymatic
reaction.
In the literature, L-asparaginase is considered as a Michaelis enzyme ([Matthews et al., 1971],
[Stecher et al., 1999]). Those enzyme operate as the following: a substrate S binds with an
enzyme E to give an intermediate ES called enzyme-substrate complex, which dissociated to
give a product P with regeneration of the enzyme E. Therefore the model equation is given
by equation 3.2, where Vmax represents the maximum initial velocity of product formation:
V = Vmax
[S]
[S] +Km
(3.2)
Those specificity are given by the calculation of two constants from the Michaelis-Menten
kinetics: the Michaelis constant Km and the turnover number kcat (maximum number if
substrate molecules converted to product per active site per unit of time). This kinetic takes
the form of an equation which describe the rate of an enzymatic reaction.
The Michaelis-Menten equation is the basic equation for enzymatic kinetics and the Lineweaver–Burk
plot allows to define the values of Km and Vmax, the maximum reaction velocity, leading to a
value of kcat thanks to the equation 3.3
kcat =
Vmax
[Enzyme]
(3.3)
3.4.4.1 Determination of the constant values
For the microtiter plate experiment, the fluorescence assay is performed in 96-wells
plates where 100µl of purified enzyme are mixed with 100µL of the reaction mixture with a
concentration of L-asparagine set between 5µM and 250µM. The fluorescence is measured
during 30 minutes (λexcitation = 532nm, λemission = 581nm) with a Spectramax Plate Reader.
For the microfluidic assay, 1 mL of solution containing purified enzyme is co-encapsulated
with the fluorescent assay from the enzymatic cascade and a concentration of L-asparagine
set between 10 and 30 µM. The fluorescence is excited with a laser at λlaser=532nm during
15 minutes.
The fluorescence is then plotted according to time for each concentration of L-asparagine
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and the value of V0, the reaction velocity, is determined by linear regression. The inverse
representation or the Lineweaver–Burk graph is then plotted as seen in figure 3.13 and the
final linear regression is calculated to calculate the enzyme kinetics parameters.
The equation of the linear regression is then used as a first way to determine the value of the
constant Km. The extrapolation of the double reciprocal plot is a second method to give a
value of Km and of kcat.
With those two methods, the enzyme showed a saturate kinetic pattern with a Km of 23 µM
& a kcat of 68 s−1 for the bulk assay (see figure 3.13a) and a Km of 38.02 µM & a kcat of 8.68
s−1 for the microfluidic assay (see figure 3.13b).
(a) Lineweaver–Burk plot in bulk. (b) Lineweaver–Burk plot in drops.
Figure 3.13: Linear correlation between the inverse of V0 and the
concentration of resorufin. (A)Reaction in 96-wells plate using a fluores-
cent assay mixed with purified enzyme (λexcitation = 532nm, λemission =
581nm). (B)Reaction in 30pL droplets of purified enzyme coupled with
a fluorescent assay (λlaser = 532nm).
The values of kcat and Km for microtiter plate and microfluidics experiments are shown
in table 3.3.
Km (µM) kcat (s−1) kcat/Km (µM−1.s−1)
E.coli L-ASNase in bulk 23 68 2.9
E.coli L-ASNase in droplets 38 9 0.24
Table 3.3: Experimental constants values.
92
Microtiter plate and microfluidic platforms are two systems reliable. The table 3.3
shows the regularity of those measurements. Indeed, from values given by the literature (see
table 3.4), Km is given between 15 & 100 µM; as for kcat the range of values is between 10 &
30 s−1.
In those range of values, there is a concordance between our results and the literature. Only
the value of kcat from bulk experiment is two times higher.
In this idea, it is safe to conclude that the microfluidic platforms developed are trust-
worthy and are a good answer for high-throughput and maniable screening of variants while
respecting all enzyme characteristics.
Km (µM) kcat (s−1) kcat/Km (µM−1.s−1)
E.coli L-ASNase ([Derst et al., 2000]) 15 24 1.6
E.coli L-ASNase ([Aung et al., 2000]) 100 30 0.3
E.coli L-ASNase ([Kotzia and Labrou, 2005]) 85 31 0.36
E.coli L-ASNase ([Moreno-Enriquez et al., 2012]) 15 21 1.6
E.coli L-ASNase (Karamitros, 2014) 22 12 0.55
Table 3.4: Literature constants values
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3.5 Materials & Methods
3.5.1 E. coli culture
From an isolation on petri dish composed of LB agar medium, a preculture in 2mL of
LB medium mixed with 35µg.mL−1 of chloramphenicol for the display expression (pAPEx4b)
or 200µg.mL−1 of ampicillin for the periplasmic and the cytoplasmic expressions (pET22b(+)
& (pET14b)) was made and incubated for 4 hours at 37◦C. At OD600nm=0.1, cultures of
10mL of LB medium mixed with the corresponding antibiotics was set and incubated at 37◦C
until reaching an OD of OD600nm=0.6-0.8. E.coli were cells were induced with 0.25mM of
IPTG and incubated overnight at 18◦C. 10mL of E. coli culture were centrifuged (4200g,
15min, 4◦C) and the cell pellets were resuspended in PBS 1X buffer and centrifuged again.
Washed cells were resuspended in 1mL of PBS 1X, and cell concentration was determined.
For the microtiter plate experiment, bacterial suspension was diluted until OD600nm = 0.03.
The fluorescent assay was performed in 96-wells plates where 100µl of E. coli suspension were
mixed with 100µL of the reaction mixture. The fluorescence was measured every 30sec during
1hour (λexcitation = 532nm, λemission = 581nm) with a Spectramax Plate Reader (SpectraMax
Paradigm, Molecular Devices). Each well was duplicated.
As for microfluidic experiments, bacterial suspension was diluted until OD600nm = 0.03 into
PBS and transfered into 1mL plastic syringe.
We will consider no sedimentation inside the syringe and the tubing considering the constant
flow inside the syringe and the diameter of the tubing.
3.5.2 Enzyme assay
The reagent mixture combines a solution of the amino-acide L-asparagine at 250µM,
the enzyme L-aspartate oxidase at 700µg.mL−1, the enzyme Horseradish peroxidase (HRP) at
0.2 U.mL−1, the cofactor Flavin adenine dinucleotide (FAD) at 20µM and finally the reagent
Amplex UltraRed (AUR) at 12.5µM.
3.5.3 Microfabrication
Microfluidic devices are fabricated using standard soft lithography methods. SU8
negative photoresist (MicroChem, USA) is deposited onto clean silicon wafers to a thickness
of 20µm and 70µm for platforms # 1& # 2 and a thickness of 30µm for platform # 3, and
patterned by exposure to UV light through a transparency photomask. The microstructures
are developed and poured into PDMS mold made with a mix of the polymer with a cross
linker at the ration 10:1. Once degassed, the mold is cured at 65◦C during at least 2 hours.
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The PDMS replica is peeled off the wafer and bonded to glass slides after oxygen-plasma
activation of both surfaces.
3.5.4 Application
The channels bonded onto the glass slide are covered with Aquapel (Autoserv, Germany)
for hydrophobic surface treatment and thus to improve the wetting of the channels. Polyethy-
lene tubing with an inner diameter of 0.3mm and an outer diameter of 0.76mm (Adtech,
FisherScientific) connects the channels to the syringes. 1mL plastic syringes (Omnifix, Carl
Roth) are used to load the aqueous and oil phases into the devices. The droplets are imaged
during experiments by a high-speed camera (Phantom, USA) at a frame rate of 2200 images
per second in bright-field mode with 10x & 20x magnifications, which is coupled to an inverted
microscope (IX71, Olympus). Two lasers are used with wavelengths of λlaser = 375nm (20mW,
Omicron) and λlaser = 532nm (25mW, Cobolt Samba). All microfluidic devices are used at
controled room temperature (25◦C).
3.5.5 Emulsification
The size and frequency of the droplets production within the microfluidic devices are
regulated by controlling the flow rate of the aqueous solutions and the total oil flow. Those
flow rates are controlled by Nemesys syringe pumps (Cetoni, Germany).
For the first microfluidic workflow, flow rates are set at Qaq = 35µL.h−1 for both aqueous
phases, at Qoil = 150µL.h−1 for the oil phase and at Qextraction = -100µL.h−1 for the oil
extraction, leading to a production of droplets at the frequency of Fformation = 300Hz
For the second microfluidic workflow, droplets are produced with a flow rates of Qaq =
100µL.h−1 for the aqueous phase (cell suspension) and Qoil = 600µL.h−1 for the oil phase.
The emulsion is reinjected into the picoinjection workflow with the pressure pumps (Fluigent,
France) setting a pressure of Pemulsion = 790mBar for the emulsion, Pspacing = 782mBar
for the spacing, Ppico = 780 mBar for the picoinjection (substrate), and a flow rate for the
extraction at Qextraction = -12µL.h−1 using the syringe pump. The picoinjection is done at
20kHz and 100mVpp with a 2 times dilution..
For the third microfluidic workflow, droplets are produced with a flow rates of Qaq = 100µL.h−1
for the aqueous phases (cell suspension and reagent mix) and Qoil = 600µL.h−1 for the oil
phase with a frequency Fformation = 1000Hz. The emulsion is incubated at room temperature
(25◦C) for 15 minutes.
3.5.6 Platform #2: Manipulation
To use the second microfluidic workflow using picoinjection, the droplets are collected
off-chip inside a vial. The septum of the vial is punched two times by a 0.5mm diameter
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Uni-Core biopsy punch (WPI, France). Two pieces of polyethylene tubing with an inner
diameter of 0.3mm and an outer diameter of 0.76mm (Adtech, FisherScientific) are connected
to the vial through the holes: one at the bottom of the vial connected to a 1mL plastic
syringes (Omnifix, Carl Roth) filled with HFE-7500 (3M, USA) and 1% of Fluosurf surfactant
(Emulseo, France); and the second one at the top of the vial which will be connected to the
collecting point of the emulsion on the microfluidic chip. Before using the vial, it must be
filled completely with HFE-7500 (3M, USA) and 1% of Fluosurf surfactant (Emulseo, France).
After being connected to the microfluidic chip, the syringe is took off, the tubing is then
placed in a trash bottle and as the droplets are coming inside the vial, the oil mixture is
pushed away through the tubing. Once the collect done, the 1mL syringe is replace inisde the
tubing.
3.5.7 Platform #3: Sorting
The sorting design is composed of three inlets. One is for the reinjection of the emulsion,
an another one is for oil mixed with 1% surfactant for the spacing of drops after the reinjection,
and the last one is also an oil entrance to help the drops to go to the trash channel when
no AC field is applied. For a screening at the frequency of Fsorting = 400Hz, the emulsion
is reinjected with a flow rate of Qemulsion = 75µL.h−1, spaced by HFE-7500 oil at a flow
rate of Qoil = 250µL.h−1 and the other oil entrance at a flow rate of Qoil = 600µL.h−1; the
parameters of the screening are set by the Labview software: F = 30KHz, cycles = 22, delay
= 0µs and Amplitude = 500V. For a screening at the frequency of Fsorting = 600Hz, the
emulsion is reinjected with a flow rate of Qemulsion = 100µL.h−1, spaced by HFE-7500 oil at
a flow rate of Qoil = 250µL.h−1 and the other oil entrance at a flow rate of Qoil = 600µL.h−1;
the parameters of the screening are set by the Labview software: F = 30KHz, cycles = 18,
delay = 0µs and Amplitude = 500V. For a screening at the frequency of Fsorting = 800Hz, the
emulsion is reinjected with a flow rate of Qemulsion = 150µL.h−1, spaced by HFE-7500 oil at a
flow rate of Qoil = 300µL.h−1 and the other oil entrance at a flow rate of Qoil = 1000µL.h−1;
the parameters of the screening are set by the Labview software: F = 30KHz, cycles = 25,
delay = 0µs and Amplitude = 500V. The detection of the droplets is done through a 10x
magnification.
3.5.8 Nessler assay
100µL of the emulsion layer of screened droplets is pipetted and diluted in 900µL of LB
medium inside a 1mL ependorf. The 1mL ependorf is vortexed and 100µL is spread onto a
petri dish filled with agar and ampiciline. The petri dish is then place at 37◦C over night. 1
colony from agar plate made after screening experiment of periplasmic E. coli is placed inside
200µL of LB medium mixed with 200µg.mL−1 of ampicillin in each wells and incubated at
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37◦C until reaching an OD of OD600nm=0.6-0.8. E. coli cells were induced with 0.25mM of
IPTG and incubated overnight at 25◦C. E. coli cultures were centrifuged (1200g, 40min, 4◦C)
and the cell pellets were resuspended in PBS buffer 1X and centrifuged again. Washed cells
were resuspended in 30µL of asparagine at a concentration of 5mM and incubated at 37◦C
during 30 minutes. In each wells, 260µL of DI water is added and 40µL of Nessler’s reagent.
The reaction is instantaneous. Fluorescence was measured in absorbance on an end point
measurement at 436nm with a Spectramax Plate Reader (Molecular Devices).
3.5.9 Kinetic measurements
The kinetic parameters are determined in bulk by using the microtiter plate platform
and in microfluidic platform.
For the bulk assay, the fluorescence assay is performed in 96-wells plates where 100µl of purified
enzyme are mixed with 100µL of the reaction mixture (L-AspOx (700µg/mL), HRP (0.2
U/mL), FAD (20µM), AUR (12.5µM)), with a concentration of L-asparagine set between 5µM
and 250µM. The fluorescence is measured during 30 minutes at 25 ◦C (λexcitation = 532nm,
λemission = 581nm) with a Spectramax Plate Reader (SpectraMax Paradigm, Molecular
Devices).
Concerning the microfluidic experiment, the first workflow developed with the co-encapsulation
on chip is used. 1mL of L-asparagine with a concentration range between 5µM and 30µM is
loaded on the chip and co-encapsulated with 1mL of the reagent mix (L-AspOx (700µg/mL),
HRP (0.2 U/mL), FAD (20µM), AUR (12.5µM)) using HFE-7500 (Novec, 3M ) and 1% of
fluosurf surfactant (Emulseo, France). Flow rates are 35µL.h−1 for both aqueous phases,
150µL.h−1 for the oil phase and -100µL.h−1 for the extraction. For the calculation of kcat, we
considered the concentration in asparagine at 0.25 µmol.ml−1.
3.5.10 Analysis of droplet fluorescence
The voltage readout of the PMTs (Hamamatsu) is recorded and transmitted to the
computer by a data acquisition card (National Instruments) and processed using LabView
software (National Instruments). Data are saved into a .txt file and analyzed using Scilab
software.
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3.6 Conclusions
In this chapter we applied three integrated microfluidic systems for the case of three E.
coli L-asparaginase expression vectors, as a positive microfluidic control. We demonstrated
that the enzymatic activity is detectable in monodisperse droplets for the display and the
periplasmic expressions, while for the enzymatic activity in the cytoplasmic expression, it
does not come out of the background. Perhaps, by the use of a lysis agent, the enzymatic
activity for the cytoplasmic expression would be higher than the background, but the use of
lysis is not of interest for our project. Control experiments have been performed by using
microtiter plate assay on the side of microfluidic experiments.
The table 3.5 represents the experimental observations for the development of different strains.
From theory to experiments, only the processability of the periplasmic expression was not as
expected. Indeed, knowing that this expression system allows the enzyme to be on the inner
face of the membrane, there is then more susceptibility to generate a cytoplasmic expression
vector instead, the enzyme tending more to secreted into the medium.
Processability Accessibility Single-cell encapsulation
Cytoplasmic 3 7 3
Display 3 3 3
Periplasmic 7 3 3
Table 3.5: Experimental features of vector expressions.
As for the screening of E. coli libraries through workflow # 3, its processability have
been demonstrated by a model screening. By using this worflow we succeed to screen 106
variants in 6 hours.
Our main goal now is the detection of the human L-asparaginase, which is the enzyme to
improve for this project.
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3.7 Résumé du chapitre
Au travers de ce chapitre, les différent modules microfluidique développés dans le chapitre
précédent vont être utilisés afin d’étudier une enzyme appelée L-asparaginase. Cette enzyme
est utilisée dans le traitement de la leucémie lymphoblastique aiguë touchant majoritairement
des enfants de moins de 15 ans.
Un traitement existe mais est basée sur l’enzyme L-asparaginase d’origine bactérienne, ce qui
conduit à déclencher des réactions immunitaires qui se traduit par l’interruption du traitement,
souvent fatale pour le patient. Cependant, une version humaine de l’enzyme L-asparaginase,
qui est moins immunogénique, n’est à l’heure actuelle pas suffisamment active pour être
utilisée.
L’objectif principal de cette thèse est d’alors d’analyser et de cribler des banques de mutants
de l’enzyme L-asparaginase en utilisant des méthodes classiques de mutagenèse et d’analyser
chaque mutant individuellement par le biais de la microfluidique en gouttes.
Ce chapitre se concentre sur l’analyse de la version bactérienne de l’enzyme, E. coli
L-asparaginase, exprimée dans trois systèmes d’expression différents: en cytoplasmique où les
protéines sont sécrétées dans le cytoplasme, en display où les protéines sont situées dans la
membrane interne et en périplasmique où les protéines sont sécrétées dans le périplasme de
la cellule. Afin de réaliser cette étude, une première étape a été menée par l’utilisation d’un
lecteur de microplaques afin de visualiser l’évolution cinétique au cours du temps de ces trois
systèmes d’expressions. L’expression périplasmique est le système le plus rapide avec une
activité enzymatique maximale au bout de 12 minutes, suivi de l’expression en display avec
une détection maximale en 36 minutes, quant à l’expression cytoplasmique, aucun maximum
d’activité atteint après 1 heure d’expérience.
Une fois caractérisés, les trois systèmes sont étudiés à l’aide des plateformes microfluiques
développées. Dans un premier temps, la plateforme numéro 1 permettant de détecter une activ-
ité enzymatique sur puce en moins de 15 minutes est utilisée. Avec l’aide de cette plateforme,
seul deux systèmes d’expressions sont détectés comme attendu suite aux résultats en lecteur
microplaque. Ces deux expressions sont en display et en périplasmique. En conséquence, les
trois systèmes d’expressions sont étudiées au travers de la plateforme numéro 2. Cette dernière
permet de détecter l’activité enzymatique sur puce en 45 minutes. Les vecteurs périplasmique
et display atteignent leur maximum d’activité au travers de cette plateforme, ce qui n’est pas
le cas du système d’expression en cytoplasmique dont l’activité ne sort pas du bruit du fond.
Ainsi pour la suite des expériences, seulement les vecteurs en display et en périplasmique sont
d’intérêt pour ce projet. Mais nous allons utiliser majoritairement le système en périplasmique
sachant que son activité enzymatique est détectable deux fois plus rapidement que celle en
display.
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Afin de pouvoir analyser et cribler des banques de mutants, un tri modèle a été effectué
à partir de la version bactérienne de l’enzyme en utilisant la plateforme développée numéro 3.
Cette plateforme permet un criblage rapide de banques. En effet, environ 106 variants sont
triés en 6 heures.
Au travers de ces résultats concluant, la suite du projet est donc d’optimiser la version
humaine de l’enzyme L’asparaginase afin de pouvoir analyser et cribler des banques de mutants
de cette version.
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Summary Chapter3
• In this chapter, we analyzed three different E. coli L-asparaginase expression vectors
(cytoplasmic, display and periplasmic) for the detection of the enzymatic activity of
L-asparaginase.
• Microtiter plate experiment is used as control parameter for the enzyme activity of the
three expression vectors.
• Three integrated microfluidic platforms developed have been optimized to finally be
well defined and suitable for this project.
• Single-cell measurements is possible in those microfluidic platforms for active variants
expressed in display and periplasmic expressions.
• Those worflows present some limits of detection for low activity variant, especially for
the variants transformed in the cytoplasmic expression.
• However, there is a possible mediation through sorting experiments by applying a
definite fluorescence threshold.
• We succeed to screen 106 variants in 6 hours within our integrated microfluidic platforms.
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Application of microfluidic systems for
the detection of the human L-asparaginse
enzymactic activity
The purpose of this chapter is to detect and screen a library of a human L-asparaginase
strain obtained by directed evolution through the same microfluidic platforms developed
previously.
As explained in the previous chapter, the L-asparaginase enzyme is related to the therapeutical
treatment for acute lymphoblastic leukemia (ALL). L-asparaginase enzyme is produced by the
human genome and could be used as an alternative treatment to the actual treatment, composed
of bacterial component and thus avoid side effects. However, the human L-asparaginase activity
is at least 1000-fold lower than the bacterial one. Human 3 L-asparaginase strain (hASNase3-
DM1) is related to the plant family of L-asparaginase enzyme and is 2300-fold less active
than E. coli strain. The characteristic of this family is the requirement of an intramolecular
cleavage to become active by glycine ([Su et al., 2013], [Michalska et al., 2006]). The idea
of this part of the project is to promote the autoproteolysis of the enzyme directly in the
bacterial culture by the addition of glycine, and to detect the enzymatic activity using the
same three step coupled assay staring amplex ultra-red.
Some preliminary results have been published by Karamitros et al ([Karamitros and Konrad,
2016]) where by directed evolution experiments, they succeeded to identify variants with
promising properties.
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4.1 Detection of the L-asparaginase human 3 strain
Before realizing a library screening, the detection of the enzymatic kinetic must be
achieved using the same fluorescent assay based on the natural substrate of the L-asparaginase
enzyme.
The hASNase3-DM1 strain was expressed in display (pAPEx4b) and periplasmic (pET22b(+))
vector expressions given the results with the E.coli strain.
4.1.1 Microtiter plate experiment
The fluorescent assay coupled with the Human 3 strain (hASNase3-DM1) was first
tested in microtiter plate to determine the kinetic of the enzymatic reaction.
In this experiment, the activity of the two expression vectors, the display (pAPEx4b) and
the periplasmic (pET22b) expressions, is measured with a plate reader and the fluorescence
intensity is plotted as a function of time. The cytoplasmic expression has not been produced
with the hASNase3-DM1 L-asparaginase strain because of the negative result obtained with
the E. coli strain.
The figure 4.1 shows the increase of fluorescence reflecting the formation of resorufin, for the
two expressions vectors of the human 3 strain developed and a blank.
104
Figure 4.1: Fluorescent assay in microtiter plate. L-asparaginase
activity was determined in 96-wells plates using a three-step coupled
enzyme assay AUR dependant. Each well contained 100µL of human 3
suspension (OD600nm = 0.05) mixed with 100µL of the reaction mixture
(L-asparagine (1mM), L-AspOx (700µg.mL−1), HRP (0.2U.mL−1), FAD
(20µM), AUR (12.5µM)). Fluorescence was measured every 3 minutes
during 7 hours (λexcitation = 532nm, λemission = 581nm) with a Spectra-
max Plate Reader (Molecular Devices). Error bars represent standard
deviation determined from duplicate measurements.
The grey curve represents the control parameter of the experiment. It is a mixture
between Phosphate-buffered saline (PBS) buffer and the substrate. The purple and blue curves
represent the periplasmic (pET22b(+)) and the display (pAPEx4b) expressions respectively.
The blank kinetic is slowly increasing with a rate of 0.97µM.min−1.
For the periplasmic (pET22b(+)), the same behavior as the E. coli assay is observed. Initially,
the fluorescence increase until the maximum value of approximately 11µM is reached in 3
hours and 30 minutes with a speed of 5.27µM.min−1. Then a slow decrease of the fluorescence
intensity is observed representing the natural oxidation of the resorufin.
As for the display (pAPEx4b) vector, the fluorescence is increasing with a speed of 2.57µM.min−1
until reaching a maximum of approximately 10µM in 6 hours and 30 minutes. After this time,
a slow decrease of the fluorescence is starting to be noted.
By comparing the microtiter plate results of the hASNase3-DM1 strain to the E. coli
strain, the key difference is the time for the different expression to raise until forming a
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maximum of resorufin. This time shifts from less than 30 minutes to more than 3 hours.
Also, with our experimental conditions, 12.5µM of resorufin is expected to be formed at the
endpoint. However, for both expression vectors, the maximum concentration of resorufin
reaches only 11µM. It is certainly due to the natural oxidation of this compound taking into
account that the experiment last hours when considering the hASNase3-DM1 L-asparaginase
strain.
4.1.2 Microfluidic experiments
The workflow # 2 is used for the microfluidic experiments using the hASNase3-DM1
L-asparaginase strain considering the low enzymatic activity of the enzyme (figure 4.2).
Figure 4.2: HTS microfluidic platform # 2. Droplets are generated,
collected into a vial & incubated off-chip for a desired amount of time.
Droplets are reinjected on chip where the fluorescent assay is picoinjected
by applying AC field (20kHz, 100Vpp) and droplets are passing through
delay lines for an on-chip incubation and the fluorescence of each droplets
is measured. Black arrows indicate the direction of the flows.
The same protocol as seen in the previous chapter is performed. The two hASNase3-DM1
expressions and a control (PBS buffer) are co-encapsulated with the L-asparagine (250µM)at
the single-cell resolution following the Poisson distribution, using co-flow drop makers with
HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo, France). Each popula-
tions are encoded with Dextran-Cascade Blue fluorescent dye with a different concentration.
Droplets of each expression are collected on ice into a vial filled with HFE-7500 (Novec, 3M )
and 1% of Fluosurf surfactant (Emulseo, France), and incubated off-chip at room temperature
for 4 hours. Then, droplets are reinjected into the second microfluidic platform where the
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droplets are injected one-by-one with the fluorescent assay, thanks to a picoinjection module
([Abate et al., 2010]). Finally, droplets are passing through delay lines and the fluorescence of
each droplets is measured at the encapsulation (t0) and through all the enzymatic check points.
The figure 4.3 represents the fluorescence evolution of the two different vector expressions
of hASNase3-DM1 strain and the fluorescence of the control parameter within an incubation
time on-chip with the reagent mix of 30 minutes.
The grey dots represent the control parameter of the experiment. The purple and blue dots
represent the periplasmic and the display expressions respectively.
Figure 4.3: hASNase3-DM1 fluorescence activity. Cells are co-
encapsulated (OD600nm = 0.03; 3.106 cells.mL−1) with L-asparagine
(250µM) into 30pL droplets at the single-cell resolution, collected into a
vial & incubated off-chip for 4 hours at room temperature. Droplets are
reinjected on chip where the fluorescent assay is picoinjected by applying
AC field (20kHz, 100Vpp). On the left: resorufin fluorescence versus
cascade blue fluorescence intensity for display and periplasmic vector
expressions (blue & purple respectively) and a blank (grey). On the right:
resorufin fluorescence intensity according to time for the periplasmic and
display expressions (blue) and the blank (red).
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In this first experiment, no population with more fluorescence intensity compare to the
background is detectable. By looking at the fluorescence intensity as a function of time, peaks
of fluorescence for the display, periplasmic expressions and the blank are visible, with a mean
intensity value of 0.12 ± 0.01 RFU for the display and periplamic expressions and 0.02 ± 0.04
RFU for the blank. However, as seen in figure 4.3, the differentiation between fluorescence
peaks from the background (blank and empty drops) and the fluorescence peaks from active
variants is not possible.
This non differentiation is expected. Indeed, taking into account the result from the microtiter
plate assay, the fluorescence intensity is slowly increasing with time. Plus, the cells dilution
inside the droplets is higher than during the assay with microtiter plate and the volume
considered smaller.
Also, by considering the fact that the emulsion is collected and incubated inside a vial,
there is a possibility of leakage. Skhiri et al ([Skhiri et al., 2012]) presented a paper where
they studied the exchange rate of resorufin between two monodisperse emulsions containing
different concentration of resorufin through time. Within this article, after 180 minutes of
incubation, the fluorescence of the two emulsions became only one fluorescence, having the
average value. However, under smaller concentration of surfactant or use of an another type
of oil and other specificities, the speed of leakage can be decrease.
Therefore, tests to measure leaking between droplets in our experiments have been done.
4.2 Preleminary leakage tests
We know that the resorufin is a sensitive and leaking compound, but we want to
determine if other compounds leak. The enzymatic cascade is a complex reaction which can
be separated into two compounds, L-asparagine and L-aspartate, the enzyme L-asparaginase
and the rest of the cascade as the fluorogenic mix. Therefore, we divide the cascade in two
parts: the first part is the study of leakage between different concentrations of commercial
L-aspartate with the fluorogenic mix, and the second one is the analysis of leakage between
two concentrations of L-asparagine coupled with the enzyme.
4.2.1 L-aspartate leakage
Three concentrations, 0µM, 25µM and 250µM of a commercial L-aspartate are encapsu-
lated in 15pL droplets using a drop maker with HFE-7500 (Novec, 3M ) and 1% of Fluosurf
surfactant (Emulseo, France). The different concentrations of L-aspartate are encoded with
Dextran-Cascade Blue fluorescent dye to labeled the three populations. Droplets are then col-
lected into a vial filled with HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo,
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France). The emulsion is incubated off-chip at T=37◦C for 7 hours. Then, droplets are
reinjected into the second microfluidic platform where the droplets are picoinjected one-by-one
with the fluorescent assay (figure 4.4a). Finally, droplets are passing through delay lines and
the fluorescence of each droplets is measured at the encapsulation (t0) and through all the
enzymatic check points.
The figure 4.4b represents the fluorescence of the three concentrations of L-aspartate in
drops within an incubation time with the reagent mix on-chip of 20 minutes.
The red dots represent the concentration in L-asparagine of 0µM, bordeaux dots represent the
concentration in L-asparagine of 10µM and the wine dots represent the concentration of 100µM.
(a) Sketch of the workflow #2. (b) 2D histogram.
Figure 4.4: Aspartate leakage assay. (A)HTS microfluidic platform.
0µM, 25µM and 250µM of a commercial L-aspartate are encapsulated,
collected into a vial & incubated off-chip for 7 hours. Droplets are
reinjected on chip where the fluorescent assay is picoinjected by applying
AC field (20kHz, 100Vpp). (B)2D histogram representing the aspartate
leakage assay for an incubation time with the reagent mix of 20 min-
utes. 0µM, 10µM and 10 µM of commercial L-aspartate oxidase are
encapsulated, incubated off-chip for 7 hours, and picoinjected with the
fluorescent assay.
Three distinct populations are visible on the 2D histogram. Therefore, no leakage
of L-aspartate oxidase is happening between the droplets of the emulsion after 7 hours of
incubation off-chip.
4.2.2 L-asparagine leakage
Two concentrations of L-asparagine are tested. 10µM and 100µM of L-asparagine are
co-encapsulated with a E. coli cells suspension at the single-cell level following the Poisson
distribution in 15pL droplets using a co-flow drop maker with HFE-7500 (Novec, 3M ) and
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1% of Fluosurf surfactant (Emulseo, France). The different concentrations of L-asparagine are
encoded with Dextran-Cascade Blue fluorescent dye to labeled the two populations. Droplets
are then collected into a vial placed on ice filled with HFE-7500 (Novec, 3M ) and 1% of Fluo-
surf surfactant (Emulseo, France). The emulsion is incubated off-chip at room temperature
for 20 hours. Then, droplets are reinjected into the second microfluidic platform where the
droplets are picoinjected one-by-one with the fluorescent assay. Finally, droplets are passing
through delay lines and the fluorescence of each droplets is measured at the encapsulation (t0)
and through all the enzymatic check points.
The figure 4.5 represents the fluorescence evolution of the two concentration of L-
asparagine within an incubation time with the reagent mix of 20 minutes.
The green dots represent the concentration in L-asparagine of 10µM and the olive dots
represent the concentration of 100µM.
Figure 4.5: Asparagine leakage assay. 10µM and 100µM of L-asparagine
are co-encapsulated with a cells suspension of E. coli at the single-cell
resolution, collected on ice into a vial & incubated off-chip for 20 hours.
Droplets are reinjected on chip where the fluorescent assay is picoinjected
by applying AC field (20kHz, 100Vpp). 2D histograms representing the L-
asparagine leakage assay for an on-chip incubation time with the reagent
mix of 1 minute, 10 minutes and 20 minutes.
Following time through the 2D histograms, a population of drops with higher fluorescence
intensity is detectable. This population corresponds at 6% or 10% of the total emulsion
population corresponding to the Poisson law dilution.
Therefore, the two concentrations of L-asparagine do not leak between drops after 20 hours of
incubation off-chip.
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4.3 Detection of the enzymatic activity on chip
Taking into account that only the resorufin compound leaks within our enzymatic
system, other several microfluidic experiments have been done with a change in parameters.
Those parameters are the time and temperature of droplets incubation off-chip.
First, we desired to remain at the single-cell resolution to keep the screening parameters.
Thus, the time and temperature of incubation off-chip is evaluated. From 4 hours off-
chip incubation previously tested at room temperature, we tested until 16 hours of off-chip
incubation at room temperature to finally check the effect on the system with a temperature
of off-chip incubation at T=37◦C, temperature where the activity has been showed more
enhenced through side experiments.
The same microfluidic experiment as the first part of this chapter is repeated with the
co-encapsulation, the incubation off-chip and the picoinjection of the reagent mix for the
periplasmic and the display expression vectors, plus a control parameter.
4.3.1 Effect of the off-chip incubation time
The figure 4.6 represents the fluorescence evolution of the periplasmic vector expression
of hASNase3-DM1 strain and the fluorescence of the control parameter under 16 hours incu-
bation off-chip at room temperature.
The grey dots represent the control parameter of the experiment and the purple dots represent
the periplasmic expression.
No population is detachable from the fluorescence of the background. The mean intensity
value for the blank and the periplasmic expression is 0.13 ± 0.01 RFU for each. By comparing
the fluorescence intensity peaks of 16 hours off-chip incubation at room temperature to 4
hours off-chip incubation at room temperature already obtained, all fluorescence peaks are
now basically the same.
Therefore, from this experiment, having an off-chip incubation longer than 15 hours is not
in interest for our system. Certainly, by taking into account the natural oxidation of re-
sorufin, the off-chip incubation time should not be more than 10 hours for the next experiments.
4.3.2 Effect of the temperature during off-chip incubation
The figure 4.7 represents the fluorescence evolution of the two different vector expressions
of hASNase3-DM1 strain, display and periplasmic expressions, and the fluorescence of the
control parameter under 7 hours off-chip incubation at T=37◦C.
111
Figure 4.6: hASNase3-DM1 fluorescence activity. Cells are co-
encapsulated (OD600nm = 0.03; 3.106 cells.mL−1) with L-asparagine
(250µM) into 30pL droplets at the single-cell resolution, collected on
ice into a vial & incubated off-chip for 16 hours at room temperature.
Droplets are reinjected on chip where the fluorescent assay is picoinjected
by applying AC field (20kHz, 100Vpp). On the left: resorufin fluorescence
versus cascade blue fluorescence intensity for the periplasmic vector ex-
pression (blue) and a blank (grey) under 16 hours off-chip incubation
at room temperature. On the right: resorufin fluorescence intensity
according to time for the periplasmic expression (blue) and the blank
(red) under 16 hours of off-chip incubation at room temperature.
The grey dots represent the control parameter of the experiment, the blue dots represent the
display expression and the purple dots represent the periplasmic expression.
We do not see clearly distinguishable population from the background. However, by
looking at the fluorescence peaks, different level of fluorescence can be seen with a maximum
fluorescence level twice higher than the first experiment. Indeed, by looking at the mean
intensity value, the periplasmic and the display expressions is equal to 0.25 ± 0.04 RFU while
for the blank it is equal to 0.21 ± 0.03 RFU. This fluctuation might correspond to the low
activity of the hASNase3-DM1 strain in droplets, and are considered as reference conditions
for the following experiments. Indeed, during the screening process, we will search for peaks
with an higher fluorescence intensity than this reference intensity.
Moreover, the conditions of an incubation off-chip for 7 hours at T=37◦C are set as
screening parameters.
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Figure 4.7: hASNase3-DM1 fluorescence activity. Cells are co-
encapsulated (OD600nm = 0.03; 3.106 cells.mL−1) with L-asparagine
(250µM) into 30pL droplets at the single-cell resolution, collected on ice
into a vial & incubated off-chip for 7 hours at T=37◦C. Droplets are rein-
jected on chip where the fluorescent assay is picoinjected by applying AC
field (20kHz, 100Vpp). On the left: resorufin fluorescence versus cascade
blue fluorescence intensity for the periplasmic and display expressions
(blue & purple respectively) and the blank (red) under 7 hours of off-chip
incubation at T=37◦C. On the right: resorufin fluorescence intensity
according to time for the periplasmic and display expressions (blue) and
the blank (red) under 14 hours off-chip incubation at T=37◦C.
4.4 Screening of positive variants using microfluidic
systems
Given the results obtained previously, the use of a screening method should be employed
to identify positive hits of the hASNase3-DM1 L-asparaginase enzyme. Positive hits from the
general strain or from librairies mutants.
But first, a model screening with the hASNase3-DM1 strain was done to ensure the efficiency
of a screening using this enzyme.
4.4.1 Model screening of hASNase3-DM1 L-asparaginase strain
A model screening has been done using E. coli and hASNase3-DM1 L-asparaginase
enzyme on the workflow # 3 (figure 4.8a).
To determine the efficiency of the sorting with the hASNase3-DM1 L-asparaginase strain,
10% of the periplasmic expression of E. coli were mixed to 90% of the hASNase3-DM1 L-
asparaginase enzyme at an OD600nm=0.03 in a 1mL solution. The mix is co-encapsulated at
the single-cell level following the Poisson distribution with the reagent mix in 30pL droplets
using a co-flow drop makers with HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant
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(Emulseo, France). The emulsion is encoded with Dextran-Cascade Blue fluorescent dye to
labeled the population. Droplets are then collected into a vial placed onto ice filled with
HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo, France). The emulsion
is incubated off-chip at room temperature for 2 hours. Afterward, droplets are reinjected
into the sorting system where selected droplets detected by the laser are deflected to the
collect arm at a frequency of Fsorting = 500Hz. During the sorting experiment, on the labview
software, a screen box has been define to select the desired population of droplets (figure
4.8b). The selected droplets are collected inside an ependorf during the experiment.
(a) Sketch of the FADS design.
(b) 2D histogram.
Figure 4.8: Screening of hASNase3-DM1 L-asparaginase enzymatic
activity. (A)Sketch of the microfluidic system used. (B)2D histogram
of the resorufin fluorescence in 30pL droplets (λlasers = 375 & 532 nm).
The blue box corresponds to the E. coli population screened, the pink
box corresponds to the hASNase3-DM1 population screened & the red
circles correspond to coalescence due to reinjection of the emulsion.
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To validate the screening efficiency, two conditions have been tested: (i) screening of
active E. coli population and (ii) screening of the hASNase3-DM1 population. The background
has a fluorescence level of 0.02RFU. The same protocol as the model screening of E. coli
have been used. The selected droplets are grew and recovered from the screening experiment,
and a colorimetric test via the Nessler test have been operated. This test was performed in
96-wells microtiter plate on which each wells contained a culture of an E. coli colony or a
hASNase3-DM1 colony screened.
(i) E. coli screening: the screening threshold was placed for a fluorescence of 0.11RFU and
approximately 10 000 droplets were screened. On the Labview software, the screening
box corresponds to 2.8% of total droplets. Those droplets were cultivated on agar plate
and 7850 ± 57% of drops were recovered (figure 4.9a). A Nessler test have been used
on 49 colonies (figure 4.9b) in a 96-wells microtiter plate.
(a) Agar plates. (b) Nessler test.
Figure 4.9: hASNase3-DM1 model screening analysis. (A)Agar plates
with active E. coli population screened on two different dilutions. 100µL
of screened droplets emulsion is mixed in 900µL of LB and different
dilutions of this mix are poured onto agar plates and incubated (37◦C
over night). (B)Nessler test on 96-wells microtiter plate for the the E.
coli population screened.
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To ensure that all the E.coli have been screened, the droplets from the trash channel
have been also grown and recovered on agar plate (figure 4.10a) to perform the Nessler
test. 35 colonies have been tested (figure 4.10b).
(a) Agar plates.
(b) Nessler test.
Figure 4.10: hASNase3-DM1 model screening analysis. (A)Agar plates
with the population of unscreened droplets. 100µL of unscreened droplets
emulsion is mixed in 900µL of LB and different dilutions of this mix are
poured onto agar plates and incubated (37◦C over night). (B)Nessler
test on 96-wells microtiter plate for the unscreened colonies.
According to the Nessler test, 5 colonies are considered negative over 49 colonies by
taking an absorbance strictly superior to 1. This condition have been chosen by taking
into account the residual absorbance of the LB medium. Some washing test have
been carried out to determine the minimum absorbance of this test: 24 wells onto the
microtiter plate have been filled with only LB medium, 12 of them have been washed
with PBS 1X buffer. The average absorbance of the cleaned wells is of 0.21 ± 0.14 and
the average absorbance of non-washed wells is 0.95 ± 0.25.
(ii) hASNase3-DM1 screening: the screening box was placed for a fluorescence of 0.05RFU
until 0.1RFU and approximately 700 droplets were screened. On the Labview software,
the screening box corresponds to 0.2% of total droplets. Those droplets were cultivated
on agar plate and 600 droplets were recovered (figure 4.9a). A Nessler test have been
used on 6 colonies (figure 4.9b) in a 96-wells microtiter plate.
According to the Nessler test, 1 colony is considered negative over 6 colonies by taking
an absorbance strictly superior to 1, considering the same condition as the E. coli
screening.
To determine the enrichment values, the model presented by Baret et al ([Baret et al.,
2009]) is used. The table 4.1 sums up the different requierement to characterize the screening
experiment.
The mean number of encapsulated cells per droplet λ and the ratio 0 have not been tested
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(a) Agar plates.
(b) Nessler test.
Figure 4.11: hASNase3-DM1 model screening analysis. (A)Agar plates
with the hASNase3-DM1 population screened. 100µL of screened droplets
emulsion is mixed in 900µL of LB, poured onto agar plates and incubated
(37◦C over night). (B)Nessler test on 96-wells microtiter plate for the
the hASNase3-DM1 population screened.
prior experiment as we expected the distribution of cells to follow the Poisson distribution.
As for the determination of ηexp, it is defined as the ratio between 0:1 where 1 is the ratio
between E. coli:hASNase3-DM1 after screening assay for the screening of E. coli and as
hASNase3-DM1:E. coli for the screening of hASNase3-DM1.
Fsorting 0 Analyzed droplets Screened droplets Purity ηtheo ηexp Absorbance
E. coli 500 Hz 0.11 4.5.105 10000 90% 101 80 2.44 (0.55)
hASNase3-DM1 500 Hz 9 4.5.105 700 84% 11 1 1.28 (0.20)
Table 4.1: Requierement data to characterize the screening experiment
of hASNase3-DM1 L-asparaginase.
According to the purity of the two screening which is superior to 80%, the model was
validated. A positive strain, E. coli in this case, can be screened compare to a low activity
strain.
Unfortunately, as seen with the screening of hASNase3-DM1 population, very few positive
hits can be recovered as the fluorescence level was very low. Those hits can be false positives,
low activity variants from the E. coli strain or low activity variants from hASNase3-DM1
strain. To ensure the composition of those hits, a sequencing should be done. However, this
has not be done in this assay as hASNase3-DM1 general strain is not a priority: we want
highly active variants.
However, this screening is quantitatively coherent with the model screening of E. coli presented
in the previous chapter. We indeed succeed to complete a biological integration within our
systems where biological solutions can be transfered from bulk to microfluidic platforms to
agar plate with a high viability rate.
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The conditions determined during the previous experiments have not been followed.
Indeed, E. coli strain being a part of the assay, the resorufin degradation would have been
too important after 7 hours of incubation and thus the active population of E. coli not
distinguishable.
Those limitations can be overcome by using only hASNase3-DM1 L-asparaginase strain
and apply directed evolution analysis to create libraries of mutants with higher kinetic
properties.
4.4.2 Screening of a library of hASNase3-DM1 L-asparaginase
strain
Three libraries containing different mutations percentage (≈ 2.25, ≈ 4.5 and ≈ 6
mutations.kbp−1 was created by mutagenesis PCR using the GeneMorph II Random Mutage-
nesis kit (Stratagene).
A mix of this three libraries was made into one solution (1/3 volume for each library) and
diluted until reaching an OD600nm=0.03 in a 1mL solution. The solution is co-encapsulated
at the single-cell level following the Poisson distribution with the reagent mix using a co-flow
drop makers with HFE-7500 (Novec, 3M ) and 1% of Fluosurf surfactant (Emulseo, France).
The emulsion is encoded with Dextran-Cascade Blue fluorescent dye to labeled the population.
Droplets are then collected into a vial placed onto ice filled with HFE-7500 (Novec, 3M ) and
1% of Fluosurf surfactant (Emulseo, France). The emulsion is incubated off-chip at room
temperature for 5 hours. Afterwards, droplets are reinjected into the sorting system where
selected droplets detected by the laser are deflected to the collect arm at a frequency of Fsorting
= 400Hz. During the sorting experiment, on the labview software, a screen box has been define
to select the desired population of droplets (figure 4.12a). 10 000 droplets have been screened
over 8.105 and on the Labview software, the screening box corresponds to 0.13% of total
droplets. The background has a fluorescence level of 0.015RFU and the screening threshold
was set at 0.03RFU. The selected droplets are collected inside an ependorf during the ex-
periment, grew and recovered on an agar plate to determine the enrichment value (figure 4.12b).
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(a) 2D histogram.
(b) Agar plate.
Figure 4.12: Screening of hASNase3-DM1 L-asparaginase library en-
zymatic activity. (A)Agar plates with the hASNase3-DM1 librairies
population screened. 100µL of screened droplets emulsion is mixed in
900µL of LB, poured onto agar plates and incubated (37◦C over night).
(B)2D histogram of the resorufin fluorescence in 30pL droplets (λlasers
= 375 & 532 nm). The pink box corresponds to the hASNase3-DM1
population screened & the red circles correspond to coalescence due to
reinjection of the emulsion.
Unfortunately, as seen in figure 4.12b, no colony have grown onto the agar plate. This
situation was expected. Indeed, during the assay, the fluorescence was very low (0.1RFU
maximum) and as seen is figure 4.12a only 0.13% of the total emulsion of droplets was detected
as positive. Perhaps, by the dilution made to recovered colonies onto agar plate, we may have
diluted over and lost potential mutants.
Therefore, an another experiment was done with the also a mix of three libraries. The
same protocol for generation, collection and screening of droplets have been followed.
For this assay, 400 droplets have been screened over 4.105 with a frequency of Fsorting =
350Hz. On the Labview software, the screening box corresponds to 0.1% of total droplets.
The background has a fluorescence level of 0.015RFU and the screening threshold was set at
0.03RFU (figure 4.13).
After overnight incubation, 4 colonies were recovered from the agar plate and placed
into culture inside 96-wells microtiter plate to perform a Nessler test, as explained before.
The four colonies have a mean absorbance of 0.13 ± 0.01. This mean value characterize the
control absorbance value. Within those positive colonies, it is supposed to hold mutants of
hASNase3-DM1 L-asparaginase enzyme produced by directed evolution. Regarding the mean
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Figure 4.13: 2D histogram of the resorufin fluorescence in 30pL droplets
(λlasers = 375 & 532 nm). The pink box corresponds to the hASNase3-
DM1 population screened.
value of absorbance, it is clear that those mutations are deleterious, meaning that there are
fatal to the organism.
The lack of positive hits could be due to a short screening in time or a non viability of
the librairies analyzed. Therefore, those preliminary results can be completed by doing other
rounds of screening with those three librairies by screening more hits, and other librairies
with different mutations percentage can be created and analyzed within the screening system.
4.5 Materials & Methods
4.5.1 Human 3 culture
From an isolation on petri dish composed of LB agar medium, a preculture in 2mL of
LB medium mixed with 35µg.mL−1 of chloramphenicol for the display expression (pAPEx4b)
or 200µg.mL−1 of ampicillin for the periplasmic expression (pET22b(+)) was made and
incubated for 4 hours at 37◦C. At OD600nm=0.1, cultures of 10mL of LB medium mixed
with the corresponding antibiotics and 50mM of glycine was set and incubated at 37◦C until
reaching an OD of OD600nm=0.6-0.8. hASNase3-DM1 cells were induced with 0.25mM of
IPTG and incubated overnight at 18◦C. 10mL of hASNase3-DM1 cultures were centrifuged
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(4200g, 15min, 4◦C) and the cell pellets were resuspended in PBS buffer 1X mixed with
100mM of glycine before being incubated for 24 hours at 25◦C. 10mL of hASNase3-DM1
cultures were centrifuged (4200g, 15min, 4◦C) and the cell pellets were resuspended in PBS
buffer 1X twice and the cell concentration was determined.
For the microtiter plate experiment, bacterial suspension was diluted until OD600nm =
0.03. The fluorescent assay was performed in 96-wells plates where 100µl of hASNase3-DM1
suspension were mixed with 100µL of the reaction mixture. The fluorescence was measured
every 30sec during 1hour (λexcitation = 532nm, λemission = 581nm) with a Spectramax Plate
Reader (SpectraMax Paradigm, Molecular Devices). Each well was duplicated.
As for microfluidic experiments, bacterial suspension was diluted until OD600nm = 0.03 into
PBS and transferred into 1mL plastic syringe.
We will consider no sedimentation inside the syringe and the tubing considering the constant
flow inside the syringe and the diameter of the tubing.
4.5.2 Enzyme assay
The reagent mixture combines a solution of the amino-acide L-asparagine at 1mM, the
enzyme L-aspartate oxidase at 700µg.mL−1, the enzyme Horseradish peroxidase (HRP) at
0.2 U.mL−1, the cofactor Flavin adenine dinucleotide (FAD) at 20µM and finally the reagent
Amplex UltraRed (AUR) at 12.5µM.
4.5.3 Microfabrication
Microfluidic devices are fabricated using standard soft lithography methods. SU8
negative photoresist (MicroChem, USA) is deposited onto clean silicon wafers to a thickness of
20µm and 70µm for platform # 2 and a thickness of 30µm for platform # 3, and patterned by
exposure to UV light through a transparency photomask. The microstructures are developed
and poured into PDMS mold made with a mix of the polymer with a cross linker at the ration
10:1. Once degassed, the mold is cured at 65◦C during at least 2 hours. The PDMS replica is
peeled off the wafer and bonded to glass slides after oxygen-plasma activation of both surfaces.
4.5.4 Application
The channels bonded onto the glass slide are covered with Aquapel (Autoserv, Germany)
for hydrophobic surface treatment and thus to improve the wetting of the channels. Polyethy-
lene tubing with an inner diameter of 0.3mm and an outer diameter of 0.76mm (Adtech,
FisherScientific) connects the channels to the syringes. 1mL plastic syringes (Omnifix, Carl
Roth) are used to load the aqueous and oil phases into the devices. The droplets are imaged
during experiments by a high-speed camera (Phantom, USA) at a frame rate of 2200 images
per second in bright-field mode with 10x & 20x magnifications, which is coupled to an inverted
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microscope (IX71, Olympus). Two lasers are used with wavelengths of λlaser = 375nm (20mW,
Omicron) and λlaser = 532nm (25mW, Cobolt Samba). All microfluidic devices are used at
controlled room temperature (25◦C).
4.5.5 Emulsification
The size and frequency of the droplets production within the microfluidic devices are
regulated by controlling the flow rate of the aqueous solutions and the total oil flow. Those
flow rates are controlled by Nemesys syringe pumps (Cetoni, Germany).
For the second microfluidic workflow, droplets are produced with a flow rates of Qaq =
100µL.h−1 for the aqueous phase (cell suspension) and Qoil = 600µL.h−1 for the oil phase.
The emulsion is reinjected into the picoinjection workflow with the pressure pumps (Fluigent,
France) setting a pressure of Pemulsion = 800mBar for the emulsion, Pspacing = 790mBar
for the spacing, Ppico = 780 mBar for the picoinjection (substrate), and a flow rate for the
extraction at Qextraction = -10µL.h−1 using the syringe pump. The picoinjection is done at
20kHz and 100mVpp with a 2 times dilution..
For the third microfluidic workflow, droplets are produced with a flow rates of Qaq = 100µL.h−1
for the aqueous phases (cell suspension and reagent mix) and Qoil = 600µL.h−1 for the oil
phase with a frequency Fformation = 1000Hz. The emulsion is incubated at room temperature
(25◦C) for 4 hours.
4.5.6 Platform #2: Manipulation
To use the second microfluidic workflow using picoinjection, the droplets are collected
off-chip inside a vial. The septum of the vial is punched two times by a 0.5mm diameter
Uni-Core biopsy punch (WPI, France). Two pieces of polyethylene tubing with an inner
diameter of 0.3mm and an outer diameter of 0.76mm (Adtech, FisherScientific) are connected
to the vial through the holes: one at the bottom of the vial connected to a 1mL plastic
syringes (Omnifix, Carl Roth) filled with HFE-7500 (3M, USA) and 1% of Fluosurf surfactant
(Emulseo, France); and the second one at the top of the vial which will be connected to the
collecting point of the emulsion on the microfluidic chip. Before using the vial, it must be
filled completely with HFE-7500 (3M, USA) and 1% of Fluosurf surfactant (Emulseo, France).
After being connected to the microfluidic chip, the syringe is took off, the tubing is then
placed in a trash bottle and as the droplets are coming inside the vial, the oil mixture is
pushed away through the tubing. Once the collect done, the 1mL syringe is replace around
the tubing.
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4.5.7 Platform #3: Sorting
The sorting design is composed of three inlets. One is for the reinjection of the emulsion,
an another one is for oil mixed with 1% surfactant for the spacing of droplets after the
reinjection, and the last one is also an oil entrance to help the droplets to go to the trash
channel when no AC field is applied. For the model screening, the emulsion is reinjected with a
flow rate of Qemulsion = 75µL.h−1, spaced by HFE-7500 oil at a flow rate of Qoil = 350µL.h−1
and the other oil entrance at a flow rate of Qoil = 650µL.h−1 to screen at a frequency of
Fsorting = 500Hz. The parameters of the screening are set by the Labview software: F =
30KHz, cycles = 32, delay = 0µs and Amplitude = 600V. For the screening of the library, the
emulsion is reinjected with a flow rate of Qemulsion = 100µL.h−1, spaced by HFE-7500 oil at
a flow rate of Qoil = 300µL.h−1 and the other oil entrance at a flow rate of Qoil = 650µL.h−1
to screen at a frequency of Fsorting = 400Hz. The parameters of the screening are set by
the Labview software: F = 30KHz, cycles = 32, delay = 0µs and Amplitude = 600V. The
detection of the droplets is done through a 10x magnification.
4.5.8 Analysis of droplet fluorescence
The voltage readout of the PMTs (Hamamatsu) is recorded and transmitted to the
computer by a data acquisition card (National Instruments) and processed using LabView
software (National Instruments). Data are saved into a .txt file and analyzed using Scilab
software.
4.5.9 Nessler assay
100µL of the emulsion layer of screened droplets is pipetted and diluted in 900µL of
LB medium inside a 1mL ependorf. The 1mL ependorf is vortexed and 100µL is spread
onto a petri dish filled with agar and ampiciline. The petri dish is then place at 37◦C over
night. 1 colony from agar plate made after screening experiment is placed inside 200µL of LB
medium mixed with the according antibiotics and incubated at 37◦C until reaching an OD
of OD600nm=0.6-0.8. hASNase3-DM1 and E. coli cells were induced with 0.25mM of IPTG
and incubated overnight at 25◦C. 100mM of glycine is added to the hASNase3-DM1 cultures
and incubated at 25◦C for 24 hours. hASNase3-DM1 cultures were centrifuged (1200g, 40min,
4◦C) and the cell pellets were resuspended in PBS buffer 1X and centrifuged again. Washed
cells were resuspended in 30µL of asparagine at a concentration of 5mM and incubated at
37◦C during 30 minutes. In each wells, 260µL of DI water is added and 40µL of Nessler’s
reagent. The microtiter plate is incubated for 30 minutes at room temperature. Fluorescence
was measured in absorbance on an end point measurement at 436nm with a Spectramax Plate
Reader (Molecular Devices).
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4.6 Conclusions
In this chapter we applied two integrated microfluidic systems for the case of two
hASNase3-DM1 L-asparaginase expression vectors (display and periplasmic) and for libraries
mutants produced from the periplasmic vector. We have demonstrated that the kinetic of
the enzymatic activity can not be perfectly detectable over time on chip at the single-cell
resolution into monodisperse droplets for the periplasmic and the display expressions. The
hASNase3-DM1 L-asparaginase strain is not of interest for therapeutic benefit with its low
activity and its fluorescence level midly higher than the fluorescence of the background for
analysis counterpart. However, this strain has thus been set as reference for the screening
experiments as a negative control. Plus, the screening of mutant libraries of hASNase3-
DM1 strain shows interesting preliminary results by the possibility of screening positive hits.
However, other experiments should be done to increase the number of positive hits and to
fully characterize the biological properties of the cells that can be retrieved during assays, by
doing more rounds of screening and sequencing with the existing mutant librairies and with
new librairies containning different mutations percentage.
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4.7 Résumé du chapitre
Au travers de ce chapitre, l’enzyme L-asparaginase hASNase3-DM1 a été étudiée. Cette
enzyme est une version humain de la L-asparaginase et appartient à la famille dite Ntn-
hydrolases. La caractéristiques majeure de cette famille est que les enzymes nécessitent un
clivage intramoléculaire afin de devenir actives.
L’enzyme hASNase3-DM1 possède une activité enzymatique 2300 fois inférieure à celle de E.
coli. Cependant, elle serait d’un intérêt pour le traitement contre la leucémie aigüe afin d’éviter
tous effets secondaires dû à l’origine bactérienne du traitement actuel. Afin de pouvoir obtenir
des variants de cette enzyme possédant de meilleures propriétés, l’ingénierie moléculaire a été
utilisée par des expériences d’évolution dirigée.
Deux systèmes microfluidiques intégrés, développés dans le chapitre précédent, ont
été utilisés dans cette étude. L’enzyme hASNase3-DM1 a été produite dans deux systèmes
d’expression, en display et en périplasmique, et des banques de mutant ont été crées à partir
de l’enzyme en périplasmique.
Nous avons démontré que l’activité enzymatique de l’enzyme en display et en périplasmique
n’est pas détectable parfaitement en gouttes dans les conditions de la cellule unique. Cependant,
cette version de l’enzyme n’est pas d’un grand intérêt pour le projet et la fluorescence des
différents systèmes d’expression est très légèrement plus élevée que le fond. Cette valeur
de fluorescence a donc été prise comme référence de fluorescence pour les expériences de tri
qui ont suivies. Durant ces expériences de criblage, quelques résultats intéressants ont été
montrés. Cependant, d’autre expériences doivent être réalisées afin de caractériser exactement
la biologie récupérée au cours des criblages, comme par example du séquençage.
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Summary Chapter 4
• In this chapter we analyzed two different hASNase3-DM1 L-asparaginase expression
vectors (periplasmic and display) for the detection of the enzymatic activity of L-
asparaginase.
• Microtiter plate experiment is used as control parameter for the enzyme activity of the
two expression vectors.
• Two integrated microfluidic platforms developed in the previous chapter have been used
for the analysis of this strain.
• The enzymatic kinetic through time is not distinguishable enough from the background
at the single-cell resolution for this enzyme.
• Those workflows present thus some limitations of detection for low activity variant.
• However, the fluorescence data from the hASNase3-DM1 strain are considered as
reference for the analysis of mutants libraries.
• Several libraries of mutants have been created through directed evolution assays and a
mix of those libraries have been screened.
• The results obtained so far are preliminary but present good attrays.
• The following experiments with those mutants libraries is to continue rounds of screening
and to sequence the interesting hits recovered.
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Microfluidic systems using surface acous-
tic waves (SAWs)
Droplet-based microfluidics is an important and blooming field in microfluidic for several
applications such as biomedical, chemistry, medicine or biological operations.
For most biological operations, electric fields are usually used by its versatility and reliable
characteristics as demonstrated in the previous chapters. However a promising alternative is
to use surface acoustic waves as a means to actuate droplets. The key here is that although
electric sorting is versatile, it is inefficient for droplet actuation when the continuous phase is a
conducting medium. Surface acoustic waves actuation overcome this limitation and therefore
represent an interesting alternative for microfluidics.
5.1 Introduction
The theory of surface waves was first discussed by Lord Rayleigh in 1885 ([Rayleigh,
1885]). Surface acoustic waves (SAWs) are a special type of surface wave. They propagate
along piezoelectric surface, with nm-scale amplitude and oscillate in the MHz range. Direct
piezoelectric surface wave transduction was first introduced in the microscale range by the
use of inter-digital transducers (IDTs), consisting of periodic electrodes on a piezoelectric
substrate. When an oscillating electrical signal of suitable frequency is applied to the IDTs, it
occurs constructive interferences between the waves generated at each electrode ([Sesen et al.,
2014]).
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The advantages to use acoustic waves is focused on the high biocompatibility and
the versatility of those waves. Indeed, the acoustic power intensity and frequency used in
SAW-based microfluidic devices are in a similar range to those used in ultrasonic imaging used
for health monitoring, and enable biological/chemical detection, fluid control and particle
manipulations. SAW technologies are capable of manipulating most microparticules, regardless
their shape, electrical, magnetic or optical properties ([Ding et al., 2013]).
5.1.1 Generation of SAWs
Saws are produced by applying an electric field to a metallic inter-digital transducer
(IDT) fabricated on the surface of a piezoelectric substrate. Depending on the piezoelectric
substrate composition, different types of acoustic waves can be generated, propagating by
mechanical stress. In the case of lithium niobate (LiNbO3) substrate, the acoustic waves
are Rayleigh waves, as the thickness of the substrate (500µm) is chosen to be much larger
than the wavelength. Those waves are propagated along the interface between solid surface
and air and changes its mode to leaky SAW when reaching a boundary between solids and
liquids, becoming leaky SAWs ([Alghane et al., 2011]). This type of waves are composed
of a longitudinal and a vertically polarized shear component ([Gedge and Hill, 2012]). The
working principle of this system is represented in figure 5.1.
Figure 5.1: Working principle of the surface acoustic wave actuation
(side view): the SAW is generated by an interdigitated transducer on
the chip and traveled along the chip surface towards the PDMS channel.
Reprinted from Schmid et al, 2014 ([Schmid and Franke, 2014]).
5.1.2 IDT components
An IDT is composed of a set of connected metallic fingers and by adjusting the number
of fingers, the spacing between them and the aperture which is the overlapping length, the
characteristics of the resulting wave change. Each IDT variants possess a set of advantages
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and disadvantages and the choice depends on the device requirement. A representation of a
metallic IDT is exhibited in figure 5.2.
Figure 5.2: Representation of a metallic IDT deposited on the piezo-
electric substrates. It generates SAWs that propagate along the substrate
surface in both directions. Reprinted from Ding et al, 2013.
Inter-digital transducers are employed to efficiently convert a high frequency electrical
input into a traveling surface acoustic wave ([Franke, 2014]) and to better control excitation
frequencies in a wide range. This is more versatile and flexible system and can acheive more
precise and controllable manipulation of fluids ans particles ([Ding et al., 2013]). The range
of excitation frequencies possible according to the SAW microfluidic system developed is
calculated with the equation 5.1.
f =
νSAW
λ
(5.1)
where f is the frequency, νSAW the speed of sound and λ is the wavelength, which is
given by the periodicity of the IDT.
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5.1.3 Applications
SAW microfluidics are an attractive field for biomedical or drug development applications
and in chemistry or engineering fields. Multiple applications are illustrated in the literature.
It could be from the production of droplets and encapsulation of particles ([Collins et al.,
2013], [Schmid and Franke, 2014]), to trap and coalescence droplets ([Sesen et al., 2014]), to
the determination of mixing efficiency inside droplets ([Tseng et al., 2006], [Shilton et al.,
2008], [Tan et al., 2009]), to biological applications ([Länge et al., 2006], [Shi et al., 2009],
[Ding et al., 2012]) with droplets and cells sorting operating at several kHz ([Franke et al.,
2010], [Schmid and Franke, 2014]), or even the creation of an acoustic pump ([Schmid et al.,
2012]).
5.2 Scope of the project
The main goal in this project is to develop a new type of microfluidic system based
on acoustic waves to induce the coalescence of stabilized droplets by surfactant, usable for
droplet fusion. This type of process is of interest for several applications such as chemical
reaction or biomolecular synthesis.
The project have been realized thanks to a grant from the University of Bordeaux called
"Initiative d’excellence de l’Université de Bordeaux" allowing a traineeship at the University of
Glasgow for three months in the group of Thomas Franke (reference: ANR-10-IDEX-03-02).
5.3 Analysis system
The microfluidic system used for this project using SAWs is available in the group of
Pr. Thomas Franke at Glasgow University. The system is composed of syringes pumps
(Harvard Apparatus) for the production of droplets, of an optical setup to monitor the ongoing
experiment and a signal generator to produce the surface acoustic waves.
5.3.1 IDT characteristics
For the project, we used an IDT system that have been made and optimized by the group
of Pr Franke. We used TIDT (tapered interdigital transducer) on substrate of Lithiumniobat
with dimensions of 17.5x17.5 mm (figure 5.3). The IDT used have a number of fingers equal
to 60, a wavelength of 23 to 24.2 µm and an aperture of 500µm. The excitation frequencies
for this TIDT is between 160MHz to 165MHz.
For all experiments explained in this chapter, we decided to work with the same excitation
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frequency F=162MHz. This frequency value allows to generate the acoustic waves in the
middle of the IDT.
Figure 5.3: TIDT. The images are showing a part of the IDT structure
in S1818 positive resist after exposure with mask aligner and development.
From left to right, the images are shown in 10x, 20x, 50x and 100x times
magnifications. The bright areas correspond after metallization and
subsequent Lift Off the IDT structure. Figure given with the courtesy of
the Thomas Franke’s group.
5.3.2 Microfluidic chip holder
The SAW microfluidic chip system used is represented in the figure 5.4. It is a system
made of handy screwed plexiglas slides on top of the PDMS chip which is aligned onto the
IDT mold. This setup allows enough pressure for the aqueous phases and the oil phase to
flow inside the channels without leaking out.
Figure 5.4: Microfluidic setup using surface acoustic waves (SAWs).
From left to right, the images show the plexiglas holder (orange) on
which the IDT mold (green) is placed with the IDT. The second image
presents the plexiglas slides and screws which serve for squeezing the
PDMS chip between the IDT and the slides as seen in the last image.
To generate the electric field, a high frequency signal generator (SMB100A, Rohde &
Schwarz) is connected to the IDT mold through connectors placed on the IDT mold.
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5.3.3 Optical setup
The optical station represented in figure 5.5 is composed of one laser (488nm with 20mW,
Omicron) focused with four objectives (5x, 10x, 20x, 40x, Olympus) into the microfluidic
channels using a set of mirrors (BB1-E02, KM100, Thorlabs). The microfluidic chip is mounted
on the x-y stage of an inverted microscope (IX73, Olympus). Droplets are images with a
high speed camera (Mini AX-50, Photron) using an halogen lamp (Olympys)from above.
The dyes in the droplet are excited by the laser and the fluorescence light is recorded by a
photomultiplier tube (H10723-20, Hamamatsu) which spectral response is between 230nm
to 920nm. Data aquisition and control are performed by a data acquisition card (National
Instruments) executing a program written in LabView (National Instruments) allowing the
detection of droplets by fluorescence peaks. The program was written within the group of Pr
Weitz in Harvard while in collaboration with the group of Pr Thomas Franke.
Figure 5.5: Schematic representation of the optical setup available at
Glasgow University in the group of Thomas Franke. A lasers (488nm
with 20mW, Omicron) is combined with an ensemble of mirrors (BB1-
E02, KM100, Thorlabs). The fluorescence light is recorded by a PMT
(H10723-20, Hamamatsu).
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5.4 Development of microfluidic tools for the merg-
ing of drops stabilized by surfactant
Merging of droplets is a key system in microfluidic box tools, using electrocoalescence
([Ahn et al., 2006], [Gu et al., 2011]) or surface acoustic waves ([Sesen et al., 2014]). However,
in acoustofluidic, the merging of droplets have been demonstrated only with unstabilized
droplets. To conduct on-chip biochemical analysis, a key step is to be able to merge droplets
selectively to initiate the required reactions, and usually those droplets are stabilized by
surfactant to avoid any unwanted coalescence or contamination, and thus have a control on
the assay.
The project will therefore focus on an on-demand random merging for stabilized droplets
(Article in preparation).
The microfluidic chip require here consists in two parts: a first part allowing the pairing
of droplets and a second part made of a merging chamber adapted to SAWs use.
5.4.1 Pairing of droplets from the literature
For the project, we need to produce two populations of droplets to merge a pair of
droplets. The phenomenon of pairing two droplets together is permitted by complex dynamical
behaviors. Droplets need to be produce at the same frequency to initiate synchronization
of pairing. It is a phenomenon sensitive to fluctuations and without synchronization of the
production of the population of droplets, the system tends to be in a complete disorder and
thus causes polydispersity of the emulsion and no control over the system.
By an analysis of the systems available in the literature, two different systems to deal
with this problematic was chosen: production on chip of two different population of droplets
or reinjection of two populations separately.
5.4.1.1 Production of droplets on-chip
Several articles shown good advantages by the design and the system involved for the
pairing of droplets by producing two emulsions on chip ([Zheng et al., 2004a], [Zheng et al.,
2004b], [Barbier et al., 2006], [Frenz et al., 2008], [Chokkalingam et al., 2008]).
In 2004, Zheng et al presents a microfluidic design using a double T-junction place in
front of each other for the production of two monodisperse populations and to be able to pair
them. The size of droplets in this design increases with the water fraction and the distance
between adjacent droplets decreased as the water fraction increased. Therefore, it seems
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difficult to have a difference between the drops volume between the two populations. Also, at
low flow rate, there is a problem of coalescence, thus contamination and polydispersity of the
emulsion (figure 5.6 A).
In 2006, Barbier et al demonstrates an another design based on the same basics as Zheng
et al. The droplets are produced with two T-junctions where water and oil feeds are placed
in parallel on the same chip. Droplets move then downstream and are collected in the same
microcanal. In the synchronize regime of this design, the emulsion is monodispersed, whereas
chaotic and quasiperiodic behaviors enhance polydispersity of the emulsion. It is a system
which depends on the geometry of each parts and presents dynamical complexity (figure 5.6
B).
Finally, in 2008, Frenz et al presents a microfluidic chip allowing the hydrodynamic coupling
of two spatially separated nozzles. The synchronization of droplet formation is promoted by
the formation and presence of a droplet in one of the two nozzle arms forcing the oil through
the second arm. The volume of the droplets produced is between Vdroplets=[50-250]pL and
the stability ratio between the two droplets is set from 1:1 to 1:5. This parameter is controlled
directly by the flow rates of the aqueous streams (figure 5.6 C).
Figure 5.6: Microfluidic designs for the pairing of droplets. (A)A
series of micrographs showing the formation of alternating droplets from
Zheng et al, 2004. (B)Sketch of the parallelized system from Barbier et
al, 2006. (C)Paring modules from Frenz et al, 2008. Two aqueous phases
are injected by the outer channels and synchronously emulsified by the
central oil channel.
All of the features of those three different designs are resumed in table 5.1.
Geometry Pairing dependance Ratio coupling Low flow rate
Zheng et al T-junctions face to face Ca & water fraction Unknown Coalescence
Barbier et al Parallel T-junctions Geometry LsL0=
1
5 Inefficient pairing
Frenz et al T-junctions spatially separated Flow rates 1:1 to 1:5 Inefficient pairing
Table 5.1: Features of three designs from the literature.
Considering the different features of those designs, we first decided to use the design
from Frenz et al (Frenz2008) to pair droplets by production on chip because of the spatially
separated nozzle and the range of volume drop manipulation.
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5.4.1.2 Reinjection of droplets
The design to pair droplets by reinjection is taken from Lee et al ([Lee et al., 2014]).
The device consists of two opposing T-junctions for reinjecting two populations of droplets in
parallel (figure 5.7). In this design, the synchronization is the result of a complex interplay
between the fluid dynamics of discrete droplets and the continuous flow of oil at the junction.
Also, the hydrodynamic coupling between two droplets in opposite channels automatically
forces the injected droplets to alternate. Indeed, when the droplet in the upper chamber
starts to emerge into the main channel, the pressure on the droplet in the lower channel
increases, holding it in place. The lower droplet therefore emerges only after the upper droplet
is released, producing an ordered pairing of the droplets. The reinjection pairing works for a
reinjection ratio of upper to lower droplets between 1:2 and 2:1. However in this design, a
disorder in the system can occur if the diameters of the upper and lower droplets are slightly
different, reducing then the hydrodynamic coupling.
Figure 5.7: Synchronized reinjection of two different kinds of droplets
from Lee et al, 2014.
Even if pairing errors can occur when the size of the two populations of droplets are
different, this design is interesting to test random pairing and therefore random merging of
the droplets.
5.4.2 Merging
Droplet merging is an essential tools in droplet-based microfluidics for applications in
biology or chemistry by bringing together reactants contained in separate drops.
In the literature, different types of merging is possible and can be grouped in two types of
merging: passive merging ([Tan et al., 2004], [Liu et al., 2007], [Baroud et al., 2007], [Pekin
et al., 2011]) and merging by electrocoalescence ([Chabert et al., 2005], [Ahn et al., 2006],
[Mazutis et al., 2009a], [Zagnoni et al., 2010]).
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The figure 5.8 represents a sketch description of the different main steps for the merging
phenomenon between two droplets.
Figure 5.8: Sketch of the merging process for two droplets. Droplets
are flowing from left to right.
Merging using surface acoustic waves have been already demonstrated by Sesen et al
but only with droplets unstabilized by surfactant ([Sesen et al., 2014]). Within their design,
the droplets are produced by use of T-junctions of continuous oil (olive oil) and water streams
(DI water), and the merging occurs when droplets are trapped in an expansion area. In this
system, SAW generated acoustic radiation forces used to stop the progress of a selected droplet,
such that the successive droplet will merge with the trapped droplet until a certain volume
is reached and then be released from the acoustic trap as the power will not be sufficient
anymore to trap the combined volume. This force are known as flow-driven effect. However,
merging of stabilized droplets using surface acoustic waves was never reported, to the best of
our knowledge.
Merging experiments in the literature happens usually using fusion chambers but also
directly in straight channels ([Jin et al., 2010]). However for our project, we will focus on
a merging using a merging chamber. Indeed, we need to take into account the flow-driven
effect, and for that, droplets need to be able to move across the channels. Flow-driven effect
is a flow effect produced by the acoustic waves inducing a motion or mixing inside a droplet.
The figure 5.9 represents two geometries of chambers that can be used for droplets fusion. Both
geometry is composed of a smaller channel before the merging chamber for the droplets to
adopt an elongated shape called a pancake shape. The droplets then collide when the channel
suddenly expands and relax to a circular shape but remain constrained in the transverse
direction.
The first geometry (figure 5.9a) was drawn using the channel characterization of a drop maker.
However, when drops are coming inside the chamber, they tend to relax from their pancake
shape too quickly. Indeed, when a pair of droplets are about to enter the merging chamber,
the first one is pushed when relaxing inside the merging chamber, leading to an unpairing of
the droplets.
The second geometry (figure 5.9b) was based on the design of Bremond et al ([Bremond
et al., 2008]). This type of merging chamber allows the droplets to enter smoothly inside
the chamber with a slow velocity due to hydrodynamic effects but the drop will not come to rest.
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(a) Geometry #1.
(b) Geometry #2.
Figure 5.9: Merging chambers. (A)Geometry #1. Instant relaxation of
the droplet when entering inside the chamber. (B)Geometry #2. Smooth
relaxation of the droplet when entering inside the chamber.
Taking into account all the characteristics of the merging chambers and the acoustic
waves that will be used, we decided to design our microfluidic systems using the geometry #
2 for the merging chamber.
5.5 Material & Methods
5.5.1 IDT manufactoring
A 4 inch Lithiumniobat wafer is washed in acetone and isopropanol for 5 minutes each
in an ultrasonic batch followed by a five minutes rinse with RO water and dried with nitrogen.
After cleaning, the wafer is put on the spin coater and held by vacuum. With a plastic pipette,
a primer is dripped onto the surface of the wafer and spin for 5 seconds at 4000 rpm. Then,
the positive photoresist S1818 (Microposit, MicroChem) is also dripped onto the surface of
the wafer and spun 30 seconds at 4000 rpm, for a height of 1.8µm of the resist, according to
the data sheet of the resist (S1800, MicroChem). Then, the wafer is placed on a hotplate
for 2 minutes at 120◦C to cure. After cooling to room temperature, the wafer is exposed
with a mask aligner (MA6, SUSS MicroTec) using a chromium mask which contains the IDT
structures. The wafer is 5 seconds illuminated. After exposing, the wafer is developed in a
MF-319 developer solution for 75 seconds. Subsequently rinsed with RO water for five minutes
and dried with nitrogen. The processed wafer is exposed to an oxygen plasma for 2 minutes
at 100 Watts to remove any residues of resist and dust particles. Then the wafer is put into a
holder for metal deposition and is built into Plassys II. Three layers are deposited, starting
with a 10nm Titanium layer, followed by a 100nm Gold layer, and finaly an 10nm Titanium
layer. The titanium layers serve as sticky layers between lithiumniobat to gold, and gold to
glass layer (silconedioxid). Then a Lift Off is performed using dimethylsulfoxid. After Lift
Off, the wafer is send out for dicing (Optocap) into 17.5x17.5 mm pieces. The final step is
again a deposition of a glass layer (silconedioxid) using DryEtch.
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5.5.2 Microfluidic chip
A 4 inch Lithiumniobat wafer is washed in acetone and isopropanol for 5 minutes each
in an ultrasonic batch followed by a five minutes rinse with RO water and dried with nitrogen.
Then the wafer is exposed to an oxygen plasma for 3 minutes at 100 Watts. After cleaning,
the wafer is put on a spin coater where the negative photoresist SU8-3025 is pourred onto
it. It is spined at 500 rpm for 10 seconds with an acceleration of 100 rpm.second−1, then at
3000 rpm for 30 seconds with an acceleration of 300 rpm.second−1, for a height of the resist
of 25µm, according to data sheet of the photoresist (SU8-3000, MicroChem). Then, the wafer
is placed on a hotplate for 12 minutes at 95◦C to realize the soft baking. After cooling to
room temperature, the wafer is exposed for 30 seconds with a mask aligner (MJB4, SUSS
MicroTec) holding the photomask (Selba S.A, Switzerland) on which the features are printed.
After exposition, the wafer is post-baked for 1 minutes at 65◦C and for 3 minutes at 95◦C.
The wafer is then developed in a developer solution (MicroChem) for 6 minutes and placed
for 3 minutes at 180◦C on a hot plate for an hard baking. Once the wafer cooled down at
room temperature, a mixture of Sylgard 184 silicon elastomer with a curing agent (Samaro,
France) at the ratio 10:1 (w/w). This mix is degassed under vacuum, poured onto the silicon
wafer and cured at 65◦C during at least 2 hours. The cured PDMS layer is pealed off and
inlets and outlets are punched out of the PDMS with a 0.75mm diameter Uni-Core biopsy
punch (WPI, France). PDMS chips are washed with isopropanol and RO water, dried out
with nitrogen and scothed several times to increase the bonding capability on the IDT chip.
When PDMS and IDT are aligned and the chip is prepared, the channels are treated with
Aquapel (Autoserv, Germany) for hydrophobic surface treatment and placed in the oven at
75◦C for 30 minutes.
5.6 Results & discussions
Two geometries from the literature were chosen to merge a pair of droplets stabilized by
surfactant.
5.6.1 Pairing of droplets
Two populations of droplets are produced in a double T-junction using DI water only
for one population, and a mix between two dyes, fluorescein 10µm (Sigma-Aldrich) dissolved
in DI water and trypan blue (Sigma-Aldrich) for the second population. The oil phase is
composed of fluorinated oil HFE-7500 combined with Fluosurf surfactant (Emulseo, France)
on a concentration from 1.5% to 3%. The syringes containing the different phases were driven
by syringe pumps (Harvard Apparatus).
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5.6.1.1 Pairing by reinjection
The design was enhanced by the addition of an extraction of oil before the droplets
enter the merging chamber.
Through this microfluidic design, two emulsions are reinjected in parallel at different flows to
control the spacing between the droplets. A flow of HFE-7500 fluorinated oil (Novec, 3M ) is
used to enhance the pairing of droplets.
The first emulsion is composed of 55µm diameter droplets containing fluorocein 1mM diluted
in water, and the second one of 65µm diameter droplets containing bromophenol blue diluted
in water. Those emulsion have been encapsulated using a simple drop maker design and 1%
Fluosurf surfactant (Emulseo, France). To collect the emulsions, two plastic eppendorf filled
with HFE-7500 have been used.
(a) Reinjection.
(b) Pairing.
Figure 5.10: Pairing by reinjection. Pairing of two populations of
droplets from the design of Lee et al: a fluorescent population composed
of fluorocein 10µM diluted in water mixed with trypan blue dye and non
fluorescent population composed of water. Droplets are stabilized with
1.5% Fluosurf surfactant. Scale bar is equal to 100µm.
Within this system, the pairing of droplets is possible (figure 5.10). Unfortunately, to
date, we do not have a smooth control over the pairing frequency, and while the frequency
raises, the success of pairing decreases.
Also, if the difference between the volume of droplets from both emulsions is superior to a
ration 1:2, then the reinjection of the small population will split the large population when
entering the commun channels, meaning that the pairing of droplets is not possible anymore.
Finally, using reinjected droplets leads to an other issue which is leakage. Indeed, depending
on the composition of the emulsion, there is a chance for leakage even while using surfactant
([Skhiri et al., 2012]).
5.6.1.2 Pairing by production on-chip
For this second microfluidic system, the design was enhanced for our project by the
addition of an extraction of oil before the droplets enter the merging chamber.
Two aqueous phase are loaded onto the chip at the desired entrance. Droplets are formed by
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using fluorinated oil HFE-7500 (3M, Novec) mixed with 1% Fluosurf surfactant (Emulseo,
France).
Figure 5.11: Production and pairing of two populations of droplets
from the design of Frenz et al: a fluorescent population composed of
fluorocein 10µM diluted in water mixed with trypan blue dye and non
fluorescent population composed of water. Droplets are stabilized with
1.5% Fluosurf surfactant. Scale bar is equal to 100µm.
Within this design, pairing of droplets is also possible (figure 5.11). Unfortunately this
is also a sensitive system which takes time to stabilize and have a monodispersity of both
emulsions.
In the article ([Frenz et al., 2008]), the pairing of droplets is possible within a volume ratio
from 1:1 to 1:5. In our experiments, the stability and pairing of droplets is feasible within a
ratio inferior to 1:1.25, otherwise the system becomes unstable and disorder is present.
5.6.2 Merging of droplets
With the advantages and disadvantages of the two designs analyzed before, we decided
to use the channels geometry from Lee et al but instead of reinjected the emulsion, we
used the entrance for flowing aqueous phases inside the channels. The design turns to a
T-junction geometry for both aqueous phases (DI water and fluorocein 10µM) and droplets
are encapsulated using fluorinated oil HFE-7500 (3M, Novec) mixed with [1.5-3]% Fluosurf
surfactant (Emulseo, France). An extraction of oil before the droplets enter the merging
chamber was added (figure 5.12).
Within this workflow, we succeeded to produce random pairing of droplets. Indeed, the
fluorescent population, the darken one on the figure 5.12, is produced at a lower frequency
compare to the non-fluorescent population. With this configuration, we have a on-demand
merging situation: the SAWs are activated only when a fluoroscent droplet pass by the laser.
By adjusting the pulse length and the delay of the acoustic waves through the LabView
software, we succeed to merge two droplets in two manners that we called right merging
(figure 5.13) and left merging (figure 5.14). Also, control experiments without SAWs have
been done where no merging of droplets was possible.
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Figure 5.12: Production and pairing of two populations of droplets
from the design of Lee et al: a fluorescent population composed of
fluorocein 10µM diluted in water mixed with trypan blue dye with a
diameter of 50µm and non fluorescent population composed of water
with a diameter of 70µm. Droplets are stabilized with 1.5% Fluosurf
surfactant. Scale bar is equal to 100µm.
Figure 5.13: Time lapse images for right merging experiment. The
fluorescent droplet (darkest droplet) is detected by the laser (yellow
cross) and the non-fluorescent droplet (lighter droplet) is pushed by the
acoustic waves against the fluorescent droplet and started the merging of
the two droplets. Droplets are stabilized with 1.5% Fluosurf surfactant.
The oil flow is from left to right. Scale bar is equal to 100µm.
Figure 5.14: Time lapse images for left merging experiment. The
fluorescent droplet (darkest droplet) is detected by the laser (yellow cross)
and pushed by the acoustic waves against the non-fluorescent droplet
(lighter droplet) and started the merging of the two droplets. Droplets
are stabilized with 1.5% Fluosurf surfactant. The oil flow is from left to
right. Scale bar is equal to 100µm.
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Two effects are visible during the merging process when SAWs are triggered.
For right merging, the pulse length and the delay are set in way that the acoustic waves
separate the fluorescent droplet from the droplet that followed it. Then give an acceleration
to the fluorescent droplet that push it against the droplet ahead and allow the merging of
those two droplets. Those steps are represented in figure 5.15.
Figure 5.15: Time lapse images for right merging experiment. The
fluorescent droplet (darkest droplet) is detected by the laser (yellow
cross) and the non-fluorescent droplet (lighter droplet) is pushed by the
acoustic waves against the fluorescent droplet and started the merging of
the two droplets. Droplets are stabilized with 1.5% Fluosurf surfactant.
The oil flow is from left to right. Scale bar is equal to 100µm.
For the left merging, the pulse length and the delay are set in way that the acoustic
waves decelerate the non-fluorescent droplet, press it to finally give it an acceleration that
push it against the fluorescent droplet, allowing the merging of those two droplets. Those
steps are represented in figure 5.16.
Figure 5.16: Time lapse images for right merging experiment. The
fluorescent droplet (darkest droplet) is detected by the laser stop (yellow
cross) and the non-fluorescent droplet (lighter droplet) is pushed by the
acoustic waves against the fluorescent droplet and started the merging of
the two droplets. Droplets are stabilized with 1.5% Fluosurf surfactant.
The oil flow is from left to right. Scale bar is equal to 100µm.
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5.6.3 Analysis
To characterize the merging phenomenon, the minimum trapping power required to
merge droplets at the same velocity is analyzed by conducting a series of experiments in which
power, pulse length and delay are combined. The results of those experiments are represented
in figure 5.17 (B) which represents the efficiency of merging two droplets according to power
for a frequency of fluorescent droplets equal to Ffluorescent = 30Hz.
Parameters for all experiments at Ffluorescent = 30Hz were set as followed (table 5.4):
% Fluosurf Qtot Qoil dnon−fluo dfluo Pulse Delay
Right merging 1.5 35µL.h−1 200µL.h−1 72µm 53µm 7ms 20ms
Left merging 1.5 35µL.h−1 200µL.h−1 72µm 53µm 10ms 25.5ms
Table 5.2: Parameters of the system for the following experiments.
Figure 5.17, 25dBm is the power setup the most successful with a right merging mode
reaching 99% of merging efficiency whereas the left merging only reaches 70% at maximum.
(a) Skecth.
(b) Efficiency graph.
Figure 5.17: Merging efficiency. (A)Sketch representing right and
left merging. (B)Efficiency according to power for left and right merg-
ing. Droplets are stabilized with 1.5% Fluosurf surfactant. Error bars
corresponding to the usual standard deviation for analysis by hands.
Therefore, both merging modes are possible and efficient with the right combinations of
parameters.
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5.6.3.1 Is the system robust?
In this project, the principal element of study is the merging of droplets stabilized by
surfactant. Therefore, the efficiency of merging according to the percentage of surfactant is
analyzed, as seen in figure 5.18 (B). The percentage is set between 1.5% and 3% of surfactant
to ensure a droplet production without satellite droplets and a range of values used in usual
bio-microfluidic experiments. The technical parameters are given in table 5.3 and the power
is fixed at 25dBM..
(a) Skecth.
(b) Efficiency graph.
Figure 5.18: Merging efficiency. (A)Sketch representing right and left
merging. (B)Efficiency according to surfactant percentage for left and
right merging. Error bars corresponding to the usual standard deviation
for analysis by hands.
1.5% Fluosurf 2% Fluosurf 3% Fluosurf
Flow rates Qtot = 35µL.h
−1 Qtot = 35µL.h−1 Qtot = 35µL.h−1
Qoil = 200µL.h−1 Qoil = 200µL.h−1 Qoil = 200µL.h−1
Drop diameter dfluorescent = 53µm dfluorescent = 57µm dfluorescent = 60µmdnon−fluorescent = 72µm dnon−fluorescent = 75µm dnon−fluorescent = 80µm
Right merging pulse = 7ms pulse = 7ms pulse = 7msdelay = 20ms delay = 19ms delay =20ms
Left merging pulse = 10ms pulse = 8.5ms pulse = 8.5msdelay = 25.5ms delay = 27ms delay = 27ms
Table 5.3: Technical parameters of the system for the merging of
drops according to the percentage of surfactant. The power was fixed to
25dBm.
The use of surfactant in the production of droplets is to stabilize the droplet surface to
avoid coalescence between them. The more surfactant are used, the more the droplet surface
is stable, therefore it is more difficult to induce coalescence between the droplets.
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Through the figure 5.18, we can see that the efficiency of merging for right or left merging is
slowly decreasing according to the percentage of surfactant used. This is in accordance with
the principle of surfactant. However, merging phenomenon is still possible according to a
concentration of surfactant desired. Therefore, it should be a question of only technical issues
with our system that prevent an efficiency superior to 90%. Perhaps, by changing the IDT or
the capacity of the signal generator by more robust ones, the merging efficiency should be
more possible with a surfactant percentage above 3%.
5.6.3.2 Effect of parameters on the system
The merging effect is a complex behavior depending on parameters.
We decided to work at 1.5% of surfactant and to decrease the frequency of production for
the fluorescent droplets. By decreasing the frequency, smaller droplets are produced, leading
to more micelles around the interface of the droplets and then a better stability against
coalescence. We tried this theory and the results are given in the graph 5.19 (B). The technical
parameters are given in table 5.4.
Ra
(a) Skecth.
(b) Efficiency graph.
Figure 5.19: Merging efficiency with a frequency of fluorescent droplets
different. (A)Sketch representing right and left merging. (B)Efficiency
according to power for left and right merging for Ffluorescent = 20Hz
and Ffluorescent = 10Hz. Error bars corresponding to the usual standard
deviation for analysis by hands.
Figure 5.19 shows that the smaller the power is, the lower the merging efficiency is:
the efficiency decreases for both right and for the left merging. For the case of Ffluorescent =
10Hz, the frequency of non-fluorescent droplets is equal to the same value as the reference
experiment, meaning Fnon−fluorescent = 100Hz. However, for the case of Ffluorescent = 20Hz,
the frequency of the non-fluorescent droplets is increased to Fnon−fluorescent = 200Hz. By
increasing the frequency, the size of the two population of droplets decreased and the merging
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Ffluorescent=10Hz Ffluorescent=20Hz Ffluorescent=30Hz
Flow rates Qtot = 21.5µL.h
−1 Qtot = 61µL.h−1 Qtot = 35µL.h−1
Qoil = 200µL.h−1 Qoil = 280µL.h−1 Qoil = 200µL.h−1
Drop diameter dfluorescent = 48µm dfluorescent = 41µm dfluorescent = 53µmdnon−fluorescent = 68µm dnon−fluorescent = 65µm dnon−fluorescent = 72µm
Right merging pulse = 10ms pulse = 9ms pulse = 7msdelay = 24ms delay = 22ms delay =20ms
Left merging pulse = 10ms pulse = 15ms pulse = 10msdelay = 36ms delay = 29ms delay = 25.5ms
Table 5.4: Technical parameters of the system for the merging of drops
according to the production frequency of the fluorescent droplets. The
concentration of surfactant was fixed to 1.5%.
efficiency decreases also with it.
Therefore, the effect of surfactant at the interface of the droplets is also visible through
those results and we can conclude that surfactant plays an important function in the merging
phenomenon.
5.6.3.3 Flow-driven efficiency
To date, there is no complete model to explain merging phenomenon by the use of
surface acoustic waves in the literature. Therefore, to understand the physics behind it, some
experiments can be done. Indeed, as seen with the previous results, the merging is enabled by
the surface acoustic waves. However, is it the push from the SAWs to the droplet that allow
the coalescence, or is it the effect of the SAWs onto the fluid that helps the droplet interface
to be destabilized or is it a mix of those two hypothesis? To answer to those questions, simple
experiments can be done.
The behavior between the reinjection of small closed pack droplets and of large closed
pack droplets is in interest to understand the phenomenon. Indeed, the surface acoustic
waves create a flow-driven force that induces a motion to the droplet. This motion have been
monitored and discussed before, but we need to understand if this motion is an important
factor for the merging behavior.
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(a) Small closed pack droplets. (b) Large closed pack droplets.
Figure 5.20: Behavior of droplets inside the merging chambers while
close packed. (A)In the case of small droplets compacted inside the
merging chamber. At 10ms the surface acoustic waves are turn on and
no merging is visible. (B)In the case of large droplets compacted inside
the merging chamber. At 10ms the surface acoustic waves are turn on
and merging is visible. Scale bar is equal to 100µm.
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For the case of small closed pack droplets, no empty places are visible so no motion for
the droplets is possible and no merging is possible with or without surface acoustic waves as
seen in figure 5.20a. For the case of large closed pack droplets, the motion between droplets
is possible since there is empty spaced between the droplets due to their circumference and
when the SAWs are activated, merging is acting on some drops as seen in figure 5.20b. Those
results are in concordance with the article from Bremond et al ([Bremond et al., 2008]) by
the fact that a pair of droplets need a motion to be able to merge with each other.
Therefore within this experiment, the flow-driven effect created by the acoustics plays
an important role in the merging between two droplets.
5.6.3.4 Nipple formation
Other experiments can be done to determine more characteristics of the merging phe-
nomenon. We could work at very high resolution and higher speed rate to see in slow motion
the merging effect between two droplets. Indeed, during merging between two droplets, a
nipple is formed at the interface between those two droplets prior to coalescence, as seen in
figure 5.21. This phenomenon is described first by Bremond et al ([Bremond et al., 2008]) as
an effect induced by low pressure and by separating the drops, and more characterized by
Bird et al ([Bird et al., 2009]) as un effect induced by electrical stresses deforming the leading
edges into a cones for two close droplets.
For Bremond et al the nipple formation brings the two droplets interfaces close enough until
they merge by separation, whereas for Bird et al, the merging will happen depending on the
angle of the nipple formation, resulting in inward flow and coalescence.
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(a) Nipple zoom.
(b) Timelapse of merging after formation of a
nipple.
Figure 5.21: Formation of a nipple between two droplets in the contact
area prior merging induced by the contact between the droplets. Scale
bar is equal to 100µm.
In our system using SAWs, the nipple formation occurs when the droplets are come into
contact and help the merging of the droplets. More physics research behind this characteristic
need to be achieve to complete the study. Indeed, in the article of Bremond et al ([Bremond
et al., 2008]), they used 0.1% in mass of Span80 (Fluka) surfactant, and noticed that the pair
of droplets are destabilized by flowing inside the merging chamber despite the saturation of
interface by surfactant. They explain it by saying that this phenomenon is interpreted to
be the result of a local depletion of surfactant molecules at the interface during the nipple
formation, as the interface area suddenly increases. In their case, the coalescence occurs
during the separation phase of two droplets after collision and not during impact. In our
project, the use of surface acoustic waves induce a pushing effect, as described before, and
this push helps the droplets to merge together while a nipple is formed just prior to this
phenomenon.
Therefore, the physics explained in the article of Bird et al ([Bird et al., 2009]) are
more relevant for this project, without taking account an angle of formation for the nipple
formation. However, to date there is still a lack of a detailed understanding of the mechanism
of coalescence. A more detailed analysis will be a valuable add-on for the future.
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5.7 Conclusions & perspectives
Within this project done in collaboration with the group of Pr Franke in Glasgow
University, the developed system provides promising first results for a platform usable for the
merging of random stabilized droplets by fluorescence detection.
During those experiments, the high-throughput of the platform has not been tested fully. The
maximum frequency rate for fluorescent drops was Ffluorescent = 30Hz and for non-fluorescent
drops Fnon−fluorescent = 200Hz.
Preliminary microfluidic experiments show that this system allows random merging of two
droplets efficiently based on fluorescence detection. Therefore, for simple biochemical experi-
ments, this system is relevant to start reaction inside a droplet at a definite time. However,
for biological experiment such as involving drop PCR, this system is not relevant enough, the
percentage of surfactant being to high to allow a competent merging.
Therefore, the next step of the project will be to enhance the design of the platform to
contribute at a high-throughput merging and to apply this platform to biological experiment.
For that, an improvement of the design can be done allowing different range of droplets volume
to be produced to enhance the throughput of the pairing. Also, by changing the characteristics
of the IDT used, a merging using higher concentration of surfactant could be possible.
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5.8 Résumé du chapitre
Un projet en collaboration avec le groupe du Pr. Thomas Franke à l’université de
Glasgow a vu le jour grâce à un financement obtenu par une bourse de l’université de Bordeaux
portant sur la mobilité et l’internationalisation des études doctorales. Le projet s’est déroulé
sur trois mois à l’université de Glasgow.
Ce project consiste à réaliser la fusion entre deux gouttes stabilisées par du tensioactif à l’aide
d’ondes acoustiques de surface. Les ondes acoustiques de surface sont des ondes acoustiques
qui se propagent le long de la surface d’une surface piézoélectrique, à l’échelle nanométrique
et oscillant dans l’ordre du méga hertz. Les ondes acoustique de surface représentent une
alternative à l’électrocoalescence utilisée dans certain systèmes microfluidique.
Au cours de ce projet, différents systèmes microfluidiques pour coupler deux gouttes provenant
de la littérature ont été utilisés afin de pouvoir développer une plateforme intégrée regroupant
les point forts du couplage et le module de fusion par ondes acoustiques de surface. Au travers
de cette plateforme développée, deux effets de fusion ont été observés: fusion par la droite et
fusion par la gauche. Comme leur noms indiquent, on peut choisir dans quel sens un couple
de gouttes va être réaliser et fusionner.
Les résultats obtenus sont très encourageants mais représentent que des résultats préliminaires.
La fusion de gouttes a été démontrée dans plusieurs conditions: concentration en tensioactif,
vitesse de production des gouttes, changement des paramètres des ondes acoustics. De part
ses résultats, plusieurs caractéristiques physiques ont pu être démontrées, comme la formation
d’un téton à la surface en contact entre les gouttes, avant leur fusion.
La suite du projet consiste en l’amélioration des designs de puces afin de pouvoir réaliser
à plus grande vitesse la fusion de gouttes, d’avoir une gamme de variation de taille de gouttes
plus étendue, et ainsi une gamme plus riche en concentration en tensioactif. Ces améliorations
seraient d’un grand intérêt afin de pouvoir appliquer ce système de fusion de gouttes par ondes
acoustique de surface à des applications biologiques précises, comme par example, l’évolution
dirigée en gouttes.
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Summary Chapter 5
• Surface acoustic waves is used as an alternative to electrocoalescence in microfluidic
devices for biochemical experiments.
• The purpose of this project was to develop new type of microfluidic systems to induce
coalescence of stabilized droplets by surfactant by the use of surface acoustic waves.
• We successfully merged random pairs of stabilized droplets using different concentration
of surfactant by changing the parameters of the IDT used. Those are preliminary
results.
• Two merging effects can be visualized: right & left merging which depend on the
experiment parameters chosen.
• Physical characteristics described in the literature are found during those assays such
as the nipple formation which occurs when two droplets are about to merge.
• For the analysis of the mechanism, we assumed that the flow-driven effect contributes
to the fusion induced by surface acoustic waves.
• However, some improvements of the designs have to be done to increase the throughput
of the pairing and thus the throughput of the merging.
• Finally, those improvements could be of interest for microfluidic systems based on
surface acoustic waves applicable to specific biological experiments such as drop PCR.
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General conclusions and outlook
The purpose of this thesis is the development and use of integrated microfluidic platforms
for the analysis and evolution of an enzyme of therapeutics interest.
In the four first chapters, the L-asparaginase enzyme is detected, analyzed and screened
through the developed microfluidic platforms. Those platforms have been validated for active
enzyme variants with the E. coli strain of L-asparaginase, and also for low activity variants
with the human strain of L-asparaginase. To optimize those platforms, three expression
vectors of the enzyme are produced, used and compared: cytoplasmic, display and periplasmic
expressions. We used the E. coli L-asparaginase as a positive control. As a validation step,
the enzymatic activity is shown to be detectable in monodisperse droplets for the display and
the periplasmic expressions, while for the enzymatic activity in the cytoplasmic expression, it
does not come out of the background. We need to take into account that for detecting an
activity within the cytoplasmic expression, a lysis step must be done inside the droplets to be
able to detect the enzymatic activity. Therefore, the display and the periplasmic expressions
were the best suitable expressions for the analysis of the human L-asparaginase, for practical
reasons. Based on these validations, we are now at a step where libraries can be systematically
analyzed and screened, a step of importance for drug discovery.
In addition, new droplet-based microfluidic modules have been developed based on
surface acoustic waves as an alternative to electrocoalescence. The preliminary results obtained
provide promising analysis theoretically and experimentally. A pair of droplets is merged by
surface acoustic waves on demand triggered by a fluorescence detection. Those results can be
applied to general biochemical experiments, as the merging of two drops to start a reaction.
These modules might provide new options for the manipulation of droplets, going beyond the
current capabilities of droplet-based microfluidics.
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Outlook
The results for the screening of the human L-asparaginase provided in chapter 4 are
promising. Although no mutants have been clearly identified yet, the screening method is
running and fully optimized.
Another version of human L-asparaginase enzyme is actually tested in the laboratory. The
preliminary researches can be seen in the thesis of Mickaël Morvan. This enzyme is the human
1 L-asparaginase and is 1000-fold less active than E. coli strain and more than two time active
compare to the human 3 strain. The results are still at the initial step but promise great
progress in the analysis of the L-asparaginase enzyme. Microfluidic tools are developed and
prepared and based on electrocalescence or surface acoustic waves for any challenges that will
occur.
As for the project in collaboration with Pr. Thomas Franke, the preliminary results must
be improved with an enhancement of the design for the microfluidic platform to contribute at
a high-throughput merging and to apply this platform to biological experiment.
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